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Thesis Portfolio Abstract 
Reduced social functioning is a key characteristic of the psychosis 
continuum. However, it is currently unclear how effective a range of psychological 
interventions are in improving social functioning in at risk mental states (ARMS) 
and first episode psychosis (FEP) populations. One treatment target that has 
received increased interest is social cognitive function. However, there has not yet 
been a comprehensive analysis of the literature investigating the relationship 
between social cognition, social functioning, and psychotic symptomatology. To 
this end we conducted a systematic review and meta-analysis to determine the 
effectiveness of psychological interventions on social functioning, and to determine 
the nature of relationship between social cognition, social functioning and 
psychotic symptoms in ARMS and FEP. Our systematic review demonstrated that 
CBT, multicomponent and service level interventions have efficacy in FEP, whilst 
there is currently no evidence that CBT, and limited evidence that other therapeutic 
modalities, are efficacious in improving social functioning in ARMS populations.  
Overall methodological quality was highly variable and there was a high risk of 
bias in many domains. Our meta-analysis revealed that in ARMS participants, 
better overall social cognitive performance and emotion recognition were related to 
better social functioning, and better emotion recognition performance was related 
to lower psychotic symptoms. In FEP, significant relationships were identified in 
all domains indicating that better social cognitive performance is related to 
enhanced social functioning and lower psychotic symptoms. Effect sizes for all 
meta-analyses were small (range r=0.1 to 0.3). Together, our findings indicate that 
there is a need for future trials targeting social functioning, particularly in ARMS 
populations. Moreover, considering the consistent significant relationship between 
  
social cognitive performance, social functioning and psychotic symptoms, interventions 
designed to target social cognition specifically in ARMS and FEP may prove beneficial in 
improving deficits in this domain, and potentially functioning and psychotic 
symptomatology.   
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1.1. Overview of Introduction  
The following section aims to introduce the key concepts, definitions, literature and 
theoretical models of relevance to this thesis. Psychosis and the psychosis continuum are 
defined and described, followed by a discussion of the Clinical Staging Model, the at-risk 
mental state concept and First Episode Psychosis.  Next, the evidence indicating that social 
functioning is impaired along the psychosis continuum is reviewed.  Social cognition is 
described and along with the commonly investigated subdomains, and the literature 
indicating that social cognitive deficits are apparent at different stages along the psychosis 
continuum, is outlined.  Following this, key psychological models that are important for 
understanding how social functioning and social cognition are affected in psychosis are 
outlined, along with a conceptual framework linking social cognition, positive and 
negative symptoms and social functioning. Finally, the thesis aims and hypothesis are 
described in the final section of this General Introduction. 
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1.2. The Psychosis Continuum   
In its broadest usage, the term psychosis refers to a set of symptoms which 
can occur in a number of psychiatric, neurodevelopmental, neurological and 
medical conditions (Arciniegas, 2015). The Diagnostic and Statistical Manual of 
Mental Disorders (5th ed.; DSM–5; American Psychiatric Association, 2013) 
defines psychotic symptoms as hallucinations in any sensory modality and/or 
delusions. When they occur in an organic condition they are referred to as 
secondary psychoses, whilst in the absence of any clear organic cause, are referred 
to as a primary affective or non-affective psychotic disorder (Arciniegas, 2015). 
Psychiatric nosology has produced discrete categorisations to identify and diagnose 
individuals presenting with particular combinations of positive symptoms 
(hallucinations and delusions) and negative symptoms which include  reduced 
initiation of goal directed behaviour (avolition), range and intensity of emotional 
expression (affective flattening) fluency and production of speech and thought 
(alogia) and expectation and experience of pleasure (anhedonia; DSM-5, 2013).  
Psychotic disorders, such as schizophrenia, are associated with significant 
personal and societal burden. Chronic course schizophrenia is associated with a 
reduced life expectancy of approximately 10 years and accounts for a 
disproportionate amount of disability when compared to all other health conditions 
(Rossler, Salize, van Os, & Riecher-Rossler, 2005). The impact of psychosis 
extends beyond the individual, impacting significantly on the family and carers of 
those who develop a psychotic disorder (Onwumere, Shiers, & Chew-Graham, 
2016). In a comprehensive analysis of studies conducted between 1950 and 2009, 
the incidence of  all new cases of psychoses in England during this time period was 
31.7 per 100,000 person-years, with the peak age of onset in the early twenties 
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(Kirkbride et al., 2012). Prior to the age of 45 years, incidence rates were higher in men, 
after which point there was no gender difference, and rates were higher in ethnic minority 
groups (Kirkbride et al., 2012).  In addition, the Adult Psychiatric Morbidity Survey 
estimated the prevalence of psychotic disorders in England as 0.7% of adults aged 16 and 
over (McManus, Meltzer, Brugha, & Bebbington, 2009). Findings in England are in line 
with the wider international literature (Häfner, 2000; McGrath et al., 2004).  
Despite the clinical and research utility of discrete psychiatric diagnostic 
categories, there has been a move in recent decades towards understanding psychosis, and 
psychotic disorders, as representing a continuum of interrelated and overlapping mental 
health conditions (Guloksuz & van Os, 2018). This is an area of ongoing debate (Curtis & 
Derks, 2017), however, there are some key points which lend weight to adopting this 
perspective. The most commonly researched psychotic disorder is schizophrenia, yet it 
represents only 30% of the of the broader psychosis continuum of disorders (Perälä et al., 
2007), in which patients have the worst outcomes. As such, an overly exclusive focus on 
the aetiology and treatment of schizophrenia will potentially miss a large number of 
individuals who experience psychotic symptoms, and will thus not be representative of the 
wider population. Recent studies have demonstrated that subthreshold psychotic 
experiences are common in the general population, with incidence rates around 2.5% 
(Linscott & Van Os, 2013). In addition, it appears that although psychotic like experiences 
have some predictive value in identifying who will later develop a psychotic disorder,  the 
combination with affective disturbance and motivational impairments produces a much 
greater risk of psychotic disorder in the future (Dominguez, Saka, Lieb, Wittchen, & van 
Os, 2010; Hanssen, Bak, Bijl, Vollebergh, & Van Os, 2005). Thus psychotic symptoms 
alone are a poor indicator of the potential to progress to a psychotic disorder, and it has 
been proposed that psychosis is best viewed as a marker of severity of psychopathology 
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more broadly, and as a transdiagnostic symptom of the psychosis continuum 
(Guloksuz & van Os, 2018). 
 
1.2.1. The Clinical Staging Model  
The clinical staging model of psychosis (McGorry, Hickie, Yung, Pantelis, 
& Jackson, 2006), has largely been adopted in research and clinical settings to 
identify and provide treatment to individuals at the earliest possible time point. 
Within the clinical staging model, the current view is that there are three key stages 
in which to identify and treat individuals with varying severity of symptoms (see 
Figure 1.1.). The first stage is the ‘at-risk’ period prior to the onset of frank 
psychotic symptoms; the second stage is the early detection and intervention for 
individuals who have developed a FEP and frank psychotic symptoms; and the 
third stage is the critical period post diagnosis of FEP, which is most commonly 
viewed to be up to five years (McGorry et al., 2006; McGorry, Killackey, & Yung, 
2008).   
 
 
 
 
 
 
 
 
 
 
Figure 1.1. The Clinical Staging Model of Psychosis. Three key phases are identified across the 
psychosis continuum. 1. The at risk phase during which the individual may experiences elevated levels 
of general psychopathology (e.g. anxiety, low mood) and low level/ transient psychotic symptoms; 2. 
The first episode phase during which the individual has crossed a threshold to frank psychosis and 
presents to services for treatment; 3. The recovery or ongoing symptom phase during which the 
individual may recover fully and all psychotic symptomatology may remit, or some level of psychotic 
symptomatology may persist.  
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1.2.2. The At Risk Mental State Concept   
A prodromal phase of psychosis has been recognised since the early 20
th
 century 
(Fusar-Poli et al., 2013). However, the ‘at risk’ concept was first fully operationalized just 
over two decades ago, with a set of standardised criteria to identify individuals as being at 
Ultra-High-Risk (UHR) of  developing a psychotic disorder (Yung & McGorry, 1996). In 
addition to UHR, there are a number of different terms in the literature referring to this 
period of illness including clinical high risk for psychosis (CHR) and at-risk mental state 
(ARMS). Herein, the term ARMS will be used to refer to UHR, prodromal and CHR.  
 Since the introduction of the UHR concept, there has been a rapid growth of 
studies utilising this criteria to investigate the risk factors and aetiological mechanisms 
involved in the development of psychosis (McHugh et al., 2018). In addition, there have 
now been a number of substantial clinical trials of psychological interventions to improve 
outcomes and prevent the progression to frank psychosis in ARMS individuals (see 
Chapter 2 for review of trials).  
The gold standard measure for identifying ARMS individuals is the clinician 
administered Comprehensive Assessment of At Risk Mental States (CAARMS; Yung et 
al., 2005). However, other measures for identifying individuals at risk of developing 
psychosis include the  Structured Interview  for  Prodromal  Syndromes (SIPS), the  Scale  
of  Prodromal  Symptoms (SOPS; Miller et al., 2003), and Early Recognition Inventory 
(Häfner et al., 2004).  
The CAARMS was developed for clinical and research use and defines individuals 
as UHR for developing psychosis if they fall into one or more of three categories; 1. 
Attenuated psychotic symptoms; 2. Brief limited intermittent psychotic symptoms; 3.Trait 
vulnerability group (see Table 1.1. for details).  In addition, the individual must be 
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between 15 and 25 years-of-age, have been referred to a specialised service for 
support, and have experienced a decline in functioning lasting at least one month 
during the past year, or sustained low functioning (Yung et al., 2005).  
Despite the utility of the CAARMS in identifying ARMS individuals, only a 
proportion of these individuals will subsequently transition to develop a full 
psychotic episode. For example, in an Australian sample of individuals identified as 
UHR, 34.9% developed psychosis during a 10-year follow-up period (Nelson et al., 
2013), and when key predictor variables are combined using complex statistical 
modelling in empirical studies, the predictive value is, at best, around 80% 
(Thompson, Marwaha, & Broome, 2016). As such, there is ongoing debate 
regarding the utility and validity of the ARMS concept (Fusar-Poli, 2018; Fusar-
Poli et al., 2013).  
In those individuals who do transition to frank psychosis, the factors driving 
this are still not fully understood. Social functioning and social cognition are two 
factors which have become an area of significant interest, and will be discussed 
further below. 
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Table 1.1. The Ultra High Risk (UHR) Criteria 
Group Criteria 
Vulnerability 
Group (state and 
trait risk factors) 
1
st
 degree relative with psychotic disorder OR schizotypal 
personality disorder in patient  
Significant decline in mental state or functioning (30% drop in 
SOFAS), maintained for at least 1 month, during the past 12 
months Or sustained low functioning for 1 year or longer (SOFAS 
score of 50 or less functioning during the past month  
Attenuated Positive 
Psychotic 
Symptoms 
1 or more of the following symptoms: ideas of reference, odd 
beliefs or magical thinking, perceptual disturbance (visual, 
auditory, olfactory, gustatory, tactile or somatic), paranoia, 
disorganised speech.  
Symptoms must occur at least 3-6 times per week, lasting more 
than one hour. Or daily, lasting one hour or more 
Symptoms must be present for the past year.  
Symptoms must be present for 1 week or more but less than or 
equal to 5 years.  
Significant decline in mental state or functioning (30% drop in 
SOFAS), maintained for at least 1 month, during the past 12 
months Or sustained low functioning for 1 year or longer (SOFAS 
score of 50 or less functioning during the past month  
Brief limited 
intermittent 
psychotic symptoms 
Transient psychotic symptoms: 1 or more of the following 
symptoms: ideas of reference, odd beliefs or magical thinking, 
perceptual disturbance (visual, auditory, olfactory, gustatory, 
tactile or somatic), paranoia, disorganised speech. 
Symptoms must be continuous/ occur several times per week 
Symptoms must have occurred during the past year.  
Symptom episode must have lasted for less than one week and 
spontaneously remitted 
Significant decline in mental state or functioning (30% drop in 
SOFAS), maintained for at least 1 month, during the past 12 
months Or sustained low functioning for 1 year or longer (SOFAS 
score of 50 or less functioning during the past month  
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1.2.3. First Episode Psychosis   
The concept of first episode psychosis (FEP) appears self-explanatory in 
that, an individual must cross a threshold to meet diagnostic criteria for one of the 
major non-affective or affective psychotic disorders, and this must be the first time 
they have presented to services for treatment and met these criteria (Fusar-Poli et 
al., 2016).  However, there are some variations in definition and conceptualisations 
in the literature which are important to outline. In addition to FEP, other terms 
include; early schizophrenia, early psychosis, recent-onset schizophrenia, early 
phase schizophrenia, early stage schizophrenia and early course schizophrenia 
(Newton et al., 2018). Even more problematically, there is variation in the 
definition of these terms regarding number of episodes, duration of symptoms, and 
severity of symptoms. In many studies it is unclear if participants are in an acute 
phase or stable remission, and the ‘cut-off’ number of years in which someone is 
still considered to be in the FEP phase of illness varies from less than one year to 
less than five years (Newton et al., 2018). Clearly, there is a need for greater 
standardisation in definition and terminology of what constitutes a FEP. However, 
for the purpose of this thesis, FEP is considered to be within five years of 
developing frank psychotic symptoms and/or presenting to services for treatment 
within this period (McGorry et al., 2008).  
 
1.2.4. Early Intervention in Psychosis  
Until the 1980s, progress in early intervention in psychotic disorders was 
hampered by the legacy of the Kraepelinian view of psychotic disorders, 
particularly schizophrenia, as neurodegenerative diseases with an invariably poor 
long term outcome (Zubin, Oppenheimer, & Neugebauer, 1985). However, 
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following seminal research conducted in the early 1980s, (Crow, MacMillan, Johnson, & 
Johnstone, 1986; Kane, Rifkin, Quitkin, Nayak, & Ramos-Lorenzi, 1982; Lieberman et al., 
1992) early intervention (EI) services were established, first in Melbourne, Australia, then 
in Europe and North America (Edwards & McGorry, 2002; McGorry, Edwards, 
Mihalopoulos, Harrigan, & Jackson, 1996). The key aim of EI services is to identify and 
provide treatment to individuals who have developed a FEP, so as to promote the best long 
term outcomes. In the UK, EI services were introduced by the National Service Framework 
in 1999 (Department of Health, 1999). Some of the key randomised controlled trials 
(RCTs) of early intervention services include the EPPIC trial in Australia (McGorry et al., 
1996), the OPUS trial in Denmark (Petersen et al., 2005), and the Lambeth Early Onset 
(LEO) trial in the UK (Craig et al., 2004). The most comprehensive of these trials was the 
OPUS which had a large sample and followed patients for up to 10 years; at the 2 year time 
point the treatment group had significantly lower psychotic symptoms and higher general 
functioning (Bertelsen et al., 2008; Secher et al., 2014). The EPPIC trial has received 
criticism due to its methodology (Raven, 2013) and the LEO trial found only significant 
differences in hospital readmissions and not in relapse rates between the treatment and 
control group.  Nonetheless, it is now widely accepted that psychological and functional 
outcomes for individuals presenting with psychosis are better when identified as early as 
possible, and treatment is provided within an EI model, rather than within a general 
community mental health team. As such, EI is now a standard of care in the UK for 
individuals suspected of having a FEP (National Institute for Health and Care Excellence, 
2014).  
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1.3. Psychosis and Social Functioning 
Social functioning broadly refers to an individual’s capacity to engage in 
meaningful activities (e.g. work and leisure activities), and their ability to develop 
maintain interpersonal relationships (Couture, Lecomte, & Leclerc, 2007). A range 
of different measures are used in the literature and clinically to assess social 
functioning (see Table 1.2. below for commonly used measures). As noted above, 
part of the diagnostic criteria for ARMS is impaired social functioning, and such 
impairments have been recognised as a significant difficulty in those who develop a 
psychotic disorder (Hodgekins et al., 2015). Negative symptoms and 
neuropsychological impairments have previously been identified as key factors 
driving functional impairments in ARMS populations (Cotter et al., 2014). It has 
been reported that the level of social functioning impairment in ARMS participants 
is not significantly different to FEP participants or those who have had multiple 
psychotic episodes (Addington, Penn, Woods, Addington, & Perkins, 2008).  
However, this study measured social functioning using the Social Functioning 
Scale (Birchwood, Smith, Cochrane, Wetton, & Copestake, 1990) and different 
results have been reported when the analysis has used a different outcome measure. 
For example, in a comprehensive study using the Time Use Survey (Hodgekins et 
al., 2015), the average number of hours per week spent in structured activity was 
compared in ARMS and FEP participants. In this study, 45 hours of structured 
activity per week was identified as the cut-off for ‘normal’ levels of functioning. 
The following rates of social disability were identified: for ARMS participants 
28.6% had no disability (≥45 hours), 21.1% were at risk of social disability (>30 
hours < 40 hours), 21.6% had social disability (>15 hours ≤ 30hours) and 28.6% 
had severe social disability (≤15 hours). In FEP participants 18.9% had no 
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disability, 13.5% were at risk of social disability, 17.9% had social disability, and 49.7% 
had severe social disability (Hodgekins et al., 2015). The difference between ARMS and 
FEP participants was statistically significant, indicating that when a more sensitive 
measure of social functioning is employed, social functioning impairments are greater 
following the development of a FEP in comparison to being in an ARMS (Hodgekins et 
al., 2015). 
The degree to which impaired social functioning precedes, or is a result of, 
psychotic symptomatology, is unclear. However, psychological models have been 
developed which provide some indication of this direction of effect and highlight the 
importance of social functioning as a treatment target (see Section 1.6. below). 
Importantly, in individuals diagnosed with a psychotic disorder, it has been reported that 
only around half return to normal social functioning and can engage in meaningful 
activities such as competitive employment (Harrison, Croudace, Mason, Glazebrook, & 
Medley, 1996; Tsai et al., 2001). The combination of a decline in social functioning along 
with co-morbid psychopathology (e.g. depression and anxiety) appears to be most 
predictive of long term social functioning impairments (Fowler et al., 2010). As such, there 
has been increased effort to better understand the psychological processes involved in 
functional outcomes, particularly social functioning, in psychotic disorders, and to develop 
better psychological interventions to alleviate these difficulties (see Chapter 2 for review 
of interventions; (Devoe, Farris, Townes, & Addington, 2018; Fowler et al., 2010; 
Hodgekins et al., 2015). One psychological process that has received increased attention in 
functional outcomes in psychosis is social cognitive functioning.  
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Table 1.2. Commonly used measures of social functioning 
Type of 
Measure  
Social 
Functioning 
Measure 
Measure Description Outcomes Available Psychometric 
Properties 
References 
Clinician Rated  SOFAS 10 anchor points assessing  social, 
occupational, academic, and 
personal functioning  
One item score (0-100) 
where higher score equals 
better functioning .  
Interrater reliability: ICC=0.94, 
good convergent and discriminant 
validity  
Burns & Patrick, (2007); 
Hilsenroth et al., (2000). 
 GAF-F  10 anchor points assessing social, 
occupational, family and work/ 
academic domains 
One item score (0-100) 
where higher score equals 
better functioning . 
Correlations between self and 
expert ratings on the GAF have 
shown to be highly correlated (r= 
0.62 p<0.001)  
Bodlund, Kullgren, 
Ekselius, Lindström, & 
von Knorring, (1994); 
Burns & Patrick, (2007). 
 GFS 10-item measure assessing the 
quality of peer relationships, level of 
peer conflict, age appropriate 
intimate relationships and 
involvement with family members 
scoring range of 1-10 
with 1 representing severe 
dysfunction and 10 
representing superior 
functioning 
excellent interrater reliability (α= 
0.78-0.84), good convergent 
validity (total score r=0.59) when 
tested in a FEP sample of 
participants, and good 
discriminant and good predictive 
validity in an ARMS populations  
Cornblatt et al., (2007); 
Piskulic, Addington, 
Auther, & A Cornblatt, 
(2011) 
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Type of 
Measure  
Social 
Functioning 
Measure 
Measure Description Outcomes Available Psychometric 
Properties 
References 
 SAS-II 53-item instrument assessing work 
role, immediate family relationships, 
extended family relationships, sexual 
functioning, romantic involvement, 
parental role, social leisure activities 
and personal well-being 
Total score in each 
domain, and overall total 
score 
Limited psychometric data 
available. Self and expert ratings 
on this scale have been shown to 
be highly correlated (r =0.72) and 
it differentiates participants 
diagnosed with schizophrenia and 
those without  
Glazer, Prusoff, John, & 
Williams, (1981); 
Schooler et al., (1979); 
Weissman & Bothwell, 
(1976). 
 RFS Four rating scales assessing the 
following domains of social 
functioning; work productivity, 
independent living and self-care, 
immediate social network 
relationships and extended social 
network relationship 
Total score in each 
domain, and overall total 
score 
Good discriminant validity, 
construct validity, inter-rater 
reliability (r= 0.64-0.92) and test-
retest reliability (r=0.85-0.92). 
Goodman et al., (1993); 
Strauss & Carpenter, 
(1977). 
 TUS Semi-structured interview assessing 
time spent in employment, 
education, voluntary work, leisure 
activities, childcare, housework and 
chores 
Weekly average hours 
spent in each activity  
Good discriminant validity in 
differentiating social functioning 
between ARMS individuals and a 
non-clinical sample (all p<0.007, 
except for sporting activities 
Gee et al., (2016); 
Hodgekins, French, et 
al., (2015). 
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Type of 
Measure  
Social 
Functioning 
Measure 
Measure Description Outcomes Available Psychometric 
Properties 
References 
Self-reported SFS 79 items assessing social 
engagement/withdrawal, 
interpersonal 
behaviour/communication, 
participation in prosocial activities, 
participation in recreational 
activities, independence-competence 
(perceived ability to complete tasks 
of everyday social functioning), 
independence performance (rate of 
completion of tasks of everyday 
social functioning), 
employment/occupation 
SFS total score which 
ranges from 0-236, with 
higher scores indicating 
better social functioning 
Good internal consistency 
(Cronbach's α= 0.69- 0.87) in 
schizophrenia.  
Differentiates between ARMS 
and non-ARMS individuals  
 Addington et al., (2008); 
Addington et al., (2017); 
Birchwood et al., (1990); 
Burns & Patrick, (2007); 
Jang et al., (2011). 
 SAS-SR 54-item instrument assessing work, 
social and leisure activities, family 
relationship, marital relationship, 
parental role, and role within the 
family unit 
Total score in each 
domain, and overall total 
score 
Significant inter-correlation 
between informant and patient 
(0.74) and interviewer and patient 
(0.70; 
Weissman & Bothwell, 
(1976). 
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Type of 
Measure  
Social 
Functioning 
Measure 
Measure Description Outcomes Available Psychometric 
Properties 
References 
 SBS Assesses a number of behaviours: 
communication, sociability, 
depression, anxiety, suicidality, odd 
ideas, restlessness, socially 
unacceptable habits or manners, 
violence, sexual behaviour, self-care, 
activity and speech, attention 
Score for each individual 
behaviour and two global 
scores: the severe 
behaviour score (BSS) 
and mild and severe 
behaviour score (BSS) 
inter-rater reliability (α= 0.94), 
and inter-informant reliability 
(α=0.91), are excellent; test-retest 
reliability (α=0.70) and Inter-
setting reliability (α=0.70) are 
acceptable 
Wykes & Sturt, (1986) 
GAF-F, Global Assessment of Functioning- Functioning subscale;  GFS; Global Functioning: Social Scale; RFS; Role Functioning Scale; SAS-II, Social Adjustment 
Scale 2
nd
 Edition; SAS-SR, Social Adjustment Scale- Self Report; SBS, Social Behaviour Schedule; SFS; Social Functioning Scale ; SOFAS, Social and Occupational 
Functioning  Assessment Scale;  TUS, Time Use Survey. 
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1.4. Social Cognition  
Social cognition is an umbrella term which refers to set of cognitive 
processes by which the individual perceives, interprets and processes social 
information (Green et al., 2008). It is considered to be a fundamental function of 
the human mind (with varying degrees apparent in other animals) which confers 
survival advantages; allows humans to learn through the consequences of other 
individuals experiences (social learning/ social referencing); underpins the ability 
to infer the intentions, desires, beliefs, wants and needs of people in the social 
environment; is the cognitive means by which humans can create a shared world 
and interact through symbols, myths, language, culture and religion; and provides 
the capacity to co-operate in small and large societies (Frith & Frith, 2007).  
Considering the role of social cognition in all of human social life, normal social 
cognitive functioning is believed to underpin general social functioning capacity 
(Schönherr, 2017) 
Within the empirical literature, there is some variation in the specific 
subdomains of social cognition. However, most commonly the key subdomains 
include emotion recognition, theory of mind (ToM), social perception and 
attributional bias (Pinkham et al., 2014). It is important to note that social cognition 
is conceptualised as distinct, but not independent of, neuropsychological functions 
such as episodic memory or executive function. For example, verbal 
comprehension and perceptual reasoning are related to a number of social cognitive 
measures (Henry, Von Hippel, Molenberghs, Lee, & Sachdev, 2016), and if an 
individual has a primary memory or executive functioning impairment, then aspects 
of social cognition may also be affected (Pinkham & Penn, 2006).  
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There is now a significant literature across all the major psychiatric diagnoses, 
neurodevelopmental disorders and neurodegenerative diseases, indicating that social 
cognitive impairments are apparent, and quite pronounced, across these conditions (Cotter 
et al., 2018). As such, social cognitive dysfunction has been proposed as a transdiagnostic 
clinical marker of psychopathology and neurological disease (Cotter et al., 2018; Henry et 
al., 2016).  
 
1.4.1. Emotion Recognition 
Emotion recognition is defined as the ability to identify others’ emotions through 
facial expressions, vocal prosody and body language (Pinkham et al., 2014). In addition, 
emotion processing refers to the ability to recognise and regulate one’s own emotions, but 
is measured distinctly, and so will be considered here as a separate domain of 
psychological function from emotion recognition. However, it should be noted that the 
ability to identify others emotion and the ability to label and regulate one’s own emotions 
are not mutually exclusive. A number of assessment methods have been developed to 
determine an individual’s emotion recognition capacity (see Table 1.3. for description of 
common tests), which have their foundation in the work by Paul Ekman (Ekman & 
Friesen, 1976) who was inspired by Darwin’s proposition of universal facial expressions of 
emotion (Darwin, 1872). Ekman and colleagues developed a set of standardised pictures of 
individuals expressing six basic emotions of happiness, sadness, anger, disgust, fear and 
surprise (Ekman & Friesen, 1976). Basic emotion is distinguished from complex emotion 
in that each basic emotion is a discrete category which can be observed and expressed 
alone, whereas a complex emotion may be a combination of basic emotions to create a new 
category (e.g. disgust and anger to form contempt). Since this early work, many variations 
on the presentation of facial emotional expressions have been developed (e.g. incremental 
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intensity of emotion, obscuring particular parts of the face, inverting faces etc), 
which have led to further understanding of the psychological and neurobiological 
processes underpinning facial emotion recognition. In addition to interpreting facial 
expressions, there has been some work in understanding emotion recognition of 
vocal prosody; variations in speech such as pitch, contour, duration and intensity, 
which convey particular emotional states (Besson, Magne, & Schön, 2002).  
 
1.4.2. Theory of Mind  
Theory of Mind (ToM) is the ability to infer more complex mental states in 
others such as beliefs, intentions, desires, needs and goals (Green, Horan, & Lee, 
2015), and is sometimes referred to as cognitive empathy, mental state attribution 
or mentalizing (Fonagy, 2018; Pinkham et al., 2014). In the literature, ToM is 
sometimes separated into cognitive and affective ToM (Arioli, Crespi, & Canessa, 
2018). However, the degree to which these represent distinct constructs is unclear. 
The pioneering work by Simon Baron-Cohen and colleagues with individuals with 
Autism Spectrum Disorders, spearheaded our understanding of ToM in the broader 
context, and introduced assessment methods to determine an individual’s ToM 
capacity (Baron-Cohen, Leslie, & Frith, 1985). Since then, a number of 
assessments of ToM have been introduced (see Table 1.3. for details). 
 
1.4.3. Social Perception  
Social perception includes social context processing and social knowledge, 
and involves the capacity to understand social rules, roles and goals, and how these 
influence how the self and others behave (Pinkham et al., 2014). Social processing 
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and social knowledge are commonly assessed independently using a number of different 
measures (see Table 1.3. for details).  
 
1.4.4. Attributional Bias 
Attributional bias refers to the tendency to utilise particular cognitive processing 
patterns to make sense of social events and interactions (Pinkham et al., 2014). A number 
of attributional biases have been discussed in the literature in both clinical and non-clinical 
populations. Indeed, all humans are vulnerable to these cognitive biases to varying degrees. 
However, when particular biases become the default cognitive process or the common 
mode in which an individual makes sense of the social world, problematic psychological 
and behavioural consequences may ensue. The key biases that have received the most 
attention in psychosis are the ‘jumping to conclusions bias,’ ‘hostile attribution bias,’ 
‘externalizing bias’ and ‘personalising bias’ (Bentall et al., 2009; Brookwell, Bentall, & 
Varese, 2013; Combs, Penn, Wicher, & Waldheter, 2007; Garety et al., 2011; So, Tang, & 
Leung, 2015; Thompson, Papas, Bartholomeusz, Nelson, & Yung, 2013). The jumping to 
conclusions bias refers to a tendency to draw conclusions in social situations based on 
limited information (Garety et al., 2011). The hostile attribution bias refers to the tendency 
to interpret ambiguous actions of others as indicative of hostile behaviour towards the self 
(Combs et al., 2007). The externalizing bias refers to the tendency to make external 
attributions for negative events (Brookwell et al., 2013), and the personalising bias refers 
to the tendency to blame other individuals for negative events (So et al., 2015). As noted 
above, social cognition and neuropsychological functions are not entirely independent of 
one another. Indeed, there is evidence that executive functioning impairments may 
underpin the Attributional Biases exhibited by individuals with psychosis (Berry, Bucci, 
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Kinderman, Emsley, & Corcoran, 2015). A number of measures have been 
developed to determine attributional biases an individual may exhibit (see Table 
1.3. for details).  
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Table 1.3. Common social cognitive assessments used to determine performance on each subdomain 
Social 
Cognitive 
Domain 
Social Cognitive Test Test description Outcome Measures Reference 
Emotion 
Recognition 
Bell Lysaker Emotion 
Recognition Task 
(BLERT) 
Participants view 21, 10 sec video clips in which a male actor 
expressed emotions through facial expressions, upper body 
movements and vocal tone. Participant chooses one of seven 
emotions that they think the man is expressing; happiness, sadness, 
fear, disgust, surprise, anger, or no emotion 
Total number correct  Bryson, Bell, & 
Lysaker, (1997) 
 Penn Emotion 
Recognition Task (ER40) 
Participants are presented with 40 colour photos of static faces 
expressing 4 emotions; happiness, sadness, anger, fear or neutral. 
Faces are balanced on gender, age and ethnicity. The stimuli-set 
includes four high and four low intensity expressions. Participants 
choose which emotion they think is correct.  
Total number correct Christian G Kohler 
et al., (2003) 
 Ekman 60 faces Participants are presented with 60 black and white photos of static 
faces expressing one of 6 emotions; anger, disgust fear, happiness, 
sadness, surprise or neutral.  
Total number correct out of 60 
Total correct for each emotion 
out of 10.  
Ekman & Friesen, 
(1976) 
Theory of 
Mind: 
Reading the Mind in the 
Eyes Task 
Participant is presented with 36 images of a person’s eye s and a 
choice of four mental states. Participant choses one of four mental 
states  
Total number correct Baron-Cohen, 
Wheelwright, Hill, 
Raste, & Plumb, 
(2001) 
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Social 
Cognitive 
Domain 
Social Cognitive Test Test description Outcome Measures Reference 
 The Awareness of Social 
Inferences Test (TASIT) 
Participates are presented with video clips of every day social 
interactions and answer four standard questions for each video that 
seek to determine the individuals understanding of th e beliefs, 
intentions and meaning of the actors in the clip. Note: The TASIT 
also consists of an emotion recognition condition which tests the 
ability of an individual to identify six basic emotions; happiness, 
surprise, anger, sadness, fear and disgust, and their ability to 
discriminate these from neutral expressions.   
Form B and C, average 
number correct.  
McDonald, 
Flanagan, Rollins, 
& Kinch, (2003) 
 Hinting Task Participants are presented with 10 short passages in which 2 
characters interact. One character drops a hint at the end of each 
passage indicating what their true intention is. Participants must 
provide an account of the characters true intent. A second hint is 
provided if participants first answer is incorrect.  
Total number correct (0-20) 
 
Corcoran, Mercer, 
& Frith, (1995) 
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Social 
Cognitive 
Domain 
Social Cognitive Test Test description Outcome Measures Reference 
 Faux-Pas Recognition 
Test 
Participants are read 20 short stories; 10 Faux Pas Stories and 10 
control stories. After each, they are asked if anyone in the story 
said something they shouldn’t have or said something socially 
awkward. Participants are also asked questions to assess their 
understanding of a characters intentions, beliefs and to assess the 
participants capacity for empathy.  
A ratio score of % correct for 
Faux Pas and Control stories 
is calculated for each 
component; control questions 
score; Faux Pas Detection 
Score; Understanding 
Inappropriateness score; 
Intentions score; Belief score; 
Empathy score. 
Stone, Baron-
Cohen, & Knight, 
(1998) 
Social 
Perception 
Situational Feature 
Recognition Test (SFRT) 
Participants are presented with 9 different situations, such as 
‘swinging a bat’ and a list of 14 actions and 14 goals. Participants 
must choose the actions and goals that are most relevant to the 
situation. Participants also rate how familiar or unfamiliar each 
situation is on a 7-point scale (1=extremely familiar to 
7=extremely unfamiliar)  
Correct identification rate of; 
concrete/abstract  features in 
familiar /unfamiliar situations; 
false positive rate of 
concrete/abstract  features in 
familiar /unfamiliar situations 
Corrigan & Green, 
(1993) 
 Relationships Across 
Domains (RAD). 
Participants are presented with 25 vignettes of a male-female dyad 
interacting. Following each vignette, 3 yes or no questions are 
completed in which the participant has to determine if a stated 
behaviour in the question is likely to be true based on their 
knowledge of the dyad from the vignette.   
Total % Correct  Sergi et al., (2009) 
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Social 
Cognitive 
Domain 
Social Cognitive Test Test description Outcome Measures Reference 
Attributional 
style: 
Ambiguous Intentions 
and Hostility 
Questionnaire (AIHQ) 
Participants are presented with 5 hypothetical, negative situations 
with ambiguous causes. Participants are asked to imagine this 
situation occurring for them and record a reason why it has 
occurred. Participants also rate on Likert scales how angry the 
situation made the, if the other person in the scenario did it on 
purpose and how much they blame the other person. Participants 
also indicate how they would respond to the situation.  
A hostility bias and aggression 
bias is determined by 
independent raters coding 
open ended responses. A 
Blame Score is calculated 
from Likert scale questions  
Combs et al., 
(2007) 
 Attributional Style 
Questionnaire  
Participants are presented with 12 hypothetical situations and are 
asked to imagine that this has occurred for them. Participants then 
record what they believe was the major cause o of the situation. 
Participants then answer three questions with a 7-point Likert scale 
response, about the cause of the situation, and answer one question 
with a 7-point Likert scale response about the situation.  
Composite scores for 
Internality, Stability and 
Globality attributional styles 
are calculated 
Peterson et al., 
(1982) 
 Internal, Personal, 
Situational Attributions 
Questionnaire  
Participants are presented with a 32-item questionnaire which 
describes 16 positive and 16 negative social situations in the 
second person. Participants are required to write down the one 
most likely cause of the situation. Participants then categorise the 
cause as being either internal (relating to the respondent), personal 
(relating to another person) or situational.  
Externalizing Bias score 
Personalizing Bias score  
Kinderman & 
Bentall, (1996) 
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1.5. Social Cognition and Psychosis  
Social cognitive functioning in psychotic disorders has been investigated most 
extensively in individuals with a diagnosis of schizophrenia. Meta-analytic studies have 
demonstrated that individuals with longer duration schizophrenia exhibit significant 
impairments in social cognition (Bora, Yucel, & Pantelis, 2009; Kohler, Walker, Martin, 
Healey, & Moberg, 2010; Savla, Vella, Armstrong, Penn, & Twamley, 2012; Sprong, 
Schothorst, Vos, Hox, & Van Engeland, 2007). For example, it has been reported that 
individuals with a diagnosis of schizophrenia have reduced ability in identifying (Cohens d 
= −0.89) and differentiating (d = −1.09) facial emotional expressions in comparison to 
control participants (Kohler et al., 2010). Similar effect size differences have been reported 
for ToM (Hedges g=0.96) and social perception (g=1.04) in individuals with a diagnosis of 
schizophrenia (Savla et al., 2012). Indeed the central importance of social cognition in 
schizophrenia was recognised by the National Institute of Mental Health’s, Measurement 
and Treatment Research to Improve Cognition in Schizophrenia (MATRICS; (Marder & 
Fenton, 2004)  initiative, which  included the Mayer-Salovey-Caruso Emotional 
Intelligence Test in the MATRICS Consensus Cognitive Battery (August, Kiwanuka, 
McMahon, & Gold, 2012). The focus of this initiative is to better characterise the nature of 
neuropsychological and social cognitive deficits in schizophrenia and to develop treatment 
approaches to alleviate these deficits. The hypothesis driving this work is that alleviating 
neuropsychological and social cognitive deficits will produce better social functioning 
outcomes with these patients (Marder & Fenton, 2004). Indeed, a meta-analysis of the 
literature reported that social cognitive performance predicts real world outcomes in longer 
term schizophrenia, such as community functioning  (Fett, Viechtbauer, Penn, van Os, & 
Krabbendam, 2011) 
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1.5.1. Social Cognition and Social Functioning in ARMS and FEP  
Following the recognition that social cognitive function is a key factor in 
the course of longer duration schizophrenia, there has been increasing interest in 
social cognitive impairment as an indicator of vulnerability to developing 
psychosis, and as potential early intervention treatment target in ARMS and FEP 
(Glenthøj, Hjorthøj, Kristensen, Davidson, & Nordentoft, 2017). There has been 
comparatively less investigation into social cognitive function in ARMS and FEP. 
However, this is a burgeoning literature with new developments rapidly emerging. 
Recent meta-analytic studies have demonstrated that ARMS individuals exhibit 
impairments on emotion recognition tasks (d= -0.46) and ToM tasks (d= -0.44) 
with medium effect size differences from controls (Cotter et al., 2015; Van 
Donkersgoed, Wunderink, Nieboer, Aleman, & Pijnenborg, 2015). In FEP, 
significant impairments on emotion recognition (d= -0.88; (Barkl, Lah, Harris, & 
Williams, 2014) and ToM (d= -1.0; (Bora & Pantelis, 2013) have been reported, 
with large effect sizes that are comparable to those found in longer duration 
schizophrenia. The degree of impairment in social perception and the difference 
between controls and ARMS / FEP on attributional biases has not been subject to 
meta-analytic study due to a lack of studies into these two social cognitive domains. 
Nonetheless, individual studies have demonstrated that ARMS and FEP 
participants exhibit impaired social perception ability and score higher on measures 
of attributional biases (see Chapter 3 for review of studies).  
Taken together, the empirical evidence suggests that social cognitive 
difficulties are apparent across the psychosis continuum. Of note is the fact that the 
effect sizes are much greater for FEP and longer duration schizophrenia than those 
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identified as ARMS. This likely reflects the impact of increased psychotic 
symptomatology, although the mechanisms involved unclear at present.  
Similar to studies in longer duration schizophrenia, there is empirical evidence 
linking social cognitive performance and social functioning in ARMS and FEP (see 
Chapter 3 for review of studies). However, this evidence has not yet been meta-analysed.   
 
1.6. Psychological Models to Understand the Link Between Social 
Cognition, Psychotic Symptoms and Social Functioning  
 
1.6.1. Cognitive Models of Positive Psychotic Symptoms 
Two commonly utilised psychological models of psychosis were introduced by 
Garety and colleagues (Garety, Kuipers, Fowler, Freeman, & Bebbington, 2001) and 
Morrison and colleagues (Morrison, 2001). Each model draws on a stress-vulnerability 
framework to explain how hallucinations and delusions may develop and become 
pathological in some vulnerable individuals. For example, if an individual has a tendency 
to utilise the jumping to conclusions bias, they rapidly interpret ambiguous internal or 
external stimuli, coming to a decision on its meaning prior to considering disconfirmatory 
evidence (Garety et al., 2001). For example, in the classic “beads task” individuals with 
delusions tend to come to a decision on the basis of less information than those without 
delusions (Ross, McKay, Coltheart, & Langdon, 2015). As such, the individual may draw 
seemingly bizarre or unusual conclusions that do not represent what others view as reality. 
Thus, delusional beliefs about the world and others may be formed and interfere with the 
individuals functioning in various ways. In line with this, another attributional bias linked 
to the development of delusional beliefs is the externalizing bias (Bentall, Kinderman, & 
Kaney, 1994).   
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 Similarly, with regards to hallucinations, normal intrusions into awareness 
by thoughts, or auditory, visual, olfactory, gustatory or somatic sensations, are 
misinterpreted, or appraised, in such a way that the individual concludes they are 
indicative of “going crazy” or “losing my mind.” The misinterpretation or negative 
appraisal of stimuli leads to increased distress (anxiety, worry etc.), which increases 
the occurrence of similar intrusions (thoughts, bodily sensations), which are further 
misinterpreted (Morrison, 2001).  This vicious cycle continues and further 
exacerbates the experience of ‘hallucinations.’ Of relevance here, a key element of 
the Garety and Morrison cognitive model of positive symptoms, is that individuals 
will tend to withdraw socially as a coping strategy for delusions and hallucinations 
(Garety et al., 2001; Morrison, 2001). This coping mechanism, although successful 
in reducing distress associated with social activities in the short term, perpetuates 
the problem as the individual has less opportunity to be exposed to disconfirmatory 
evidence of their delusions or hallucinations.   
Taken together, it can be seen that an attributional biases and cognitive 
misinterpretations of anomalous stimuli may contribute to the development and 
maintenance of positive symptoms of psychosis leading to a reduction in social 
functioning as a coping response.  
 
1.6.2. Cognitive Model of Negative Psychotic Symptoms  
Beck and colleagues proposed a cognitive model of negative symptoms in 
psychosis (Beck, Rector, Stolar, & Grant, 2011; Rector, Beck, & Stolar, 2005). As 
with the models of positive symptoms described above, the cognitive model of 
negative symptoms draws on a stress vulnerability model to explain how negative 
symptoms of psychosis including affective flattening, alogia, volition and  
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anhedonia, may be influenced by particular negative beliefs and negative expectancies that 
may become activated in individuals vulnerable to psychosis  (Rector et al., 2005). This 
model proposes that these negative beliefs and expectancies can influence negative 
symptoms independently of the secondary effects of positive symptoms. The problematic 
cognitive appraisals associated with negative symptoms in psychosis involve low 
expectancies for pleasure, success, and acceptance, and the perception of limited personal 
resources to manage social activities.  
Low expectancy of pleasure in psychosis is characterised by thoughts such as 
“what’s the point?” or “it’s not worth it in the end” when provided with the opportunity to 
partake in pleasurable activities (Rector et al., 2005). As such, participants with psychosis 
predict less pleasure and positive emotion of engaging in pleasurable activities. However, 
when engaged in such activities they do report experiencing positive emotion, indicating 
that the motivational process to engage in activities is affected (Germans & Kring, 2000).  
Low expectancy for success in psychosis is characterised by individuals expecting 
that they will fail to meet a given goal which leads to impaired motivation and action 
(Rector et al., 2005). For example, an individual with psychosis may avoid performance 
based tasks such as making an appointment to see their doctor as they have the thought “I 
will sound odd on the phone or will not be able to make it clear why I am calling.” 
However, it should be noted that individuals with psychosis do exhibit cognitive 
difficulties that may impact their performance in various ways. However, it appears these 
cognitive difficulties do not account for all aspects of impaired goal directed action in 
psychosis and ‘defeatist’ beliefs may become reinforced in the individual when they do not 
meet there own or others expectations, and this may strengthen cognitive appraisals that 
they will not succeed (Beck et al., 2011).  
31 
 
Low expectancies for acceptance refers to the stigma attached to a diagnosis 
of a psychotic disorder, in addition to repeated failures to meet self-imposed or 
externally imposed standards and goals (Beck et al., 2011; Rector et al., 2005). 
Many individuals with psychosis may develop beliefs that they are worthless or 
incompetent and their perceived self-efficacy may be reduced, leading to a 
conclusion of “what’s the point?” (Beck & Rector, 2002), and withdrawal from 
pursuing various activities.  
Finally, perception of limited resources refers to a negative cognitive 
appraisal in which the individual with psychosis will have thoughts such as “it’s too 
much” or “it will be too much for me to handle” when presented with the 
opportunity to engage in pleasurable or meaningful activities (Rector et al., 2005). 
In some cases, this may be related to neuropsychological difficulties such as 
impaired processing speed (Basso, Nasrallah, Olson, & Bornstein, 1998). However, 
within the cognitive model of negative symptoms, cognitive appraisals of having 
limited resources to manage a given situation are viewed as an excessive cognitive 
distortion in which the individual with psychosis, in reality, has greater resources to 
manage than they perceive (Rector et al., 2005).   
Taken together, the influence of negative expectancy appraisals on the 
expression of negative symptoms in psychosis may lead to social functioning 
difficulties.  
 
1.6.3.  The Theory of Mind Model of Psychosis 
 The role of ToM difficulties in psychosis has been recognised for over two 
decades. Frith (1992) first proposed that schizophrenia may be viewed as a disorder 
of ‘self-awareness.’ In this view, three key factors combine to produce psychosis;  
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first is that there is a deficit in willed action; second, there is a dysfunction in the ability to 
self-monitor (thoughts, emotions, sensory stimuli); and third, there is a deficit in 
monitoring the intentions of others (Frith, 1992). A deficit in willed action is proposed to 
produce apathy and bizarre behaviour due to the individual having reduced awareness of 
their own intentions and difficulties recognizing their behaviour as a result of their willed 
action (Harrington, Siegert, & McClure, 2005). Reduced ability in self-monitoring 
thoughts, or sensory stimuli is proposed to result in the individual with psychosis 
misinterpreting these experiences as being external and being perceived as 
auditory/sensory hallucinations. Finally, the ability to accurately monitor the intentions of 
others may lead to erroneous interpretation of others thoughts, beliefs, intentions and 
desires, leading to delusional thinking in reference to others, and disorganised 
communication which heavily relies on the ability to interpret and predict the mind of 
others (Frith, 1992; Frith, 2014; Harrington et al., 2005).  
 
1.6.4. Conceptual Framework Linking Social Cognition and Social 
Functioning  
As noted above, psychological models of positive and negative symptoms of 
psychosis have helped to understand how such symptoms may develop and be maintained. 
Each model describes that social functioning problems may ensue due to attributional 
biases, negative appraisals of ambiguous internal or external stimuli, ToM deficits leading 
to impaired self and other monitoring, or negative expectancy appraisals of pleasure, 
success and acceptance. However, how social functioning difficulties occur in psychosis is 
conceptualised differently in each model. The cognitive models of positive symptoms 
suggest that social withdrawal is a coping mechanism as interacting with others is 
problematic when difficult experiences of hallucinations are present, or if a delusional 
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belief centres on others being the source of danger or threat (Garety et al., 2001; 
Morrison, 2001). On the other hand, the cognitive model of negative symptoms 
indicates that negative expectancy appraisals directly influence the occurrence of 
negative symptoms (Beck et al., 2011; Rector et al., 2005). An increase in negative 
symptoms may result in reduced social functioning through difficulties in 
interacting with others due to flattening of affect, low expectancies of pleasure 
derived from social interactions, low expectancy of ability to successfully complete 
social activities and avoidance of others due to reduced expectancy that others will 
accept that the individual has psychosis (Beck et al., 2011; Rector et al., 2005).  
The role of attributional biases and negative appraisals has been clearly 
outlined in each model. ToM difficulties have also been described above as regards 
to self and other monitoring difficulties may result in aberrant perceptual 
processing and social communication difficulties due to reduced ability to infer 
others intentions, desires, beliefs and emotional state. The models discussed above 
do not explicitly discuss the role of emotion recognition and social perception in 
psychosis. However, a basic model has been described in which difficulties with 
recognising others emotions or inferring social norms, may lead to distress and 
difficulties in navigating the social world, or indeed, a fear or concern of others 
intentions and withdrawal from social activities (Couture, Penn, & Roberts, 2006). 
This basic model conceptualising the interrelationship between social 
cognition and social functioning, in the context of positive symptoms is presented 
below (see Figure 1.2.).  As is shown in Figure 1.2., emotion recognition and 
social perception are considered to be more automatic and less deliberative 
responses to social stimuli than ToM and attributional biases, and so occur earlier 
in the process of exposure to experience, appraisal and subsequent behavioural 
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response (Couture et al., 2006). In this schematic, social cognitive difficulties may interact 
with the experience of hallucinations and/or delusions to impact on the individual’s ability 
to accurately make sense of their social world, leading to social withdrawal as a coping 
response.  
 
 
Figure 1.2.  Schematic outlining how social cognitive impairment may interact with positive psychotic 
symptoms and lead to social withdrawal. Adapted from Couture et al., (2006).  
 
In Figure 1.3. below a schematic indicating the interactions between social 
cognition, negative symptoms and social functioning is presented. Within this framework, 
negative appraisals of engaging in social activities may lead to reduced engagement with 
such activities and to the production of negative symptoms. In the conceptualisation below, 
negative cognitive appraisals, avoidance of social engagement and negative symptoms 
affect one another in a bidirectional fashion. Emotion recognition, ToM and social 
perception difficulties are not specifically described in the cognitive model of negative 
symptoms. However, below, we include these social cognitive functions as being involved 
in the individual’s negative appraisals of oneself and others. These social cognitive factors 
may thus contribute to the expression of negative symptoms, but may also be affected by 
negative symptomatology.  
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Figure 1.3. Schematic representation outlining the interactions between negative appraisals and other social cognitive 
functions, negative symptoms and reduced social engagement in psychosis. 
 
1.7. Psychological Interventions for Improving Social Cognition and 
Social Functioning In Psychosis  
1.7.1. Social Cognition  
In light of the fact that social cognitive impairments are a feature of the 
psychosis continuum and may be related to the development and maintenance of 
positive and negative symptoms, there has been a focus on targeting social 
cognitive performance to improve outcomes (Grant, Lawrence, Preti, Wykes, & 
Cella, 2017). In a meta-analysis of studies targeting social cognitive outcomes in 
mostly longer duration schizophrenia, post-treatment moderate to large effect sizes 
were identified for emotion recognition ability (identification d= 0.71, 
discrimination d=1.01) and ToM (d= 0.46; (Kurtz & Richardson, 2011). Fewer 
studies have targeted social perception or attributional biases in schizophrenia, 
however, there is some evidence that interventions targeting these social cognitive 
domains can improve performance (see Grant et al., (2017) for review). Grant and 
colleagues, in their systematic review of the literature concluded that there was 
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little evidence that improving social cognition led to better functional outcomes in longer 
duration schizophrenia (Grant et al., 2017). However, in an independent meta-analytic 
study, a significant improvement in facial affect recognition was associated with large 
improvements in social functioning (g= 0.98; Bordon, O'Rourke, & Hutton, 2017).  
Taken together, there is some evidence that interventions aimed at improving social 
cognitive deficits in longer duration schizophrenia are effective and may be associated with 
improved social functioning. The effects of such interventions in ARMS and FEP 
populations has received comparatively less investigation. However, some studies have 
focused on social cognitive function as the target of psychological intervention and these 
will be reviewed in Chapter 2. The degree to which targeting social cognition may lead to 
a positive outcome in psychotic symptoms and social functioning in ARMS and FEP is 
unclear at present. However, as an initial step in determining the efficacy of such 
interventions, there is a need for a systematic analysis of the empirical literature to 
determine the strength of the relationship between social cognitive performance, psychotic 
symptoms and social functioning in ARMS and FEP participants (see Chapter 3).  
 
1.7.2. Social Functioning  
An alternative to targeting social cognition to improve functional outcomes in 
psychotic disorders is to target social functioning directly. However, few psychological 
interventions have been developed which specifically target social functioning. Social 
functioning is a common outcome measure in psychological intervention studies in 
psychotic disorders, but it is unclear which psychological interventions confer the greatest 
benefits. A specified approach- Social Recovery CBT- has been introduced, and has 
demonstrated good outcomes in FEP (Fowler et al., 2018; Fowler et al., 2009). A recent 
meta-analytic study, published during the course of this thesis, concluded that no 
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psychological interventions were effective in improving social functioning in 
ARMS participants (Devoe et al., 2018). However, there are some methodological 
considerations when interpreting these findings (see Chapter 2). Moreover, the 
evidence that psychological interventions improve social functioning in FEP has 
not yet been subject to a systematic analysis.   
Taken together, individual studies suggest that psychological interventions 
can improve social functioning in FEP. However, the evidence in ARMS 
populations is conflicted at present with individual studies indicating a beneficial 
outcome (see Chapter 2 for review of studies) and one meta-analysis suggesting no 
beneficial effect. To date, no study has systematically reviewed the evidence base 
to determine if psychological interventions can improve social functioning in 
ARMS and FEP combined.  As such, there a clear need for a synthesis of the 
current evidence, comparing and contrasting the evidence in ARMS and FEP.  
 
1.8. Primary aims and hypotheses of thesis:  
Drawing on the literature reviewed above, which indicates an important 
interplay between social cognitive performance, psychotic symptomatology and 
social functioning in ARMS individuals, and those who have experienced a FEP, 
this thesis has two main aims to answer the following research questions:  
 
Aim 1: Do psychological interventions improve social functioning in ARMS and FEP 
participants? Is there a difference between intervention approaches, and do these 
have a differential effect at different stages of psychotic illness (i.e. ARMS versus 
FEP)?  
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We aimed to conduct a comprehensive systematic review of the literature to 
determine which psychological interventions are most effective in improving social 
functioning in ARMS and FEP participants.  In addition, we aimed to compare and contrast 
our findings to determine if there are apparent differences in the effectiveness of specific 
psychological interventions (e.g. CBT or cognitive remediation). We also aimed to 
compare and contrast the effectiveness of psychological interventions in improving social 
functioning between ARMS and FEP participants.  
 
Aim 2:  Is overall social cognitive performance, and performance on specific 
subdomains, related to psychotic symptomatology and social functioning in ARMS 
and FEP participants? Is there a difference in the strength and/or direction of 
relationship between social cognitive performance, psychotic symptoms and social 
functioning at different stages of psychotic illness?  
 
We aimed to conduct a comprehensive review and meta-analysis of the literature to 
determine the strength and direction of relationship between performance on social 
cognitive subdomains (emotion recognition, ToM, social perception, attributional biases), 
psychotic symptomatology (positive and negative symptoms) and social functioning, in 
ARMS and FEP participants. In addition, we aimed to conduct a quantitative between 
group analysis (ARMS versus FEP) of this data to identify differences in the strength of 
relationship between overall social cognitive performance, performance on specific 
subdomains, psychotic symptomatology and social functioning.
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2.1. Abstract 
Reduced social functioning is a key component of the at-risk mental state (ARMS) 
and first episode psychosis (FEP). However, to date, the primary outcome measure in most 
randomised controlled trials (RCTs) of psychological interventions with these populations 
has been a change in psychotic symptomatology. Considering the central role of social 
functioning in the course and development of psychosis, it is of importance to understand 
which psychological interventions are effective in improving social functioning in ARMS 
and FEP populations. An extensive literature search of four databases was conducted. 
Twenty-two studies were included that provided a social functioning outcome measure and 
investigated the efficacy of structured psychological therapy interventions. Twenty-one 
were RCTs and one a non-randomised controlled trial. Overall, there is some evidence 
from individual trials that psychological interventions are efficacious in improving social 
functioning in ARMS and FEP participants. CBT has demonstrated efficacy in FEP, whilst 
to date, there is no evidence that CBT is efficacious in improving social functioning in 
ARMS populations. Multicomponent and service interventions have reported positive 
effects for social functioning in FEP participants. Overall methodological quality was 
variable and there was a high risk of bias in many domains for many of the included 
studies. As such, these conclusions should be interpreted with caution. A small number of 
methodologically rigorous trials have demonstrated that psychological therapy can 
improve social functioning in FEP. The current evidence base for ARMS populations is 
limited. Future trials are needed to determine the efficacy of CBT and CRT in ARMS and 
FEP populations. 
                                                                                                                                                    
 
41 
 
2.2. Introduction  
Social functioning is a broad outcome referring to an individual’s ability to 
engage in meaningful activities such as work and social activities, and their ability 
to develop and maintain interpersonal relationships (Couture et al., 2007).  Reduced 
social functioning is a key characteristic of the psychosis continuum (Hodgekins et 
al., 2015), and a decline in social functioning is a diagnostic requirement to identify 
individuals as at-risk mental state (ARMS) for developing psychosis (Addington et 
al., 2008; Jang et al., 2011). To date, the primary outcome measure in most 
randomised controlled trials (RCTs) of psychological interventions in ARMS or 
FEP populations has been a change in psychotic symptomatology, with social 
functioning largely included as a secondary outcome measure. However, there is 
increasing interest in targeting social function and improving social recovery in 
individuals who have experienced psychosis (Devoe et al., 2018; Fowler et al., 
2010; Hodgekins et al., 2015). In a prospective longitudinal study conducted over a 
20 year period, poor social functioning at baseline was shown to predict later 
negative functional outcomes in individuals with psychosis, including reduced 
educational achievement, unemployment and the ability to live independently 
(Velthorst et al., 2017). There is some variability in the social recovery profiles 
within cohorts of individuals who have experienced a FEP. For example, the 
majority of individuals who enter a specialised early intervention service (EI) with 
low social functioning, appear to remain at this level of functioning (66%), whilst a 
smaller proportion who enter with moderate functioning show improved recovery 
(27%) and those with high functioning show decreased social recovery rates (7%) 
(Hodgekins et al., 2015). These findings suggest that targeted interventions for 
those who enter EI services with low levels of social functioning are required to  
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improve social recovery.  
In ARMS populations poor social functioning is consistently demonstrated as a 
common impairment, along with difficulties with neuropsychological functioning 
(Cornblatt et al., 2011; Fusar-Poli, Deste, et al., 2012; Seidman et al., 2010). Moreover, 
low social functioning is a key variable in predicting later transition to psychosis in ARMS 
(Addington et al., 2017; Cornblatt et al., 2011).  
Considering the importance of social functioning in the course of illness in 
psychosis, it is pertinent to determine which interventions are most effective in improving 
social recovery in ARMS and FEP. As noted above, the majority of studies do not assign 
social functioning as a primary outcome measure. However, a recent well conducted RCT 
utilising social recovery focused CBT demonstrated a significant benefit of this targeted 
intervention for social functioning in individuals with FEP (Fowler et al., 2018). However, 
it is unclear the extent to which other psychological interventions produce positive social 
functioning outcomes in FEP participants.  
A recent meta-analysis has addressed this question in youth at risk of developing 
psychosis (Devoe et al., 2018). The authors of this study concluded that CBT or cognitive 
remediation therapy (CRT) did not significantly improve social functioning in ARMS 
participants. However, considering the small number of studies included in this meta-
analysis (Devoe et al., 2018), it seems premature to conclude that these interventions have 
no benefit in improving social functioning in ARMS. In addition, this meta-analysis did 
not include studies with individuals who have experienced a FEP. Considering the clinical 
staging model of psychosis (McGorry et al., 2006), it is of importance to compare the 
efficacy of treatments at different stages of illness, which may inform more targeted 
clinical intervention approaches.   
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Taken together, there is a clear need for a detailed analysis of the current 
evidence base for the efficacy of psychological therapies in improving social 
functioning in ARMS and FEP participants. As noted above, most studies do not 
assign social functioning as the primary outcome. As such, here we aim to assess 
the efficacy of psychological therapies in studies that do and do not assign social 
functioning as the primary outcome. Thus, this review has three main aims;  
1. To determine the quantity and quality of evidence that psychological therapy 
improves social functioning in ARMS participants. 
2. To determine the quantity and quality of evidence that psychological therapy 
can improve social functioning in FEP participants.  
3. To compare and contrast the efficacy of specific psychological therapies in 
improving social functioning in ARMS and FEP participants.  
 
2.3. Materials and Methods 
2.3.1. Protocol  
This systematic review was conducted in accordance with PRISMA 
guidelines and was pre-registered on the PROSPERO database of systematic 
reviews, number: CRD42018093769.  
 
2.3.2. Search Strategy  
A comprehensive search of the literature was conducted using the following 
databases: MEDLINE (Ovid), EMBASE (Ovid), CINAHL (EBSCO), and 
PsychINFO (EBSCO) from 1980 to June 2018. Search terms were: Ultra high risk 
for psychosis OR UHR OR clinical high risk of psychosis OR CHR OR at risk 
mental state* OR prodromal psychosis OR prodromal schizophrenia OR prodromal 
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phase OR prodrome OR prodromal stage OR prodromal symptoms AND first episode 
psychosis OR early psychosis OR FEP AND cognitive behaviour therapy  OR CBT OR 
cognitive remediation OR cognitive remediation therapy OR behaviour therapy OR 
behavioral therapy  OR psychological treatment OR psychological intervention OR 
psychological therapy OR cognitive enhancement OR cognitive enhancement therapy OR 
social skills OR social skills training OR social skills training intervention OR mindfulness 
OR mindfulness-based cognitive therapy OR mindfulness based stress reduction OR 
acceptance and commitment therapy AND social functioning OR social impairment OR 
social dysfunction OR social adjustment. Google Scholar was also searched to identify 
further articles. None were identified. Google Scholar alerts for the above search terms 
were set up to receive updates of new articles that may fit the inclusion criteria for this 
review. The search terms were chosen so as to capture a broad range of studies. As can be 
seen in Figure 2.1., a large number of studies were excluded at the screening stage. The 
main exclusion reasons were studies that were non-interventional, drug trials, or studies 
investigating cross-sectional relationships between factors involved in the development/ 
progression of psychosis.  Titles and abstracts were initially screened by the first author 
using Covidence systematic review software. Full text articles were screened by two 
reviewers (PK, JH) for eligibility for inclusion. Full text screening for eligibility was 
carried out by two independent reviewers (PK, JH) and discrepancies discussed to come to 
a final decision.   
 
2.4. Selection Criteria 
Studies were included in this systematic review based on the following 
inclusion/exclusion criteria: 
Inclusion Criteria:  
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1. Primary research including randomised and non-randomised controlled trials 
(double or single blind); open label trials, pragmatic trials, pilot trials. 
2. Participant age range 16-65 years old;  
3. Male or female;  
4. Participants identified as being at-risk for developing psychosis as defined by the 
Comprehensive Assessment of At Risk Mental States (CAARMS; (Yung et al., 
2005), Criteria of Prodromal States (COPS) using the Structured Interview for 
Prodromal Symptoms (SIPS), Scale of Prodromal Symptoms (SOPS; (Miller et al., 
2003) or Early Recognition Inventory (Häfner et al., 2004);  
5. Participants identified as having experienced a FEP diagnosed according to DSM-
IV, DSM-IV-TR, DSM-V, ICD-10 criteria. The duration of illness must have been 
≤5 years and the first and only time an individual had a psychotic episode (McGorry 
et al., 2006). 
6. Psychological intervention defined as structured, evidence-based, theory driven 
intervention to include CBT, CBT for psychosis (CBTp), CBT for ultra-high risk 
(CBTuhr), Acceptance and Commitment Therapy and other Mindfulness based 
therapies, and Cognitive Remediation Therapy. Other therapeutic approaches 
including psychodynamic therapy, group therapy, family therapy, social skills 
training were also considered. The focus of intervention did not have to be social 
functioning.  
7. Control group to include, but not limited to; waiting list control, case management 
or ongoing pharmacotherapy.  
8. Studies reporting a social functioning outcome measure (primary or secondary) to 
include, but not limited to, clinician rate, self-report and performance based 
measures; Social and Occupational Functioning Assessment Scale (SOFAS; Burns 
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& Patrick, 2007); Multnomah Community Ability Scale (MCAS; Barker, Barron, 
McFarland, & Bigelow, 1994); Global Assessment of Functioning- Functioning 
subscale (GAF-F; Burns & Patrick, 2007); Global Functioning: Social Scale (GFS; 
Barbara A. Cornblatt et al., 2007); Social Adjustment Scale-II (SAS-II; Schooler, 
Hogarty, & Weissman., 1979); Role Functioning Scale (RFS; Goodman, Sewell, 
Cooley, & Leavitt, 1993); Social Functioning Scale (SFS; Birchwood et al., 1990); 
Social Adjustment Scale-Self Report (SAS-SR; Weissman & Bothwell, 1976); and 
Social Skills Performance Assessment (Patterson, Moscona, McKibbin, Davidson, 
& Jeste, 2001). The above measures were identified in a pre-screen of the literature 
to identify commonly used social functioning measures.  
 
Exclusion Criteria:  
1. Drug only trials  
2. Other interventions including occupational therapy, exercise and dietary studies  
3. Studies comparing a psychological intervention to pharmacotherapy 
4. Studies that include only a wider measure of functioning such as general 
functioning and quality of life. The rationale for this is that, although social 
functioning may be a component of these measures, they will capture a broader 
range of factors such as symptoms, which is not the focus of this systematic review.   
 
2.4.1. Quality Assessment:  
Studies were assessed for quality using the Cochrane risk of bias assessment tool 
(Higgins et al., 2011) in the Covidence systematic review program. A random sample of 
25% of included papers were quality assessed by an independent reviewer to determine 
inter-rater reliability, which showed moderate agreement (κ= 0.45, p<0.001). Where 
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disagreements arose, the raters discussed the ratings in reference to the Cochrane 
risk of bias manual and a final decision was made on the appropriate rating. The 
remainder of quality assessments were carried out by the first author. The Cochrane 
risk of bias assessment tool covers the following seven domains to determine 
methodological quality of RCTs: random sequence generation (selection bias), 
allocation of concealment (selection bias), blinding of participants and personnel 
(performance bias), blinding of outcome assessment (detection bias), incomplete 
outcome data (attrition bias), selective reporting (reporting bias) and other sources 
of bias as determined by the investigator. For this review we considered other 
sources of bias to include; reporting of sample size calculations; if a study was 
adequately powered to detect changes in social functioning; general quality of 
reporting of methodology; control group not matched in terms of important 
variables such as ‘time spent with clinician.’    
 
2.4.2. Data Extraction 
Data were extracted from each study based on (1) study characteristics (year 
of publication, country where study was conducted, sample size); (2) characteristics 
of ARMS, FEP and control participants (mean age, %female in sample); (3) clinical 
assessment/ diagnostic instruments used to identify ARMS participants and FEP 
participants; (4) The name of the psychological intervention; (5) Primary outcome 
measure; (6) % conversion to psychosis in ARMS studies; (7) social functioning 
measure; (8) details of the effect of the intervention on social functioning; (9) post 
intervention, between group effect sizes on social functioning. Effect sizes are 
expressed as Hedges g and were calculated using Comprehensive Meta-Analysis 
software (CMA; Borenstein, Hedges, Higgins, & Rothstein, 2013).
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reasons 
(n = 113) 
 Wrong study design (n=40) 
 Duplicate/ follow up of data 
reported another publication 
(n=15) 
 No control condition (n=13) 
 Study Protocol (n=11) 
 Review Article (n=9) 
 Wrong patient population (n=8) 
 Conference Abstract (n=7) 
 Social functioning outcome not 
reported (n=5)  
 Full text not available (n=2) 
 Wrong intervention type (n=1) 
 Case series (n=1) 
 Not in English (n=1) 
 
Studies included in 
qualitative synthesis 
(n = 22) 
Figure 2.1. PRISMA Flow chart of literature search, 
study review and study inclusion.  
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2.5. Results 
A total of 22 studies, published between 1980 and 2018, with 21 
independent samples, were identified for inclusion within this review. Of these, 
seven studies with a population of individuals categorised as being ARMS for 
developing psychosis were included, and 15 studies included a sample of 
participants who had experienced a FEP. Sample sizes of studies ranged from 32 to 
201 for ARMS studies and 40 to 557 for FEP studies. The overall sample size for 
included studies was 1947.  Twenty-one of included studies used RCT 
methodology with one study a non-randomised clinical trial. Intervention length, 
and number of sessions varied widely between included studies (see Table 2.1. for 
details). Of the included studies with an ARMS population, four investigated the 
effects of CBT and three investigated the effects of cognitive remediation. Within 
included FEP studies, six investigated the effects of CBT, four the effects of 
cognitive remediation, two the effect of a service level intervention, one the effect 
of a psychodynamic therapy intervention, and two the effect of multicomponent 
therapeutic interventions (See Table 2.2. and 2.3. for details).  
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Table 2.1. Details of each intervention used in included studies. 
Study Population Primary 
Intervention 
Length of 
Intervention 
Maximum No. of 
Sessions/ Hours 
Mean No. of 
Sessions/ Hours 
Addington e al.,  (2011) ARMS CBT 6 months 20 12 sessions 
Bechdolf  et al., (2007) ARMS CBT 12 months 25 1:1/ 15 group/ 
12 CRT 
23.4 1:1 & group 
sessions 
Ising et al., (2016) ARMS CBT 6 months 26 sessions 10 sessions 
Van der Gaag et al., 
(2012) 
ARMS CBT 
6 months 26 sessions 10 sessions 
Choi et al., (2017) ARMS CRT 2 months 30 hours 30.32 hours 
Holzer et al., (2014) ARMS CRT 2 months 12 hours 10 hours 
Piskulic et al., (2015) ARMS CRT 3 months 40 hours 20 hours 
Drake et al., (2014) FEP CBT 
NS six to thirty weeks 
median 7 
sessions 
Fowler et al., (2009) FEP CBT 9 months mean 12 sessions mean 12 sessions 
Fowler et al., (2018) FEP CBT 9 months median 15 sessions mean 16.49 
Gleeson et al., (2013) FEP CBT 7 months 30 sessions 8.51 sessions 
Jackson et al., (2008) FEP CBT 3.5 months 20 sessions mean 9 sessions 
Fernandez-Gonzalez et 
al., (2015) 
FEP CRT 
NS minimum 15 hours 30.7 hours 
Fisher et al., (2015) FEP CRT 2 months 40 hours 34.65 
Lee et al., (2013) FEP CRT 2.5 months 20 hours NS 
Wykes et al., (2007) FEP CRT 3 months 40 hours NS 
Harder et al., (2014) FEP Psychodynamic NS 3 years NS 
Penn et al., (2011) FEP Multicomponent NS 36 sessions 19 sessions 
Peterson et al., (2005) FEP Multicomponent 24 months NS NS 
Craig et al., (2014) FEP Service Level 
12 months 
3 day training on 
MI and IPS NS 
Garety et al., (2006) FEP Service Level 18 months NS NS 
 
 
 
ARMS, at-risk mental state; CBT, Cognitive Behavioural Therapy; FEP, first episode psychosis; CRT, Cognitive Remediation Therapy; 
NS, not stated.  
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2.5.1. Outcome Measures 
2.5.1.1. Summary of Outcome Measures  
Clinician rated social functioning measures were used by the following 
studies: Six studies used the SOFAS (Addington et al., 2011; Drake et al., 2014; 
Gleeson et al., 2013; Holzer et al., 2014; Ising et al., 2016; Jackson et al., 2008; van 
der Gaag et al., 2012), two studies the GAF-F (Harder, Koester, Valbak, & 
Rosenbaum, 2014; Petersen et al., 2005), two studies the GFS (Fisher et al., 2015; 
Piskulic, Barbato, Liu, & Addington, 2015), two studies used the Time Use Survey 
(TUS; Fowler et al., 2018; Fowler et al., 2009), one study the SAS-II (Bechdolf et 
al., 2007), and one study used the RFS (Penn et al., 2011).  
Self-reported social functioning measures were used by the following 
studies: Three studies used the SFS (Addington et al., 2011; Fernandez-Gonzalo et 
al., 2015; Lee et al., 2013), one study the SAS-SR (Choi et al., 2017), and one study 
the Social Behaviour Schedule (SBS; Wykes et al., 2007). In addition, two studies 
measured post treatment increases in employment/vocational and educational 
outcomes (Craig et al., 2014; Garety et al., 2006).  
The measures utilised by included studies vary on a number of dimensions 
and a decision as to which is most appropriate depends on the primary question and 
outcome in each study. As this review includes studies in which social functioning 
is and is not the primary outcome measure, a number of different outcome 
measures have been selected. For those studies in which social functioning is the 
primary outcome, a measure such as total time in employment/ vocational activity 
or education, and total hours of structured activity per week/ month as in the TUS, 
is likely to provide the most sensitivity to change and relate to real world 
meaningful changes for the individual.    
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2.5.2. Psychological Interventions:  
French and Morrison (2004) Cognitive Therapy Manual: One study used the French and 
Morrison (2004) treatment protocol for ARMS participants (Addington & Piskulic, 2011). 
This protocol is formulation driven and based on a specific cognitive model of psychosis 
(Morrison, 2001). The intervention is limited to a maximum of 26 sessions over six months 
and incorporates modules on psychoeducation and normalisation, generating and testing 
alternative beliefs, identification and modification of safety behaviours, work on 
metacognitive beliefs, core beliefs and social isolation, and relapse prevention (French & 
Morrison, 2004). The primary outcome of studies using this manual included here was the 
number of ARMS participants that transitioned to psychosis.  
 
CBT Ultra High Risk (CBTuhr): Of the included at risk studies, two publications of the 
same trial used a specific CBTuhr manual (Ising et al., 2016; van der Gaag et al., 2012). 
CBTuhr is based on the protocol outlined above (French & Morrison, 2004) with 
additional psychoeducational components on dopamine super sensitivity and how this 
relates to perception and thinking. Additional exercises are included to experience 
cognitive biases including jumping to conclusions, selective attention to threat, 
confirmatory bias, negative expectation bias and covariance bias (van der Gaag et al., 
2012). CBTuhr consists of a maximum of 26 weekly sessions and includes behavioural 
goals focused on school and work attendance, fostering interactions with friends and 
relatives, and a reduction of cannabis use, where relevant. The primary outcome of studies 
using this manual included here was the number of ARMS participants that transitioned to 
psychosis.  
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Other CBT based interventions: One included study used a treatment manual developed 
by the investigators (Bechdolf et al., 2007). This protocol combined 25 individual therapy 
sessions consisting of psychoeducation, stress management, symptom management and 
crisis management; 15 group therapy sessions consisting of positive mood and enjoying, 
training social perception and skills, and mastering difficult situations; 12 sessions of 
cognitive remediation consisting of training of concentration, attention, vigilance and 
memory; 3 sessions of family psychoeducation  (Bechdolf et al., 2007). The primary 
outcome measure in this study was a change on the SAS-II.  
 
CBT for Psychosis (CBTp): One included study used a CBTp manual (Drake et al., 2014) 
although the authors do not reference a specific manual. Typically, CBTp consists of up to 
26 sessions over six to nine months (Morrison, 2017) drawing on a cognitive model of 
psychosis (Garety et al., 2001; Morrison, 2001). Phases of the protocol include, 
engagement and formulation, normalisation, advantages and disadvantages of events, 
appraisals and responses, coping strategies, generating alternative explanations, role 
play/skills practice, safety behaviours and behavioural experiments, metacognitive beliefs 
and strategies, attentional strategies, imagery modification, core beliefs, schema change, 
and relapse prevention (Morrison, 2017). The included study in this review had a reduction 
in psychotic symptoms as the primary outcome measure following this intervention (Drake 
et al., 2014).  
 
Social Recovery Therapy: Two included trials used Social Recovery Therapy (Fowler et 
al., 2018; Fowler et al., 2009) which is specifically designed to target social functioning 
impairments in psychosis. This intervention consists of three main phases. The first phase 
involves engagement, formulation, goal setting, value identification, motivational 
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assessment, and identification of how symptoms affect activity levels and setting day to 
day activity targets. Stage two involves preparatory work in beginning new activities by 
identifying pathways to achieve new activities. Cognitive strategies are included to 
promote agency and reduce hopelessness, and behavioural experiments are introduced. 
Phase three involves engagement in new activities and behavioural experiments to address 
specific problems related to engagement in activities (Fowler et al., 2018). Social Recovery 
therapists take an assertive outreach approach and visit participants at home or community 
settings (Fowler et al., 2018). The primary outcome measure in the studies by Fowler et al., 
(2009; 2018) was a change in structured activity on the TUS.  
 
Active Cognitive Behaviour Therapy for Early Psychosis (ACE): One included study 
used ACE as an intervention (Jackson et al., 2008) which consists of a maximum of 20 
sessions over a 14 week period (Bendall, Killackey, Marois, & Jackson, 2005). This 
intervention consists of standard CBT stages and focuses on priority symptoms (e.g. 
positive symptoms), then co-morbidity, negative symptoms, identify issues and relapse 
prevention (Jackson et al., 2008). The primary outcome measure in the Jackson et al., 
(2008) trial was psychotic symptoms.  
 
Supportive Psychodynamic Therapy (SPP): One study used SPP as an intervention 
approach (Harder et al., 2014) which is non-specific regarding number and frequency of 
sessions. Therapy is provided to participants for up to two years and is developed from 
prior psychotherapy manual (Holmes & Bateman, 2002). SPP consists of a range of 
psychodynamic therapy techniques including transference interpretations, explorative 
interventions, meaning making, and understanding of interpersonal and intra-psychological 
process (Harder et al., 2014).   
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Graduated Recovery Intervention Program (GRIP): One study used GRIP as an 
intervention approach (Penn et al., 2011) which consists of up to 26 weekly sessions 
comprised of four main phases: engagement and wellness management, substance use, 
persistent symptoms and functional recovery (Waldheter et al., 2008). It utilises a CBT 
approach with a focus on functional recovery by targeting social skills and role and 
community functioning. The primary outcome measure in the trial by Penn et al., (2011) 
was community functioning and social skills.    
 
Assertive Community Treatment: One study used Assertive Community Treatment which 
was integrated with CBT, family therapy, social skills training and medication (Petersen et 
al., 2005). Assertive Community Treatment is an assertive outreach approach in which 
patients receive a high frequency of contact with clinicians who actively encourage and 
motivate the individual to engage in the recovery process. The primary outcome measure 
in the trial by Petersen et al., (2005) was not specified.  
 
Individual Placement and Support (IPS) with Motivational Interviewing (MI): One study 
used an integrated IPS and MI intervention (Craig et al., 2014). IPS is a specific approach 
which provides support in job searching, pre-vocational preparation and ongoing support. 
MI is a therapeutic technique which aims to reduce an individual’s ambivalence to change 
and encourages behavioural change using a person centred approach (Miller & Rollnick, 
2012). The primary outcome measure in the trial by Criag et al., (2014) was the proportion 
of participants in paid employment by 12 month follow up.    
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Early Intervention Service: One included trial was conducted using an Early Intervention 
approach (Garety et al., 2006). This is an integrated approach utilising CBTp, vocational 
support, family therapy and medication management. The primary outcome measure in the 
trial by Garety et al., (2006) was vocational and educational activity.  
 
CRT Trials  
Processing Speed Training (PST): One study used PST as an intervention approach (Choi 
et al., 2017) which is delivered over approximately 30 hours over a two month period. PST 
consists of repetitive drill and practice tasks centred on pupillometric cognitive load, 
working memory and motivational theory (Choi et al., 2017). The primary outcome 
measure in the trial by Choi et al., (2017) was processing speed.  
 
Captain’s Log® neuropsychological training software: This intervention was used by one 
study (Holzer et al., 2014) and consists of a maximum of 12 hours of training delivered 
over two months. The training modules aim to train attention skills, concentration, 
memory, eye-hand coordination, problem solving/ reasoning skills, self-esteem and self-
control (Sandford & Browne, 1988). The primary outcome measure in the trial by Holzer 
et al., (2014) was neuropsychological performance.  
 
Posit Science Brain Fitness Training: One study used this CRT program as an 
intervention approach (Piskulic et al., 2015) which consists of a maximum of 40 hours of 
training over a three month period. It is focused on training auditory processing speed, and 
interpretation of semantic and emotional aspects of speech (Piskulic et al., 2015). The 
primary outcome measure in the trial by Piskulic et al., (2015) was not specified by the 
authors.  
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NeuroPersonalTrainer-Mental Health (NPT-MH): One study used the NPT-MH program 
as an intervention approach (Fernandez-Gonzalo et al., 2015) which consists of a minimum 
of 15 hours of training focused on attention, memory, executive function, emotional 
processing, theory of mind and cognitive biases (Caballero-Hernández et al., 2014). The 
primary outcome measure in the trial by Fernandez-Gonzalo et al., (2015) was not 
specified by the investigators.  
 
Neuropsychological and Educational Approach to Remediation (NEAR): One study used 
the NEAR as an intervention approach (Lee et al., 2013) which consists of a maximum of 
20 hours of training over a period of 10 weeks. NEAR is comprised of psychoeducation on 
cognitive deficits and drill and practice sessions which are tailored to the individuals 
particular neuropsychological profile (Lee et al., 2013). The primary outcome measure in 
the trial by Lee et al., (2013) was neuropsychological performance.  
 
Non Specific CRT: One study used a non-specific treatment manual of CRT (Wykes et al., 
2007) which consists of 40 hourly sessions focused on complex planning, memory and 
problem solving (Delahunty, Reeder, Wykes, Newton, & Morice, 1999). The primary 
outcome measure in the trial by Wykes et al., (2007) was neuropsychological performance.  
 
2.5.3. Methodological Quality  
Quality of ARMS studies: Risk of bias assessments for ARMS studies included in this 
review are summarised in Figure 2.2. and 2.3. All CBT trials had a high risk of bias 
regarding blinding of participants and personnel. This is usual with psychotherapy trials as 
it is not possible for a therapist to be blind to the treatment they are providing, and the 
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psychoeducational component of therapy means socialising participants to the model. With 
this caveat in mind, the trial by van der Gaag et al., (2012)/ Ising et al., (2016) was the 
most methodologically rigorous trial included in this review. In contrast, the two other 
included CBT trials had relatively small sample sizes, did not provide adequate detail on 
allocation concealment and were not preregistered trials meaning it was not possible to 
ascertain if all data were reported and analysed as a-priori planned (Addington et al., 2011; 
Bechdolf et al., 2007). CRT studies with ARMS populations in this review were conducted 
with small sample sizes and two did not provide adequate reporting of statistical power 
analyses (Choi et al., 2017; Holzer et al., 2014; Piskulic, Addington, Auther, & Cornblatt, 
2011). Overall, CRT studies had a high or unclear risk of bias. With one exception 
(Bechdolf et al., 2007) CBT and CRT trials reported here did not have social functioning 
as the primary outcome measure. As such, drawing conclusions as to the effectiveness of 
CBT or CRT on social functioning in ARMS is limited by poor methodological quality and 
by most studies not being powered with social functioning as the primary outcome 
measure.  
 
Quality of FEP Studies: The risk of bias assessments for FEP studies included this review 
are summarised in Figure 2.4. and 2.5. CBT trials were of varying quality with all studies 
suffering from a high risk of bias for blinding of participants and personnel. One CBT trial 
was methodologically rigorous, had an overall low risk of bias, and showed a positive 
outcome on social functioning (Fowler et al., 2018). Drake et al., (2014) was limited by 
attrition bias, but scored as low risk of bias in five of seven domains. The remaining CBT 
studies suffered from a number of sources of bias which may be the result of insufficient 
reporting of methodology in the published article (Fowler et al., 2009; Gleeson et al., 
2013). Of the CRT studies, one was rated as low in risk of bias in five of seven domains 
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(Wykes et al., 2007), with the remaining rated as high or unclear risk of bias in most 
domains; again potentially due to insufficient reporting of methodology (Fernandez-
Gonzalo et al., 2015; Fisher et al., 2015; Lee et al., 2013). The one psychodynamic 
intervention trial included in this review was rated as high risk of bias across almost all 
domains (Harder et al., 2014). Similarly multi-component studies were rated as high or 
unclear risk of bias across most domains (Penn et al., 2011; Petersen et al., 2005). Finally, 
the two service level interventions included here were divergent in methodological quality. 
One study was rated as high or unclear risk across five of seven domains (Craig et al., 
2014) whilst the other was rated as having low risk of bias in all domains except blinding 
of participants and personnel (Garety et al., 2006).   
 
2.5.4. Description of studies:  
The effect of CBT on Social Functioning in ARMS Participants: Four studies (RCTs) 
reported a social functioning outcome measure following a CBT intervention with ARMS 
participants (see Table 2.2 for details). Of these, two studies were conducted within the 
same sample following the initial trial period (van der Gaag et al., 2012) and a four year 
follow up (Ising et al., 2016) using the CBT for ultra-high risk (CBTuhr) specific manual 
(Van der Gaag, Nieman, & Van den Berg, 2013). There was no significant change on the 
SOFAS at the 6, 12, and 18 month time point (Van der Gaag et al., 2013) nor the 4 year 
follow-up (Ising et al., 2016). Similarly an earlier small open label RCT reported no 
significant improvement on the SFS following treatment with CBT in ARMS individuals 
(Addington et al., 2011). Finally, Bechdolf et al., (2007) reported a significant 
improvement in social functioning in both the treatment and control group as measured by 
the SAS-II, with no differential effect between groups. In comparing effect sizes and 
methodological quality, the post intervention effect size for the study by van der Gagg et 
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al., (2012) which was rated as having overall low risk of bias, was g= 0.23,  and for 
Addington et al., (2011) which had high risk or unknown risk of bias was also g=0.23. In 
contrast, the study by Bechdolf et al., (2007) which had a significant post intervention 
effect size on social functioning of g=0.41, was the lowest quality study with the highest 
risk of bias across domains.  
 
The effect of Cognitive Remediation on Social Functioning in ARMS Participants: 
Three studies were included that reported a social functioning outcome measure following 
treatment with cognitive remediation in ARMS participants. Choi et al., (2017) reported 
that compared to an active control, Processing Speed Training resulted in a significant 
improvement in social functioning as measured by Social Adjustment 
Scale-Self Report with a large post intervention effect size of g=1.0.  Piskulic et al., (2015) 
reported a significant improvement in social functioning, as measured by the GFS, in the 
CRT group between baseline and 9 month follow-up, whilst there was no change in the 
control group. However, it is important to note that this finding appears to represent a 
within group change and the authors do not report a treatment by time interaction with 
post-hoc comparisons and suitable corrections for multiple comparisons (Piskulic et al., 
2015). The between group post intervention effect size for this study was negligible (g= 
0.05; Piskulic et al., (2015). Finally, Holzer et al., (2014) reported a significant within 
group change in social functioning as measure by the SOFAS in both the treatment and 
control group. However, the post intervention effect size difference was g= -0.05. The 
study by Choi et al., (2017) was rated a low risk of bias in only three of seven domains, 
while the study by Holzer et al., (2014) was rated as low risk of bias in five of seven 
domains. The trial by Piskulic et al., (2015) was very poor methodologically and was rated 
as high or unknown risk across all domains. Taken together, the efficacy of CRT in 
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improving social functioning in ARMS participants is unclear when considering the 
methodological quality of studies and differences in post intervention effect sizes.  
 
The effect of CBT on Social Functioning in FEP: Five trials were included that report a 
social functioning outcome measure with a CBT focused treatment (see Table 2.3. for 
details). The largest and well conducted trial (Fowler et al., 2018), found that social 
recovery-CBT (SR-CBT), when compared to TAU in a specialised early intervention 
service, resulted in a significant increase in structured activity of 8.1h as measured by the 
TUS with a post intervention effect size of g=0.39. An earlier study with a smaller sample 
size utilising SR-CBT reported no overall effect on the TUS in a combined affective and 
non-affective psychosis group (Fowler et al., 2009). However, when these groups were 
separated, there was a significant improvement in social functioning in the non-affective 
psychosis group following treatment with an effect size of g=0.27 (Fowler et al., 2009). 
(Jackson et al., 2008) reported the effect size difference at each time point in a trial 
utilising Active Cognitive Therapy for psychosis (ACE) versus befriending. The authors 
report a moderate effect size favouring ACE at treatment endpoint (d= 0.39) which had 
reversed by the end-of-treatment to follow-up (d=- 0.31). Gleeson et al., (2013) reported 
the outcome on the SOFAS following treatment with Relapse Prevention Therapy 
(combined CBT/family therapy) versus specialised FEP care. The authors report a 
significant group by time interaction on the SOFAS which was no longer significant when 
medication adherence was controlled for, producing a post intervention effect size of 
g=0.15 (Gleeson et al., 2013).  Finally, Drake et al., (2014) reported outcomes on the 
SOFAS following a trial investigating CBTp plus social contact vs. CBTp plus cognitive 
remediation in FEP. The authors found no significant differential effect of treatment group 
on social functioning and the effect size was not able to be calculated (Drake et al., 2014). 
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Taken together, the evidence indicates that one trial (Fowler et al., 2018) was 
methodologically rigours and found a meaningful post intervention effect size for 
improving social functioning. The study by Drake et al., (2014) was rated as low risk in 
five of seven domains and so can be considered as moderately rigorous trial. The other 
studies (Fowler et al., 2009; Gleeson et al., 2013) were of low or unknown risk of bias 
across domains and as such should be interpreted with caution. However, it should be 
noted that the same intervention was used by the same research team in the most recent 
well conducted trial (Fowler et al., 2018) and earlier less rigorous trial (Fowler et al., 
2009). In addition, it should be noted that the trial by Fowler et al., (2018) specifically 
recruited participants who had very low levels of social functioning at baseline, whilst this 
was not specified in other trials.  
 
The effect of Cognitive Remediation on Social Functioning in FEP: Four included trials 
reported a social functioning outcome measure following treatment with cognitive 
remediation therapy (see Table 2.3. for details). One study reported a significant 
improvement in social functioning following CRT  (Lee et al., 2013) whilst three found no 
differential effect of treatment (Fernandez-Gonzalo et al., 2015; Fisher et al., 2015; Wykes 
et al., 2007). Lee et al., (2013) reported that Neuropsychological and Educational 
Approach to Remediation improved social functioning, as measured by the SFS, when 
compared to TAU. The authors reported that the treatment effect on social functioning was 
large, accounting for 14.6% of the variability in improvement (Lee et al., 2013). However, 
the post intervention effect size was small (g=0.21) Fernandez-Gonzalo et al., (2015) 
reported a significant improvement in social functioning, as measured using the SFS, in 
both the CRT (NeuroPersonalTrainer-Mental Health) and control group, but with no 
differential effect of treatment. This study produced a small post intervention effect size 
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(g=0.31). Finally, Fisher et al., (2015) found no significant improvement on the GAF-S 
following CRT (g=0.16); and Wkyes et al., (2007) found no significant effect of CRT on 
the SFS with FEP participants (g= -0.36; lower score= improved functioning). Although 
non-significant, the trial by Wykes et al., (2007) produced the largest post intervention 
effect size and was the most methodologically rigorous. The one trial by Lee et al., (2013) 
that reported a significant intervention effect for social functioning, had an overall small 
effect size (g=0.21) and was of very poor methodological quality. Taken together, effect 
sizes for the best conducted trials are in the small to moderate range, however, the 
evidence base for CRT improving social functioning in FEP is limited.   
 
The effect of psychodynamic and multi-component therapy on Social Functioning in 
FEP: One included trial reported a social functioning outcome measure following a 
psychodynamic therapy intervention (Harder et al., 2014) and two following a multi-
component therapy intervention (Penn et al., 2011; Petersen et al., 2005). Harder et al., 
(2014) conducted a non-randomized trial with a relatively large sample size (n= 269) of 
individuals experiencing a FEP. Trial participants received manualised psychodynamic 
therapy or standard treatment. The authors found no significant improvement in social 
functioning, as measured by the GAF-S, in the treatment versus control group, with a very 
small post-intervention effect size (Harder et al., 2014). Penn et al., (2011) randomized a 
small sample (n=46) of individuals with FEP to GRIP (psychoeducation, CBT, MI and 
social skills training) versus TAU and reported a significant increase in work functioning 
as measured by the RFS, with no effect on other social functioning measures (g=0.29). 
Finally, Peterson et al., (2005) randomized a large sample (n=547) of individuals with FEP 
to Integrated Treatment (Assertive Community Treatment, psychoeducational family 
intervention, social skills training and CBT) versus TAU, and reported a significant 
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improvement in work and education following treatment (g= -0.65; reduction equals better 
functioning). Although the trial by Peterson et al., (2005) reported a moderate post 
intervention effect size for work and educational engagement, this trial was very poor 
methodologically, being rated as high risk of bias in six of seven domains. Similarly, the 
trial discussed above by Harder et al., (2014) was of poor quality as was Penn et al., 
(2011). Taken together, there is no evidence that psychodynamic focused interventions 
improve social functioning in FEP. For multicomponent studies, one study suggests a 
multifaceted approach may be beneficial, but considering the methodological quality, 
further studies are needed to confirm this finding.  
 
The effect of service level interventions on social functioning in FEP: Two included 
studies reported a social functioning outcome measure following a service level 
intervention in FEP (Craig et al., 2014; Garety et al., 2006). Both studies reported a 
significant beneficial effect of the intervention on social functioning in FEP. Craig et al., 
(2014) randomized FEP participants (n=159) to receive individual placement and support 
(IPS) from clinicians additionally trained in motivational interviewing (MI), versus with 
IPS clinicians not trained in MI. The authors reported that IPS plus MI was superior to IPS 
alone in increasing the number of participants in paid employment by the trial endpoint 
(g=0.69; (Craig et al., 2014). In one of the first studies to trial a specialised early 
intervention for psychosis service (EIS) in the UK (The Lambeth Early Onset trial), Garety 
et al., (2006) randomized FEP participants (n=144) to EIS (medication management, CBT, 
vocational input and family intervention) versus standard care, and reported that the EIS 
group was engaged in significantly more months of structured activity compared to the 
control group at treatment end (g=0.45). The post intervention effect size was moderate for 
the trial by Craig et al., (2014) but this trial had a high risk of bias in five of seven 
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domains. In contrast, Garety et al., (2006) reported a smaller, but moderate, effect size and 
had a high risk of bias only for blinding of participants. Taken together, there is evidence 
that EI service level approach is beneficial for improving social functioning in FEP 
participants.  
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Table 2.2. Psychological Interventions for Social Functioning with ARMS Participants  
Study Country Study 
Design 
N 
Study 
Sites 
Treatments  N at 
Baseline 
Age 
(M, SD) 
Female 
(N, %) 
ARMS 
Measure 
Intervention Details Primary 
Outcome 
Measure 
% 
Conversion 
to Psychosis  
Social 
Functioning 
Measure 
Effect of 
intervention 
on social 
functioning 
Post 
Intervention 
Between 
Group 
Effect size  
CBT               
Addington et 
al., (2011) 
Canada  RCT 
(Single 
Blind) 
1 CBT 
 
Supportive 
Therapy 
27 
 
24 
20.8 (4.51) 
21.1 (3.74) 
 
17.7 
 
11.8 
 
COPS/ SIPS CBT: 20 sessions over 
6 months 
Transition 
to 
psychosis 
0 
 
12.5 
SFS No 
significant  
change 
6 months: 
g= 0.23 
Bechdolf et al., 
(2007) 
Germany RCT 4 CBT 
 
Supportive 
Counselling 
54 
 
59 
25.2 (5.3) 
26.4 (5.7) 
35.2 
 
32.2 
Early 
Recognition 
Inventory 
Individual CBT x 25 
sessions 
Group therapy x 15 
sessions 
Cognitive 
Remediation   
x 12 sessions 
Information & 
counselling of 
relatives  
x 3 sessions. 
Social 
Adjustment  
N/A  SAS II Significant 
within 
group 
increase in 
both 
groups,  but 
no 
differential 
effect 
between 
groups 
Post 
treatment: 
g=0.41 
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Study Country Study 
Design 
N 
Study 
Sites 
Treatments  N at 
Baseline 
Age 
(M, SD) 
Female 
(N, %) 
ARMS 
Measure 
Intervention Details Primary 
Outcome 
Measure 
% 
Conversion 
to Psychosis  
Social 
Functioning 
Measure 
Effect of 
intervention 
on social 
functioning 
Post 
Intervention 
Between 
Group 
Effect size  
Ising et al., 
(2016) 
Netherlands RCT 6 CBT 
 
TAU 
95 
 
101 
22.7 
(5.6) 
22.6 
(5.4) 
47 
(49.5) 
52 
(51.5) 
CAARMS CBT for UHR specific 
treatment manual 
Transition 
to 
psychosis  
15.7% 
(CBT)  vs 
25.5 (TAU) 
SOFAS No 
significant 
change due 
to 
treatment. 
d= -1.43; 
converters 
vs. non 
converters.  
 
For non-
converters: 
d = -0.1 
CBTuhr vs. 
control 
across all 
timepoints 
van der Gaag et 
al., (2012) 
Netherlands RCT 4 CBT 
 
TAU 
98 
 
103 
22.9 
(5.6) 
22.6 
(5.5) 
49 (50) 
 
50 (54) 
CAARMS CBT for UHR specific 
treatment manual 
Transition 
to 
psychosis 
9.8% 
(CBTuhr) 
vs. 22.66% 
(TAU) 
SOFAS No 
significant 
difference 
between 
groups due 
to treatment  
6 months: 
g= 0.23 
Cognitive 
Remediation  
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Study Country Study 
Design 
N 
Study 
Sites 
Treatments  N at 
Baseline 
Age 
(M, SD) 
Female 
(N, %) 
ARMS 
Measure 
Intervention Details Primary 
Outcome 
Measure 
% 
Conversion 
to Psychosis  
Social 
Functioning 
Measure 
Effect of 
intervention 
on social 
functioning 
Post 
Intervention 
Between 
Group 
Effect size  
Choi et al., 
(2017) 
USA RCT  CRT 
 
Active 
Control 
30 
 
32 
18.17(3.81) 
 
18.53(3.72) 
48 
 
50 
(SIPS/SOPS) Processing Speed 
Training 
Processing 
Speed  
N/A Social 
Adjustment 
Scale-Self 
Report 
(SAS-SR), 
Significant 
improveme
nt in social 
adjustment 
in CRT 
group 
compared 
to control 
4 months:  
g= 1.0 
Holzer et al., 
(2014) 
Switzerland RCT 1 CRT 
 
Active 
Control 
18 
 
14 
15.4 (1.3) 
 
15.7 (1.4) 
9 (50) 
 
5 (36) 
(SIPS/SOPS) Captain’s Log® 
software 
Neuropsych
ological 
Function 
N/A SOFAS Significant 
effect of 
time 
showing 
increase in 
social 
functioning 
but no 
differential 
group 
effect  
g= -0.05 
Piskulic et al., 
(2015) 
Canada RCT 1 CRT 
 
Computer 
Games 
18 
 
14 
19.72(5.71) 
 
17.5(3.48) 
7 
(38.8) 
 
4 
(28.6) 
(SIPS/SOPS) Posit Science Brain 
Fitness Training 
Not 
specified 
n/a GF S Significant 
within 
group 
change in 
treatment 
group 
9 months: 
g= 0.05 
CAARMS, Comprehensive Assessment for At Risk Mental State; COPS, Criteria of Prodromal States; CBT, Cognitive Behavioural Therapy;  CRT, Cognitive Remediation Therapy;  GFS, Global Functioning Social; RCT, 
Randomised Controlled Trial;  SAS-II, Social Adjustment Scale 2nd Version; SFS, Social Functioning Scale; SOFAS, Social and Occupational Functioning Scale;  SIPS/SOPS; Structured Interview for Prodromal Syndromes/Scale 
of Prodromal Symptoms;  TAU, Treatment as Usual. 
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Figure 2.3. A summary of risk of bias in each domain (expressed as a percentage) 
of all included ARMS studies.  
Figure 2.2. Risk of bias summary across each 
domain for each ARMS study included in this review 
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Table 2.3. Psychological Interventions for Social Functioning with FEP Participants 
Study Country Study 
Design 
N Study 
Sites 
Treatments  N at 
Baseline 
Age 
(M, SD) 
Female 
(N, %) 
FEP 
Catego
risatio
n 
Intervention Details Primary 
Outcome 
Measure 
Social 
Functionin
g Measure 
Effect of 
intervention on 
social 
functioning 
Post Intervention 
Between Group 
Effect size 
CBT              
Drake et 
al., (2014) 
UK RCT 1 CBPp + Social 
Contact   
 
CBPp+ 
Cognitive 
Remediation  
31 
 
 
 
31 
24.7  
(5.2) 
 
 
23.4 
(4.4) 
10 (32) 
 
 
 
14 (47) 
DSM-
IV 
CBTp manual not 
specified 
Cognitive remediation:  
Computerised Interactive 
Remediation of 
Cognition – Interactive 
Training for 
Schizophrenia’ 
(CIRCUITS) software  
PSYRATS SOFAS No significant 
group differences 
between groups at 
follow up. 
 
Data not reported 
for ES   
Fowler et 
al., (2018) 
UK RCT 
(Single 
Blind) 
4 Social Recovery 
Therapy 
 
TAU 
75 
 
 
79 
Median 
(IQR): 24.84 
(20.73-29.04) 
24.15 (22.17-
27.79) 
19 (25%) 
 
 
19 (24%) 
NS Social recovery therapy 
based CBT vs. TAU in a 
specialised early 
intervention team 
TUS TUS Social recovery 
therapy group had 
increase in 
structured activity 
of 8.1 h  
9 months: 
g= 0.39 
Fowler et 
al., (2009) 
UK RCT 2 Social Recovery 
Therapy 
 
TAU 
 
35 
 
 
 
42 
27.8(6.1) 
 
 
 
30.0(7.2) 
10 (28.6) 
 
 
12 (28.6) 
N.S. Social recovery therapy 
based CBT vs. TAU in a 
specialised early 
intervention team 
TUS TUS No significant 
effect in combined 
affective and non-
affective 
psychosis groups. 
Significant 
improvement in 
non-affective 
psychosis group 
9 months: 
g= 0.27 (non-
affective group) 
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Study Country Study 
Design 
N Study 
Sites 
Treatments  N at 
Baseline 
Age 
(M, SD) 
Female 
(N, %) 
FEP 
Catego
risatio
n 
Intervention Details Primary 
Outcome 
Measure 
Social 
Functionin
g Measure 
Effect of 
intervention on 
social 
functioning 
Post Intervention 
Between Group 
Effect size 
Gleeson et 
al., (2013) 
Australia RCT 
Single  
Blind 
2 Relapse 
Prevention 
Therapy 
 
Specialised FEP 
care 
41 
 
 
 
40 
20.1  
(2.9) 
 
 
20.1 
(3.2) 
14 (34.1) 
 
 
16 (40) 
DSM-
IV 
Combined CBT/Family 
therapy 
 
 
 
Number of 
relapses/tim
e to relapse 
SOFAS RPT group had 
significantly 
lower functioning 
at 30 months 
compared with the 
TAU group. No 
significant group 
x time interaction 
effect when 
medication 
adherence 
controlled for.  
Across all 
timepoints:  
g= 0.15  
Jackson et 
al., (2008) 
Australia RCT 1 CBT 
 
Befriending 
31 
 
31 
22.13 
(3.3) 
22.45 
(3.82) 
12 (38) 
 
5 (16) 
DSM-
IV 
Active 
Cognitive Therapy for 
Early Psychosis: ACE 
BPRS/SAN
S 
SOFAS Moderately large 
effect baseline 6 
weeks  (g=0.50) 
which lowered at 
end of tx 12 
weeks (0.39) and 
tx follow up at 1 
year (-0.31).  
12 weeks:  
g= 0.39 
Cognitive 
Remediati
on 
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Study Country Study 
Design 
N Study 
Sites 
Treatments  N at 
Baseline 
Age 
(M, SD) 
Female 
(N, %) 
FEP 
Catego
risatio
n 
Intervention Details Primary 
Outcome 
Measure 
Social 
Functionin
g Measure 
Effect of 
intervention on 
social 
functioning 
Post Intervention 
Between Group 
Effect size 
Fernandez-
Gonzalo et 
al., (2015) 
Spain RCT 1 CRT 
 
Control 
28 
 
25 
30.9(5.9) 
 
30.02(7.4) 
11 (39.3) 
 
8 (32) 
DSM-
IV 
NeuroPersonalTrainer- 
Mental Health (NPT-
MH) 
Not 
specified 
SFS Significant main 
effect of time 
within both 
groups but no 
significant group 
or interaction 
effects  
Post treatment: 
g=0.31 
Fisher et 
al., (2015) 
USA RCT 1 CRT 
 
Computer 
Game 
43 
 
43 
21.7 (3.26) 
 
20.74(3.37) 
12 (27.9) 
 
10 (23.2) 
DSM-
IV 
Posit Science Brain 
Fitness Training 
MATRICS  GFS No significant 
interaction of 
condition x time  
Post treatment: 
g=-0.16 
Lee et al., 
(2013) 
Australia RCT 1 CRT 
 
TAU 
28 
 
27 
22.88 (4) 
 
22.74 (4.7) 
14 (53.8) 
 
11 (40.7) 
DSM-
IV 
Neuropsychological and 
Educational Approach 
to Remediation  
Neuropsych
ological 
Assessment 
SFS Controlling 
for diagnosis, 
CRT significantly 
greater effect on 
social functioning 
 
g=0.21 
Wykes et 
al., (2007) 
UK RCT 1 CRT 
 
TAU 
21 
 
19 
18.8(2.6) 
 
17.5 (2.2) 
8 (38) 
 
6 (32) 
DSM-
IV 
CRT Delahunty et al., 
(1999) 
Neuropsych
ological 
Assessment 
SBS No significant 
effect 
Across all time 
points  
g= -0.36 
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Study Country Study 
Design 
N Study 
Sites 
Treatments  N at 
Baseline 
Age 
(M, SD) 
Female 
(N, %) 
FEP 
Catego
risatio
n 
Intervention Details Primary 
Outcome 
Measure 
Social 
Functionin
g Measure 
Effect of 
intervention on 
social 
functioning 
Post Intervention 
Between Group 
Effect size 
Psychodyn
amic 
Interventio
ns 
             
Harder et 
al., (2014) 
Denmark Not RCT 14 Supportive 
psychodynamic 
psychotherapy 
 
Standard 
Treatment 
119 
 
 
 
150 
Median (min-
max) 
24.6 (17.6-
35.9) 
23.2 (16.2-
35.6) 
41 (35) 
 
 
 
46 (31) 
ICD-10 Supportive 
Psychodynamic Therapy 
GAF-Social 
Functioning 
GAF- 
Functioning 
No 
significant 
interaction. 
 
Across all time 
points: g= 0.17 
Multi-
compnent 
therapy 
approache
s 
             
Penn et al., 
(2011) 
USA RCT 1 GRIP 
 
TAU 
23 
 
23 
23.48 (3.89) 
20.96 (2.14) 
9 (39.1) 
 
9 (39.1) 
SCID-
P 
GRIP includes elements 
of psychoeducation, 
CBT, MI, social skills 
training. 
Quality of 
life, 
community 
functioning
, and social 
skill. 
RFS Only significant 
effect is increased 
work functioning 
on RFS in GRIP 
vs TAU. No other 
significant effects  
g= 0.29 
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Study Country Study 
Design 
N Study 
Sites 
Treatments  N at 
Baseline 
Age 
(M, SD) 
Female 
(N, %) 
FEP 
Catego
risatio
n 
Intervention Details Primary 
Outcome 
Measure 
Social 
Functionin
g Measure 
Effect of 
intervention on 
social 
functioning 
Post Intervention 
Between Group 
Effect size 
Petersen et 
al., (2005) 
 
 
 
 
 
 
 
 
 
Denmark RCT 3 Integrated 
Treatment 
 
TAU 
275 
 
 
272 
26.6(6.4) 
 
 
26.6(6.3) 
115 (42) 
 
 
108 (40) 
ICD-10 Assertive Community 
Treatment 
(ACT; psychoeducation, 
family intervention, 
social skills training, 
CBT) 
No single 
measure 
GAF 
(Functionin
g) 
Significant 
improvement in 
IT group on work 
and education 
d= - 0.65 
 
Service 
Level 
Interventio
ns 
             
Craig et al., 
(2014) 
UK RCT 
 
4 IPS 
 
IPS+MI (for 
clinicians) 
78 
 
81 
24 (4.2) 
 
24 (4.2) 
24  (30.8) 
 
18 (22.2) 
Not 
specifi
ed 
IPS: support to search 
for work and pre-
vocational preparation.  
MI for one group of 
clinicians.  
Proportion 
of 
participants 
in paid 
employmen
t at 12 
month 
follow up 
Active 
employmen
t 
IPS+MI was 
superior to IPS 
alone in 
increasing the 
number of 
participants in 
paid employment 
12 months:  
d= 0.69 
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Study Country Study 
Design 
N Study 
Sites 
Treatments  N at 
Baseline 
Age 
(M, SD) 
Female 
(N, %) 
FEP 
Catego
risatio
n 
Intervention Details Primary 
Outcome 
Measure 
Social 
Functionin
g Measure 
Effect of 
intervention on 
social 
functioning 
Post Intervention 
Between Group 
Effect size 
Garety et 
al., (2006) 
UK RCT 2 Early 
Intervention 
Service 
 
Standard Care 
71 
 
 
 
73 
 
 
 
 
Average age 
of whole 
sample: 26 
years 
35% of 
whole 
sample 
female 
ICD-10 EI Service: medication 
management, cognitive–
behavioural 
therapy, vocational input 
and family 
interventions was 
provided according to 
individual need 
Relapse 
rates  
Vocational 
and 
Educational 
Activity 
Intervention group 
was 
engaged in an 
activity for 
significantly more 
months (6.9 
months) than 
the control group 
(4.2 months) 
 
18 months:  
g= 0.45 
BPRS, Brief Psychiatric Rating Scale; CBT, Cognitive Behavioural Therapy; CRT, Cognitive Remediation Therapy; EI, Early Intervention; GAF, Global Assessment of Functioning; IPS, Individual Placement and Support; MI, 
Motivational interviewing; MCAS; Multnomah Community Ability Scale; PSYRATS, Psychotic Symptom Rating Scales; RCT, Randomised Controlled Trial; RFS, Role Functioning Scale; SANS, Scale for the Assessment of 
Negative Symptoms ; SIPS/SOPS; Structured Interview for Prodromal Syndromes/Scale of Prodromal Symptoms ; SFS, Social Functioning Scale; SOFAS, Social and Occupational Functioning Scale; TAU, Treatment as Usual; 
TUS, Time Use Survey; UK, United Kingdom.  
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Figure 2.4. Risk of bias summary across each domain 
for each first episode psychosis study included in this 
review 
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2.6. Discussion 
This systematic review aimed to determine the effect of psychological 
interventions on social functioning in ARMS and FEP participants. No ARMS 
studies, but three of five FEP studies (Fowler et al., 2018; Fowler et al., 2009; 
Jackson et al., 2008) reported a positive effect on social functioning following a 
CBT focused intervention. Our findings in ARMS participants are in line with 
findings from a recent meta-analysis (Devoe et al., 2018). Two of three ARMS 
studies (Choi et al., 2017; Piskulic et al., 2015) and one of three FEP study (Lee et 
al., 2013) reported a positive effect on social functioning following CRT treatment. 
We found no evidence from one trial that psychodynamic therapy produced a 
positive outcome on social functioning in FEP (Harder et al., 2014). In contrast, 
both multi-component trials  (Penn et al., 2011; Petersen et al., 2005) and both 
service level intervention trials (Craig et al., 2014; Garety et al., 2006) included in 
this review, reported a significant improvement in social functioning in FEP. There 
Figure 2.5. A summary of risk of bias in each domain (expressed as a 
percentage) of all included first episode psychosis studies.  
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are a number of considerations to take into account when interpreting these findings.  
 Of the CBT studies that showed a positive outcome in social functioning in FEP 
participants, most (Fowler et al., 2018; Fowler et al., 2009) but not all (Jackson et al., 
2008) had social functioning as the primary outcome measure. This suggests that CBT 
studies not showing a positive outcome on social functioning in ARMS or FEP were not 
adequately powered to do so as sample size calculations were powered on other primary 
outcomes (e.g. symptoms). Another important consideration is the therapeutic target of 
each CBT intervention. For example, the largest and most methodologically rigorous trial 
of CBT in ARMS participants (Ising et al., 2016; van der Gaag et al., 2012) did not find a 
significant improvement in social functioning. This trial utilised CBTuhr (Van der Gaag et 
al., 2013) which is focused primarily on psychotic symptom reduction. Similarly, studies 
which utilised specialised CBT for psychosis manuals which focus on symptom reduction 
found no significant effect on social functioning in ARMS participants (Addington et al., 
2011) or FEP participants (Drake et al., 2014; Gleeson et al., 2013). In contrast, the most 
methodologically rigorous CBT trial in FEP participants which did find a significant 
improvement in social functioning, utilised a CBT intervention which specifically targets 
social functioning (Fowler et al., 2018). An earlier study using the same CBT intervention 
also reported a positive outcome on social functioning in non-affective FEP participants 
(Fowler et al., 2009). Of note, the trial by Jackson et al., (2008) did report a moderate 
positive effect size on social functioning at the treatment end point. However, this effect 
had reversed by treatment follow-up. Moreover, the authors did not report if this effect was 
statistically significant (Jackson et al., 2008). Taken together, these findings indicate that 
CBT has efficacy in improving social functioning in FEP participants but not ARMS 
participants.  However, this is dependent on studies being adequately powered to detect 
                                                                                                                                                    
 
79 
 
changes in social functioning and, moreover, social functioning being a primary 
treatment target of the intervention.   
The methodological quality of most of the CRT trials was poor and these 
findings should be interpreted with caution. While there is more evidence that CRT 
is more effective in improving social functioning in ARMS than FEP participants, 
clearly a difference of one study is insufficient to draw meaningful conclusions. A 
previous meta-analysis concluded that there was no global benefit of CRT in 
improving social functioning in ARMS participants (Devoe et al., 2018). However, 
it is noteworthy that the authors only analysed effect sizes of CRT studies in ARMS 
participants at a 2-3 month time point (Devoe et al., 2018). This approach may have 
served to mask treatment effects which were apparent at later time points (e.g. 9 
months in (Piskulic et al., 2015). As such, our findings that two studies included in 
the current review showed positive effects of CRT on social functioning in ARMS 
participants (Choi et al., 2017; Piskulic et al., 2015) are not in contention with 
previous findings (Devoe et al., 2018). The apparent discrepancy represents that we 
interpreted a positive treatment effect being eligible at any time point, whereas 
Devoe et al. (2018) only included treatment effects at 2-3 months in the meta-
analysis.   
The two multi-component therapy studies included in this review were of 
low or unclear methodological quality. The trial by Peterson et al., (2005) had a 
very large sample size, whilst Penn et al., (2011) conducted a small pilot study. 
Nevertheless, both studies reported a significant positive effect on social 
functioning in FEP participants. Drawing conclusions as to which aspect of the 
intervention was beneficial for social functioning is not possible. Both trials 
incorporated CBT as part of the intervention but there was variation as to how 
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many sessions each participant received. Both trials also incorporated social skills training 
which may have had a more direct effect on social functioning. In particular, work 
functioning was the main social functioning domain in which participants in both trials 
showed significant improvements. Taken together, multicomponent therapeutic 
interventions appear to show good efficacy in improving social functioning in FEP. 
However, it is unclear if specific elements or the treatment as a whole confers these 
benefits. Moreover, the trials here are of questionable methodological quality and as such, 
these findings may not be reliable.    
Finally, both service level interventions we included in this review reported 
positive outcomes in social functioning in FEP. One trial specifically targeted work 
placement support training and found that participants who received an intervention from 
therapists trained in MI had achieved more full-time employment than participants who 
received an intervention with an IPS only trained therapist. An earlier trial by Garety et al., 
(2006) which was the first service level RCT of a specialised EI service provided a multi-
component intervention consisting of CBT, vocational input and family interventions 
according to each individuals need. Similar to the multicomponent therapeutic 
interventions discussed above, it is unclear if individual elements of the intervention 
described by Garety et al., (2006) were most beneficial for social functioning, or if the 
combined elements are needed to produce a positive effect. Taken together, these studies 
indicate that service level interventions can provide beneficial outcomes in social 
functioning for individuals experiencing a FEP. However, as these studies focused on work 
and educational outcomes alone, it is not clear if these interventions had any beneficial 
effect on other domains of social functioning such as engagement in hobbies or social 
activities with family and friends.   
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Strengths & Limitations  
This systematic review included 22 studies with 21 independent samples 
investigating the effect of structured psychological therapies on social functioning 
in ARMS  and FEP participants. An extensive literature search was carried out 
across a number of databases and to the best of our knowledge, this is the first 
systematic review to specifically compare the effects of a range of psychological 
interventions on social functioning in ARMS and FEP participants. Nevertheless, a 
number of limitations should be noted when interpreting our findings and 
conclusions.  
Across trials, different treatment manuals were utilised. As such, in trials in 
which the treatment modality was broadly similar (e.g. CBT, CRT), there are 
differences in the target of intervention and so generalising across studies is 
problematic.  
With some exceptions (Fowler et al., 2018; van der Gaag et al., 2012) the 
methodological quality of many of the studies included in this review was poor and 
there was a high risk of bias across a number of domains. Many studies did not 
report a sample size calculation and as such it is not possible to tell if they were 
sufficiently powered to detect the desired change in their primary outcome. Within 
the context of this review, few studies had social functioning as their primary 
outcome measure. As such, most studies in this review, even when a sufficient 
sample size calculation was conducted, may have been underpowered to detect 
changes in social functioning.  
In line with methodological issues, there was little consistency in the 
specific social functioning measured used between studies. As such, the different 
psychometric properties of instruments used to measure social functioning may 
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have affected results across studies. Some standardisation to outcome measures used in 
ARMS and FEP populations would allow for greater confidence in making generalisations 
as to the specific intervention effects.  
 
Conclusions & Future Directions  
As noted above, the combined methodological quality of trials included in this 
review was mixed with some studies showing good methodological rigour and others poor. 
Individual studies suggest that CBT, CRT, multicomponent and service level interventions 
have efficacy in improving social functioning in ARMS and FEP populations. However, 
there is clearly a need for further investigation to determine which interventions work for 
whom and at what stage of psychosis. To date, there have been no trials to determine if 
social functioning focused CBT has efficacy in improving social functioning in ARMS 
populations. This is perhaps surprising considering that a change in social functioning 
forms part of the criteria to identify an individual in an at-risk state (Yung et al., 2005). 
Considering the methodological limitations of CRT studies included in this review, 
there is a need for larger, well powered studies to establish the efficacy of this therapeutic 
approach in improving social functioning in ARMS and FEP participants. As with CBT, 
these interventions may need to be tailored to both the clinical presentation (ARMS / FEP) 
and the desired outcome (e.g. improved social functioning). A potential focus of future 
CRT trials may be to focus on social cognition training (Kurtz, Gagen, Rocha, Machado, & 
Penn, 2016) for which there is some evidence of beneficial effects on social functioning 
with individuals diagnosed with schizophrenia (Grant et al., 2017).  
Specialised EIP services are established in a number of regions of the UK (Neale & 
Kinnair, 2017) other European countries, North America and Australia (Csillag et al., 
2018), and have been subject to RCTs to determine efficacy in treating FEP (e.g. (Garety et 
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al., 2006). However, the efficacy of specialised ARMS services in improving 
outcomes is unclear at present  (Fusar-Poli, McGorry, & Kane, 2017). Determining 
the efficacy of such services in preventing the transition to psychosis and 
improving key outcomes, including social functioning, is necessary in future RCTs. 
Finally, future trials are needed to determine if multi-component interventions have 
greater benefit in improving social functioning than individual treatment modalities 
alone.
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3.1. Abstract 
Social cognition, including the domains of emotion recognition (ER) and 
theory of mind (ToM), underpin an individual’s ability to navigate their social 
environment. Meta-analytic studies have demonstrated that individuals in an at-risk 
mental state (ARMS) for developing psychosis, or having experienced a first 
episode psychosis (FEP), exhibit impaired social cognitive functioning across most 
domains.  Recent interest has been on the impact of impaired social cognition on 
functional outcomes and psychotic symptomatology. However, to date, no meta-
analysis of the literature has been conducted to determine the strength and direction 
of relationship between social cognitive performance, social functioning and 
psychotic symptoms in ARMS and FEP. A comprehensive literature search of four 
databases was conducted.  Thirty-two studies were included that reported on the 
relationship between at least one social cognitive domain, social functioning and/or 
psychotic symptoms. Overall social cognitive performance was positively 
correlated with social functioning in ARMS (0.12, p=0.015) and FEP (0.205, 
p<0.001), and negatively correlated with positive (-0.178, p<0.001) and negative 
symptoms in FEP (-0.221, p<0.001). Emotion Recognition (ER) was positively 
correlated with social functioning in ARMS (0.131, P=0.01) and FEP (ER: 0.222, 
P<0.001), negatively correlated with positive symptoms in FEP, (-0.166, p<0.001), 
and negative symptoms in ARMS (-0.11, p=0.021) and   FEP (-0.211). ToM was 
positively correlated with social functioning in ARMS (0.178, p=0.01) and FEP 
(0.208, P<0.001), and negatively correlated with positive (-0.189, p<0.001) and 
negative (-0.3) symptoms in FEP. Pooled correlation coefficient estimates did not 
differ significantly between ARMS and FEP participants for each social cognitive 
domain and outcome analysed (all p>0.05). These findings indicate that better 
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social cognitive performance is associated with enhanced social functioning and lower 
psychotic symptomatology. However, effect sizes were generally small and the clinical 
impact of targeting social cognitive performance to enhance outcomes in ARMS and FEP 
is unclear at present.  
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3.2. Introduction  
Social cognition is an umbrella term for a number of related psychological 
constructs which underpin an individual’s ability to navigate their social 
environment and to develop, maintain and understand inter and intra personal 
relationships (Harvey & Penn, 2010). There is some variation in the literature 
regarding which specific subdomains comprise the concept of social cognition and 
there is some overlap between domains. Nevertheless, the most commonly defined 
social cognitive subdomains are emotion recognition , theory of mind (ToM), social 
perception and attributional biases (Green, Olivier, Crawley, Penn, & Silverstein, 
2005; Green et al., 2008). Social cognitive function has received increased attention 
over recent years as a clinical marker of the major psychiatric and 
neurodevelopmental disorders (Cotter et al., 2018). A large focus has been on 
psychosis spectrum conditions, in particular, schizophrenia (Cotter et al., 2018). 
Meta-analytic studies have consistently demonstrated that individuals with chronic 
course schizophrenia exhibit a significant impairment in social cognition when 
compared to healthy controls, with large effects sizes ranging from 0.88 to 1.04 
depending on the sub domain (Bora et al., 2009; Kohler et al., 2010; Savla et al., 
2012; Sprong et al., 2007). Similarly, meta-analyses have demonstrated that 
individuals who have experienced a first episode of psychosis (FEP; Barkl et al., 
2014; Bora et al., 2009; Cotter et al., 2018), and individuals defined as being in an 
at-risk mental state (ARMS) of developing psychosis (Cotter et al., 2018; Lee, 
Hong, Shin, & Kwon, 2015; Van Donkersgoed et al., 2015), exhibit impaired social 
cognitive performance across the major subdomains.  Taken together, the current 
evidence suggests that social cognitive impairment is apparent across the psychosis 
                                                                                                                                                    
 
88 
 
continuum. As such, there has been increasing investigation into the effect of modulating 
social cognitive functioning to improve outcomes in psychosis.  
Of particular interest has been the relationship between social cognition and 
functional outcomes. Cognitive models of positive psychotic symptoms incorporate 
attributional biases as key in the development of hallucinations and delusions, with social 
withdrawal as an important coping response (Garety et al., 2001; Morrison, 2001). A ToM 
model of psychosis was described over two decades ago, and proposes that difficulties with 
processing sensory information and deficits in self and other monitoring play a role in 
positive symptoms of psychosis, with resulting reduction in social functioning (Frith, 
1992). In addition, a cognitive model of negative psychotic symptoms highlights negative 
expectation biases in relation to pleasure, success, acceptance and perceived resources, 
may influence the development of negative symptoms and lead to social functioning 
impairments (Beck et al., 2011; Rector et al., 2005). Emotion recognition has received less 
empirical investigation in relation to psychosis and functional outcomes, however a basic 
model has been proposed where by deficits in emotion recognition and social perception 
may lead to anxiety and difficulty navigating the social world, which may lead to 
withdrawal and reduced social functioning (Couture et al., 2006).     
A meta-analysis in chronic course schizophrenia demonstrated that social cognition 
is a stronger predictor of functional outcome than neuropsychological performance (Fett et 
al., 2011). Of note, in this study, the strongest association was found between ToM and 
community functioning (Fett et al., 2011).  A number of individual studies have reported 
the relationship between social cognition and functional outcomes in FEP and ARMS 
populations (e.g. Cotter et al., 2018; Palmier-Claus et al., 2016). However, these data have 
not yet been combined using meta-analytic methods to allow for a quantitative analysis of 
all studies in the literature.  
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Considering the important role of social cognition in psychosis and the 
evidence that, in chronic course schizophrenia, social cognition is strongly related 
to functional outcomes, it is of importance to determine the strength of relationship 
between social cognition and functional outcomes in FEP and ARMS participants.  
In addition to social functioning, it is of interest to determine the strength of 
relationship between social cognition and psychotic symptomatology in ARMS and 
FEP. As with functional outcomes, individual studies have reported correlations 
between social cognition and psychotic symptoms in ARMS and FEP participants 
(e.g. Green et al., 2012; Ntouros et al., 2014). However, again, these findings have 
not yet been combined using meta-analytic methods.  
 A better understanding of the relationship between social cognition, 
functional outcomes, and psychotic symptoms in FEP and ARMS participants, may 
provide important information for more targeted therapeutic interventions. For 
example, in chronic course schizophrenia, social cognitive training has shown 
promise as a treatment for improving social cognitive impairments, with some 
effects in treating negative symptoms (Kurtz et al., 2016). Moreover, there is 
evidence that improving facial affect recognition in schizophrenia is associated 
with large improvements in social functioning (Bordon et al., 2017). At present, it 
is unclear which social cognitive domains are most strongly related to functioning 
and psychotic symptomatology in ARMS and FEP, and thus, which domains 
should be the target of therapeutic intervention. It is also unclear if the relationship 
between social cognition, functioning and psychotic symptoms differs due to stage 
of illness i.e. when in the ARMS stage or following the development of frank 
psychotic symptoms.   
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As such, the current study aims to address the gap in the evidence by conducting a 
meta-analysis to determine the following:  
1. The strength of relationship between social cognition, social functioning and positive 
and negative psychotic symptoms in ARMS and FEP participants.  
2. The strength of relationship between each social cognition subdomain (emotion 
recognition, ToM, social perception and attributional biases), social functioning and 
positive and negative psychotic symptoms in ARMS and FEP participants.  
3. The effect of demographic moderator variables on the strength of relationship between 
social cognition, social functioning and positive and negative psychotic symptoms in 
ARMS and FEP participants.  
 
3.3. Method 
3.3.1. Search Strategy  
A comprehensive search of the literature was conducted using the following 
databases: MEDLINE (Ovid), EMBASE (Ovid), CINAHL (EBSCO), and PsychINFO 
(EBSCO) from 1980 to June 2018. Search terms were: Ultra high risk for psychosis OR 
ultra high risk OR ultra-high risk OR UHR OR clinical high risk of psychosis OR clinical 
high risk OR CHR OR at risk mental state OR at-risk mental state OR ARMS OR 
prodromal psychosis OR prodromal schizophrenia OR schizophrenia prodrome OR 
prodromal phase OR prodrome OR prodromal stage OR prodromal symptoms OR 
attenuated psychotic symptom OR  attenuated psychosis syndrome AND first episode 
psychosis OR early psychosis OR FEP OR early schizophrenia AND social functioning 
OR social impairment OR social dysfunction OR social adjustment OR social recovery OR 
functioning OR impaired functioning OR general functioning OR functional impairment 
AND psychotic symptoms OR delusions OR hallucinations OR paranoia AND social 
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cognition OR social cognitive OR theory of mind OR emotion recognition OR 
affect recognition OR facial affect recognition OR emotional prosody OR 
emotional body language OR social perception OR mentalizing OR mentalising OR 
empathy OR faux pas OR social faux pas OR attributional style OR attributional 
bias  
 
3.3.2. Selection Criteria 
Studies were included in this meta-analysis based on the following 
inclusion/exclusion criteria: 
 
Inclusion Criteria:  
1 Primary research including observational and intervention studies reporting a 
relationship between a social cognition measure, functioning measure, and/or psychotic 
symptom measure. 
2 Participant age range <65 years old;  
3 Male and female;  
4 Participants identified as being at-risk for developing psychosis as defined by the 
Comprehensive Assessment of At Risk Mental States (CAARMS; Yung et al., 2005),  
Criteria of Prodromal States (COPS) using the Structured Interview for Prodromal 
Symptoms (SIPS), Scale of Prodromal Symptoms (SOPS; Miller et al., 2003) or Early 
Recognition Inventory (Häfner et al., 2004).  
5 Participants identified as having experienced a FEP diagnosed according to DSM-IV, 
DSM-IV-TR, DSM-5, ICD-10 criteria. 
                                                                                                                                                    
 
92 
 
6 Studies reporting a social cognition measure including but not limited to emotion 
processing (facial emotion recognition, emotion prosody), Social Perception, Theory 
of Mind and Attributional Style. 
7 Studies reporting a reliable and valid social functioning outcome measure to include, 
but not limited to, clinician rate, self-report and performance based measures; Social 
and Occupational Functioning Assessment Scale (SOFAS; Burns & Patrick, 2007); 
Multnomah Community Ability Scale (MCAS; Barker et al., 1994); Global 
Assessment of Functioning- Functioning subscale (Burns & Patrick, 2007); Global 
Functioning: Social Scale (Cornblatt et al., 2007); Social Adjustment Scale-II 
(Schooler et al., 1979); Role Functioning Scale (Goodman et al., 1993); Social 
Functioning Scale (SFS; Birchwood et al., 1990); Social Adjustment Scale-Self Report 
(Weissman & Bothwell, 1976); and Social Skills Performance Assessment (Patterson 
et al., 2001).  
8 Studies reporting a reliable and valid psychotic symptom outcome measure including 
but not limited to Brief Psychiatric Rating Scale (BPRS), Positive and Negative 
Syndrome Scale (PANSS), Scale for the Assessment of Positive Symptoms (SAPS); 
Scale for the Assessment of Negative Symptoms (SANS).  
 
Exclusion Criteria:  
1. Studies not reporting a cross-sectional relationship between a social cognition 
measure and social functioning or psychotic symptoms.  
2. Studies not including at-risk or FEP participants.  
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3.3.3. Quality Assessment:  
Studies were assessed for quality using the QualSyst tool (Kmet, Cook, & 
Lee, 2004). The QualSyst tool provides 14 quality assessment items which are 
scored depending on if the study meets criteria fully (yes=2) partially (partial=1) 
not at all (no= 0) or if the criteria is non-applicable (N/A). For the current study, 
three of 14 criteria pertaining to interventional trials were rated N/A for each study 
and these three criteria were excluded when determining the overall score, as 
described in the original article (Kmet et al., 2004).  
A random sample of 20% of included papers were blind quality assessed by 
an independent reviewer to determine inter-rater reliability, which showed fair 
agreement (84% agreement; κ= 0.35, p=0.001). Where disagreements arose, the 
assessors referred to the QualSyst scoring manual to discuss and agree on a final 
score.  The remainder of quality assessments were carried out by the first author.  
Each of 14 quality assessment items are added together to give an overall 
quality score for each study with a maximum score of 28. The total score is then 
divided by the maximum total score. As three items on the QualSyst tool pertain to 
interventional trials, the total number of items for each study in the current review 
was 11, providing a maximum total score of 22 for each paper and a maximum 
global rating (total score/ total number of quality items rated) of one for each study. 
A cut-off score of <0.5 was used to determine study inclusion (Kmet et al., 2004).  
 
3.3.4. Data Extraction 
Data were extracted from each study based on (1) study characteristics (year 
of publication, country where study was conducted, sample size); (2) characteristics 
of ARMS and FEP participants (mean age, ratio of male to female in sample, 
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duration of illness, IQ, chlorpromazine equivalent of medication use in milligrams per day 
(CPZ equiv/ mg per day); (3) clinical assessment/ diagnostic instruments used to identify 
ARMS and FEP participants (including the specific diagnosis that FEP participants where 
available); (4) measures used to assess social functioning and psychotic symptomatology; 
(5) social cognitive tests employed in each study and social cognitive domain assessed by 
this test (ER, ToM, SP, AB); (6) statistical correlation data between each available social 
cognitive measure and functioning/psychotic symptom outcomes. Data was not imputed if 
missing, unclear and/or not made available by the study authors.  
 
3.3.5. Summary Measures and Synthesis of Results for Meta-analysis  
Meta-analyses were conducted by computing a pooled correlation coefficient of 
extracted data using Comprehensive Meta-Analysis (CMA; Borenstein et al., 2013).  When 
meta-analysing correlational data, CMA conducts all statistical analysis on transformed 
standardised effect sizes (Fishers Z). However, for clarity, all data are presented as 
correlation coefficients (Pearson’s r).  
For each study, effect size (r values), 95% confidence interval (CI), Z and p values 
were computed based on the correlation coefficient data on the relationship between a 
social cognitive function test and social function/ psychotic symptom outcome. As between 
study heterogeneity was expected, the pooled correlation coefficient estimate and 95% CI 
were calculated using a random effects model. A random effects model accounts for within 
study variance and sample size to provide a weighted estimate of effect size and 95% CI.  
A series of meta-analyses were conducted to investigate the relationships of interest 
following the same protocol for each.  First, an analysis of the relationship between overall 
social cognitive performance (calculated by averaging all relevant correlational data 
provided in each study) and the outcome (social functioning, positive psychotic symptoms, 
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negative psychotic symptoms) was conducted. Next, we determined the 
relationship between each social cognitive domain individually (where data were 
available) and each outcome (social functioning, positive psychotic symptoms, 
negative psychotic symptoms). We determined that a minimum of three studies 
were required to incorporate in a meta-analysis (Borenstein et al., 2013). If less 
than three studies were unavailable for quantitative analysis, a narrative synthesis 
of available studies is provided.      
For each analysis determining the strength of relationship between a social 
cognitive measure) and outcome, a pooled correlation coefficient estimate was 
computed for ARMS and FEP groups individually. Following this, analysis of 
variance (ANOVA) were conducted to determine if the pooled correlation 
coefficient estimates significantly differed between ARMS and FEP participants. Z 
and p-values are reported for ANOVA and significance was set at p<0.05.  Finally, 
the overall pooled correlation coefficient for the combined ARMS and FEP groups 
is reported along with Z, p-values and 95% CI.  
Heterogeneity in effect size estimates between studies was determined using 
Chi-square based on Cochrans Q-statistic (Cochran, 1950). The proportion of 
variability in the pooled effect size due to between study heterogeneity is provided 
by the I
2
 value. An I
2= 
25% corresponds to low heterogeneity, 50% to moderate and 
75% to high (Higgins & Thompson, 2002).  As I
2 
has low sensitivity in detecting 
heterogeneity, alpha level of significance was set at p<0.1 (Song, Sheldon, Sutton, 
Abrams, & Jones, 2001).   
Where heterogeneity was significant in either ARMS or FEP groups, 
random effects meta-regression was conducted on the groups combined to 
determine which variables might account for heterogeneity. Variables entered into 
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the meta-regression model were publication year, continent in which study was conducted, 
study quality, sample size, mean age and gender (% of males in sample). Q and p values 
are reported for meta-regression analysis in addition to % of variance accounted for by the 
model, where relevant.  
Risk of bias was determined using funnel plots of Fishers Z standard error (SE) and 
the trim and fill method (Duval & Tweedie, 2000). The trim and fill method calculates how 
many studies might be missing from each meta-analysis to correct for funnel plot 
asymmetry and provides adjusted effect size estimates based on the inclusion of missing 
studies.  
 
3.4. Results 
A total of 45 studies, published between 1980 and January 2019 were identified for 
inclusion in this meta-analysis. Of these studies, 40 were independent samples. However, 
the authors of 8 other studies were unable to provide study data or were uncontactable, 
leaving a total of 32 studies included for quantitative analysis (see Figure 3.1. for details). 
In cases where data sets were overlapping, the authors were contacted to provide the 
original data set. Where this was not possible, data was extracted from the earliest 
publication and used for analysis. Of included studies, six studies had only a population of 
at risk participants (Amminger et al., 2013; Barbato et al., 2013; Cotter et al., 2015; Eack et 
al., 2010; Glenthoj et al., 2018; Piskulic et al., 2016), 20 studies with only a population of 
FEP participants (Achim, Ouellet, Roy, & Jackson, 2012; Addington, Saeedi, & 
Addington, 2006;  Bozikas et al., 2018; Bozikas et al., 2015; Caletti et al., 2018; Catalan et 
al., 2018; Catalan et al., 2016; Eack et al., 2010; Gardner et al., 2017; Hooper et al., 2010; 
Humphreys & Barrowclough, 2006; Koelkebeck et al., 2010; Langdon, Connors, Still, 
Ward, & Catts, 2014; Ludwig, Pinkham, Harvey, Kelsven, & Penn, 2017; Mazza et al., 
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2012; Ntouros et al., 2014; Romero-Ferreiro et al., 2016; Stouten, Veling, Laan, 
van der Helm, & van der Gaag, 2014, 2017; Tsui et al., 2013),  and six studies 
which included a sample of both at-risk and FEP participants (Clayson et al., 2018; 
Green et al., 2012; Lee et al., 2015; Ntouros et al., 2018; Ohmuro et al., 2016; 
Palmier-Claus et al., 2016). The total number of participants in the combined at risk 
(n=1403) and FEP sample (n=1596) was n=2999. However, it should be noted that 
in the at-risk group one study had a much larger sample size (n=746) than all other 
studies (Piskulic et al., 2016). The sample size ranged from 12 to 746. The age 
range of participants was 14.25 to 37.8 years with a mean of 23.03 years. The 
majority of included studies had a predominantly male sample (range: 27.5% to 
100% male, mean= 63.74%).  
A total of 21 studies included a social functioning measure and 23 a 
psychotic symptom measure. A total of 23 studies included a measure of emotion 
recognition, 20 a ToM measure (see Table 3.1. and 3.2. for details of tests), nine a 
Social Perception measure and four an Attributional Bias measure. As there were 
too few studies to combine Social Perception and Attributional Bias in a meta-
analysis for ARMS and FEP participants, these social cognitive domains were not 
analysed and only overall social cognition, emotion recognition and ToM were 
included.  
 
3.4.1. Study quality  
No studies which were quality rated fell below the <0.5 cut-off score and so 
no studies were excluded on this basis. As such, all studies met quality criteria. The 
range was 0.59 to 1.0 with a mean of 0.9 (S.D. ±  0.089).  Quality ratings for each 
study are presented in Table 3.3. below.  
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Records identified through 
database searching 
(n = 1888 ) 
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Additional records identified 
through other sources 
(n = 8 ) 
Records after duplicates removed 
(n = 1359) 
Records screened 
(n =1359) 
Records excluded 
(n =1035) 
Full-text articles assessed 
for eligibility 
(n = 326) 
Full-text articles excluded, with reasons 
(n =294) 
1. No social cognition measure 
(n=75) 
2. Chronic Schizophrenia (n=45) 
3. No correlation data reported 
(n=37) 
4. Incorrect correlation statistic  
(n=26) 
5. Unclear Duration of Psychosis 
(n=23) 
6. Full correlation data not 
reported (n=16) 
7. Conference abstract (n=12) 
8. Wrong patient population (n=10) 
9. Authors not contactable/ unable 
to provide data (n=8) 
10. Chronic duration psychosis (n=6) 
11. Full text not available (n=6) 
12. Meta-analysis (n=5) 
13. Non Clinical Sample (n=5) 
14. Overlapping samples (n=5) 
15. Drug trial (n=4) 
16. Wrong study design (n=4) 
17. Systematic review (n=2) 
18. Thesis (n=1) 
19. Animal study (n=1) 
20. Book (n=1) 
21. Narrative review article (n=2) 
Figure 3.1. PRISMA Flow chart of literature search, 
study review and study inclusion.  
 
Studies included in 
quantitative synthesis 
(n =32 ) 
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Table 3.1. Studies included in review with AMRS participants  
Study Country N Age 
(M, SD) 
Gender  
(n; 
M:F,) 
Duration 
of illness 
IQ 
M, SD 
ARMS 
Measure 
Social 
Functioning 
Measure 
Psychotic Symptom 
Measure 
Social Cognition Measure Social Cognitive  
Domains 
Amminger et al., (2013) Australia 79 16.5 (2.1) 26:53 NR NR NR NR NR Facial Recognition/Vocal 
Prosody 
ER 
Barbato et al., (2013) USA, 
Canada 
137 19.96 
(4.67) 
81:56 NR NR SIPS SFS NR FEIT, FEDT, RMET ER 
Clayson et al., (2018) USA 43 18.8 (3.9) 31:12 NR NR SIPS GFS:Social NR FEIT ER 
Cotter et al., (2015) Australia 30 19.1 (2.8) 14:16 NR 103.3 (16) CAARMS SOFAS NR DANVA-2, Hinting Task, 
MSCEIT,  
SCST-R, ANSIE 
ER, ToM, SP, AB 
Eack et al., (2010) Spain 70 16.3 
(3.4)19 
38:32 NR 104.11 SIPS/SOP
S 
NR SIPS/SOPS ER-40 ER 
Glenthoj et al., (2018) Denmark 146 24.3 (4.2) 66:80 NR 105 (12.9) CAARMS SOFAS/PSP NR CANTAB ERT ER 
Green et al., (2012) USA 50 18.25 
(3.12) 
36:14 NR NR SIPS NR SAPS/SANS MSCEIT, TASIT, RADS ER, SP 
Lee et al., (2015) South 
Korea 
40 19.9 (3.6) 25:15 NR 104.1 (11.8) SIPS Social 
Anhedonia 
Scale 
Chapman Perceptual 
aberration scale 
Ekmans Faces ER 
Ntouros et al., (2018) Greece  12 24.5 (3.1) 12:0 NR NR CAARMS NR PANSS PESIT ToM 
Ohmuro et al., (2016) Japan 36 20.9 (4.7) 14:22 NR 101.1 (11.7) CAARMS
-J 
SFS NR Picture Stories Task ToM 
Palmier-Claus et al., 
(2016) 
UK 14 22.6 (5.2) 6:8 NR NR CAARMS PSP NR RMET,  
Hinting Task 
ToM 
Piskulic et al., (2016) USA, 
Canada 
746 18.5 
(4.23) 
436:328 NR NR COPS  SIPS/SOPS Penn Emotion 
Differentiation task, TASIT, 
RADS 
ER, ToM, SP 
ANSIE, Adult Nowicki Strickland Internal External locus of control scale; CAARMS, Comprehensive Assessment of At-Risk Mental States; COPS, Criteria of Psychosis-risk Syndromes; DANVA-2, Diagnostic Analysis of 
Nonverbal Accuracy 2; ER, Emotion Recognition; ER-40, Penn Emotion Recognition Task;  FEIT, Face Emotion Identification Task; FEDT, Face Emotion Discrimination Task; GFS, General Functioning Scale; MSCEIT, 
Mayer–Salovey–Caruso Emotional Intelligence Test;  NR, Not reported; PANSS, Positive and Negative Symptom Scale; PESIT, Perception of Social Inference Test; PSP, Personal and Social Performance Scale; RADS, 
Relationship Across the Domains test; RMET, Reading the Mind in The Eyes Test; SIPS/SOPS, Structured Interview for Psychosis-risk Syndromes/ Scale Of Psychosis-risk Symptoms; SP, Social Perception; 
SOFAS, Social and Occupational Functioning Assessment Scale; SCST-R, Schema Component Sequencing Task–Revised; TASIT, The Awareness of Social Inference Test; ToM, Theory of Mind.  
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Table 3.2. Studies included in review with participants with first episode psychosis 
Study Country N 
(patients) 
Age 
(M, SD) 
Gender  
(M:F) 
Duration 
of illness 
(months, 
mean) 
IQ 
(mean, 
SD) 
Meds (CPZ 
equiv/mg 
per day(SD) 
Diagnosis Social 
Functioning 
Measure 
Psychotic 
Symptom 
Measure 
Social Cognition 
Measure(s) 
Social 
Cognitive 
Domains 
Achim et al., 
(2012) 
Canada 31 24.9 (4.5) 26:5 20.9 100.4 
(15.1) 
NR Schizophrenia (n=23), schizoaffective 
disorder (n=2), 
delusional disorder (n=4), and 
psychosis not otherwise specified 
(n=2) 
SOFAS NR Ekman Faces, Hinting 
Task,  False Belief 
Task,  Faux Pas, 
Strange Stories Test, 
Social Knowledge Test, 
SCRT 
ER, ToM, 
SP 
Addington et 
al., (2006) 
Canada 50 25.1 (8.0) 30:20 NR NR 343.5 Schizophrenia 
(n=32) , schizophreniform 
(n=12), delusional disorder (n=1), 
brief psychotic disorder (n=1), 
psychotic disorder not otherwise 
specified (n=3) and schizoaffective 
(n=1) 
Quality of Life 
Scale, 
Assessment of 
Interpersonal 
Problem 
Solving 
PANSS Emotion Recognition, 
Discrimination, SFRT 
ER, SP 
Bozikas et al., 
(2015) 
Greece 27 26.33 
(4.51) 
24:3   538.09 
(67.32)  
DSM-IV-TR, psychotic disorder  PANSS PESIT SP 
Bozikas et al., 
(2018) 
Greece 35 32.77 
(7.56) 
19:16 NR  358.37 
(200.41) 
Schizophrenia (n=21), Schizoaffective 
disorder, (n=1), Delusional disorder 
(n=2), Unspecified psychotic disorder 
(n=2), Brief psychotic disorder (n=5), 
Bipolar disorder ( n=4)  
 PANSS Facial affect 
recognition 
ER 
Caletti et al., 
(2018) 
Italy 208 30.2 (10.3) 118:90 NR 109.8 
(6.9) 
NR  ICD-10 for psychosis  PANSS MEC ER 
Catalan et al., 
(2018) 
Spain 32 37.8 (13) 13:19 NR 91.1 
(17.3) 
NR DSM-IV psychotic disorder  PANSS MASC ToM 
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Study Country N 
(patients) 
Age 
(M, SD) 
Gender  
(M:F) 
Duration 
of illness 
(months, 
mean) 
IQ 
(mean, 
SD) 
Meds (CPZ 
equiv/mg 
per day(SD) 
Diagnosis Social 
Functioning 
Measure 
Psychotic 
Symptom 
Measure 
Social Cognition 
Measure(s) 
Social 
Cognitive 
Domains 
Catalan et al., 
(2016) 
Spain 64 35.5 (12.9) 41:23 NR 95.3 
(14.4) 
NR Schizophrenia or schizophreniform 
disorder 
(n = 32), Affective psychosis (n = 18), 
Brief psychotic episode (n = 7), 
Delusional disorder (n = 7) 
 PANSS MASC TOM 
Clayson et al., 
(2018) 
USA 63 22.7 (3.5) 46:17 NR NR NR DSM-IV diagnostic criteria for 
schizophrenia, schizoaffective 
disorder, or schizophreniform disorder 
GFS:Social  FEIT ER 
Eack et al., 
(2010) 
USA 64 25.78 
(6.15) 
44:20 38.4 
(27.72) 
NR NR schizophrenia (n = 37), schizoaffective 
(n = 23), or schizophreniform 
disorder (n = 4) 
Performance 
Potential 
Inventory 
 MSCEIT ER 
Gardner et al., 
(2017) 
Australia 146 20.49 
(2.41) 
101:45 8.9 (16.11) 92.4 
(13.93) 
NR Schizophrenia ( n=56), 
Depression with psychotic features 
(n=21),  
Schizoaffective disorder (n=19), 
Psychosis not otherwise specified 
(n=17), 
Bipolar disorder with psychotic 
features (n=16), 
Schizophreniform disorder (n=8), 
Delusional disorder (n=8), Brief 
psychotic disorder (n=1)  
SOFAS  DANVA, False Belief 
and Deception Stories 
ER, ToM 
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Study Country N 
(patients) 
Age 
(M, SD) 
Gender  
(M:F) 
Duration 
of illness 
(months, 
mean) 
IQ 
(mean, 
SD) 
Meds (CPZ 
equiv/mg 
per day(SD) 
Diagnosis Social 
Functioning 
Measure 
Psychotic 
Symptom 
Measure 
Social Cognition 
Measure(s) 
Social 
Cognitive 
Domains 
Green et al., 
(2012) 
USA 81 22.02 
(4.18) 
30:20 NR NR NR Schizophrenia (n = 46), 
Schizoaffective disorder (n =10), 
Schizophreniform disorder (n = 25) 
 SAPS/SA
NS 
MSCEIT, TASIT, 
RADS 
ER, SP 
Hooper et al., 
(2010) 
USA 119 14.25 
(2.41) 
     VABS  RMET ToM 
Humphreys & 
Barrowclough, 
(2006) 
UK 35 27.91 
(7.81) 
28:7 NR NR NR Schizophrenia, Schizophreniform, 
Schizoaffective disorder. 
 PANSS ASQ, IPSAQ AB 
Koelkebeck et 
al., (2010) 
Germany 23 24.5 (5.6) 11:12 36.4 (34.5) NR 539.7 (296.9) SCID-I  PANSS Moving Shapes 
paradigm 
ToM 
Langdon et al., 
(2014) 
Australia 23 20.91 
(1.83) 
22:1 11.8 (6.88) 96.65 
(8.41) 
NR ICD-10 criteria 
 Paranoid Schizophrenia (n=17); 
Undifferentiated 
Schizophrenia (n=4); Schizoaffective 
Disorder – Bipolar Subtype (n=1); 
Other Non-Organic Psychotic 
Disorder (n=1) 
SOFAS SAPS/SA
NS 
False belief, Joke  
Appreciation, Story 
comprehension 
ToM 
Lee et al., 
(2015) 
South Korea 24 20.5 (3.3) 8:16 9.5 (10.8) 96 
(15.7) 
454.7 (307.6) NR Social 
Anhedonia 
Scale 
Chapman 
Perceptual 
aberration 
scale 
Ekmans Faces ER 
Ludwig et al., 
(2017) 
USA 38 23.5 (3.01) 33:5 NR NR NR Schizophrenia( n=25) 
Schizoaffective (n=6) 
Psychosis NOS (n= 7) 
SSPA  ER-40, BLERT, 
TASIT, Hinting Task, 
RADS, AIHQ 
ER, ToM, 
SP, AB 
Mazza et al., 
(2012) 
Italy 49 26.4 (7.56) 33:16 NR 79.7 
(12.9) 
 DSM-IV-TR diagnoses of 
schizophrenia or schizoaffective 
disorder 
VADO 
Personal and 
Social 
Functioning  
Scale  
 Strange Stories Test ToM 
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Study Country N 
(patients) 
Age 
(M, SD) 
Gender  
(M:F) 
Duration 
of illness 
(months, 
mean) 
IQ 
(mean, 
SD) 
Meds (CPZ 
equiv/mg 
per day(SD) 
Diagnosis Social 
Functioning 
Measure 
Psychotic 
Symptom 
Measure 
Social Cognition 
Measure(s) 
Social 
Cognitive 
Domains 
Ntouros et al., 
(2014) 
Greece 27 26.33 
(4.51) 
24:3 NR NR 538.09 NR  PANSS PESIT ER, ToM 
Ntouros et al., 
(2018) 
Greece 25 25.48 
(5.41) 
25:0 NR NR 555.32 
(388.67) 
NR  PANSS PESIT ToM 
Ohmuro et al., 
(2016) 
Japan 40 22.9 (6.3) 11:29 NR 99.1 
(8.3) 
371.9(343.1) Schizophrenia (n=24,); 
Schizophreniform disorder (n=4);  
Brief psychotic disorder (n=1); 
Delusional disorder (n=1), Bipolar 
disorder with psychotic features (n=2), 
Psychotic disorder not otherwise 
specified (n=8) 
SFS  Picture Stories Task ToM 
Palmier-Claus 
et al., (2016) 
UK 20 24.6 (5.2) 16:4 NR NR NR Cut-off scores on the Positive and 
Negative Syndrome Scale 
PSP Green 
Paranoid 
Thought 
Scales 
RMET, 
Hinting Task 
ToM 
Romero-
Ferreiro et al., 
(2016) 
Spain 21 15.6 (1.63) 13:7 NR NR 206.45 
(128.63) 
ICD-10  PANSS NimStim set facial 
affect recognition 
ER 
Stouten et al., 
(2014) 
Netherlands 153 27.8 111:42 NR NR NR Schizophrenia (n=81),  
brief psychotic disorder (n=9), 
delusional disorder (n=5), shared 
psychotic disorder (n=2), 
psychotic disorder NOS (n=56) 
PSP PANSS Hinting Task TOM 
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Study Country N 
(patients) 
Age 
(M, SD) 
Gender  
(M:F) 
Duration 
of illness 
(months, 
mean) 
IQ 
(mean, 
SD) 
Meds (CPZ 
equiv/mg 
per day(SD) 
Diagnosis Social 
Functioning 
Measure 
Psychotic 
Symptom 
Measure 
Social Cognition 
Measure(s) 
Social 
Cognitive 
Domains 
Stouten et al., 
(2017) 
Netherlands 162 27.61 (6.3) 116:46 NR NR NR Schizophrenia (n=81)  
Schizoaffective disorder (n= 9); 
Brief psychotic disorder (n= 9);  
Delusional disorder (n=5) 
Shared psychotic disorder (n=2);  
Psychotic disorder NOS (n=56) 
PSP PANSS Amsterdam 
Neuropsychological 
Tasks (emotion  
processing speed), 
Hinting Task, WAIS III 
Picture Arrangement, 
Davos Assessment of  
Cognitive Biases Scale 
ER, TOM, 
SP, AB 
Tsui et al., 
(2013) 
China 36 22 (4.6) 18:18 29.6 (20.1) 105.3 
(15.6) 
358.1 (23.1) Schizophrenia   SAPS/SA
NS 
Facial emotion 
categorization 
ER 
AB, Attributional Bias; AIHQ, Ambiguous Intentions Hostility Questionnaire; ANSIE, Adult Nowicki Strickland Internal External locus of control scale; ASQ, Attributional Style Questionnaire; BLERT, Bell Lysaker Emotion Recognition Task; 
CANTAB ERT, Cambridge Neuropsychological Test Automated Battery-Emotion Recognition Test; DANVA-2, Diagnostic Analysis of Nonverbal Accuracy 2; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders; ER, Emotion 
Recognition; ER-40, Penn Emotion Recognition Task; FEIT, Face Emotion Identification Task; FEDT, Face Emotion Discrimination Task;GFS, General Functioning Scale; IPSAQ, International, Personal, and Situational Attributions 
Questionnaire; ICD, International Classification of Diseases; MASC, Movie for the Assessment of Social Cognition; MEC, Montreal Evaluation Protocol of Communication; MSCEIT, Mayer–Salovey–Caruso Emotional Intelligence Test; NR, 
Not reported; PANSS, Positive and Negative Symptom Scale; PESIT, Perception of Social Inference Test; PERT, Penn Emotion Recognition Test; PSP, Personal and Social Performance Scale; RAD, Relationship Across the Domains test; 
RMET, Reading the Mind in The Eyes Test; SIPS/SOPS, Structured Interview for Psychosis-risk Syndromes/ Scale Of Psychosis-risk Symptoms; SP, Social Perception; SOFAS, Social and Occupational Functioning Assessment Scale; 
SAPS/SANS, Scale for the Assessment of Positive Symptoms/ Scale for the Assessment of Negative Symptoms; SCST-R, Schema Component Sequencing Task–Revised; SCID-I, Structured Clinical Interview; SFRT, Situational Features 
Recognition Test; SP, Social Perception; SSPA, Social Skills Performance Assessment; TASIT, The Awareness of Social Inference Test; ToM, Theory of Mind; VABS, Vineland Adaptive Behavior Scale; VSIT, Video Social Inference Task; 
WAIS, Wechsler Adult Intelligence Scale. 
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Study Objective Study 
Design 
Recruitment 
Method 
Sample 
Characteristics 
Measures Sample 
Size 
Analysis  Estimate of 
Variance 
Confounding 
Variables 
Results  Valid 
Conclusions 
Global 
Score 
Achim (2012) 
 
2 2 2 2 2 1 2 0 2 1 2 0.82 
Addington 
(2006) 
 
2 2 2 2 2 1 2 0 2 1 2 0.82 
Amminger 
(2013) 
 
2 1 1 1 1  0 1 2 0 2 2 0.59 
Barbato (2013) 
 
2 2 2 2 2 2 2 2 2 2 2 1.00 
Bozikas (2015)  
 
2 2 2 2 2 0 2 2 2 2 2 0.91 
Bozikas (2018) 
 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Caletti (2018) 
 
1 2 1 2 2 1 2 2 2 2 2 0.86 
Catalan (2016)  
 
2 2 2 2 2 1 1 2 2 1 2 0.86 
Catalan 2018  
 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Clayson (2018) 
 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Cotter (2015) 
 
2 1 2 2 2 0 1 2 1 2 2 0.77 
Eack, Greeno 
(2010)  
 
2 2 2 2 2 1 1 2 1 2 2 0.86 
Eack, Mermon 
(2010) 
 
2 2 2 2 2 1 0 2 2 2 2 0.86 
Gardner (2017) 
 
2 2 2 2 2 1 2 2 1 2 2 0.91 
Glenthoj (2018) 
 
2 2 2 2 2 2 2 2 2 2 2 1.00 
Green (2012)  
 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Hooper (2010)  
 
1 2 2 2 1 1 2 2 1 2 2 0.73 
Humphreys 
(2006)  
 
2 2 2 2 2 1 0 2 2 2 2 0.86 
Table 3.3. Quality ratings for each included study  
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Koelkebeck 
(2010) 
 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Langdon (2014) 
 
2 1 2 2 2 2 2 2 2 2 2  0.95 
Lee (2015)   
 
2 1 2 2 2 1 2 2 2 2 2  0.91 
Ludwig (2017) 
 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Mazzaetal.(2012) 
 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Ntouros (2014) 
 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Ntouros (2018)  
 
2 2 2 2 0 0 2 2 2 2 2 0.82 
Ohumuro (2016)  
 
2 2 2 2 2 2 2 2 2 2 2 1.00 
Palmier-Claus 
(2016) 
 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Piskulic (2016) 
 
2 2 2 2 2 1 2 2 2 2 2 1.00 
Romero-Ferreiro 
(2016) 
2 2 2 2 2 1 2 2 2 2 2 0.95 
Stouten (2014) 
 
2 2 2 1 2 1 2 2 0 2 2 0.82 
Stouten (2017) 
 
2 2 2 2 2 1 2 2 0 2 2 0.86 
Tsui (2013) 
 
2 2 2 2 1 1 2 2 2 2 2 0.91 
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3.4.2. Results from Meta-analyses 
The results from each meta-analysis are summarised in Table 3.3. For 
ARMS participants, a significant positive relationship was identified between 
overall social cognition (r= 0.118 (95% CI: 0.023 to 0.210), emotion recognition 
(r= 0.131 (95% CI: 0.031 to 0.228), ToM 0.178 (95% CI: 0.043 to 0.306) and 
social functioning. In addition, a significant negative relationship was identified 
between emotion recognition performance and negative symptoms in ARMS 
participants (r= -0.11 (95% CI: -0.201 to -0.017). Only two included studies 
reported the correlation coefficient between ToM performance and negative 
psychotic symptoms in ARMS participants. As such these were not included in a 
quantitative analysis. These studies reported differing results and had notable 
differences in sample size. Piskulic et al., (2016) reported a weak negative 
correlation between these variables (r= -0.07, n=764) whilst Ntouros et al., (2018) 
reported a weak positive correlation (r=0.042, n=12). Significant pooled effect sizes 
in each analysis were small. For non-significant findings in ARMS participants, 
similarly small effect sizes were identified for each social cognitive domain, social 
functioning and psychotic symptoms (see Table 3.4. for details). Between study 
heterogeneity varied depending on the analysis and ranged from I
2
 = 0% to 58.82%.  
In FEP participants, significant pooled effect sizes were identified for each 
meta-analysis (see Table 3.4. for details). Overall social cognition, emotion 
recognition and ToM were significantly positively related to social functioning and 
significantly negatively related to positive and negative psychotic symptoms (see 
Table 3.4.). Effect sizes in each analysis were small ranging from r= -0.3 to r= 
0.222. The largest effect size was identified for the negative relationship between 
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ToM performance and negative symptoms. Across analyses between study heterogeneity 
was low, ranging from I
2 
= 0% to 19.18% (see Table 3.4.). Forest plots with results from 
individual studies in each meta-analysis can be inspected in Appendix C.
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2.4. Summary table of all meta-analyses carried out to determine the relationship between overall social cognition, social functioning and psychotic symptoms in ARMS and FEP participants 
Social Cognitive 
Domain 
Outcome 
Measure 
ARMS 
N 
ARMS 
Κ 
studies 
ARMS  
Pooled 
Estimate 
 (95% CI) 
Z Pooled 
Estimate 
P value 
Q Df I2 
(%) 
Tau2 H  
P value 
FEP 
 N 
FEP  
K 
Studies 
FEP 
Pooled Estimate 
(95% CI) 
Z Pooled 
P value 
Q Df I2 Tau H 
P 
value 
Overall Social 
Cognition 
Social 
Functioning 
446 7 0.118 (0.023 to 
0.210) 
2.443 0.015 2.458 6 0 0.0 0.873 965 14 0.205 (0.143 to 
0.266) 
6.327 <0.001 7.448 13 0 0.0 0.878 
 Positive 
Symptoms 
940 6 -0.144 (-0.315 
to 0.035) 
-1.575 0.115 12.14
1 
5 58.82 0.025 0.033 833 15 -0.178 (-0.245 to 
0.109) 
-2.036 <0.001 13.40
5 
15 0 0.0 0.571 
 Negative 
Symptoms 
885 4 -0.131 ( -0.277 
to 0.021) 
-1.691 0.091 5.01 3 40.11 0.01 0.171 973 14 -0.211 (95% CI: -
0.282 to -0.137) 
-5.514 <0.001 16.08
6 
13 19.
18 
0.004 0.245 
Emotion 
Recognition 
Social 
Functioning 
396 5 0.131 ( 0.031 to 
0.228) 
2.571 0.01 1.651 4 0 0.00 0.8 577 8 0.222 (0.141 to 
0.299) 
5.3 <0.001 10.97 7 0 0.00 0.993 
 Positive 
Symptoms 
913 5 -0.144 (-0.315 
to 0.035) 
-1.575 0.115 12.14
1 
5 58.82 0.025 0.033 459 8 -0.166 (-0.234 to 
0.069) 
-4.633 <0.001 8.914 14 0 0.00 0.836 
 Negative 
Symptoms 
945 4 -0.11 (-0.201 to 
-0.017) 
-2.317 0.021 3.64 3 17.59 0.002 0.303 677 9 -0.211 ( -0.283 to 
-0.137) 
-5.465 <0.001 6.086 8 0 0.00 0.638 
ToM Social 
Functioning 
217 4 0.178 ( 0.043 to 
0.306) 
2.571 0.01 2.134 3 0 0.00 0.545 767 10 0.208 ( 0.138 to 
0.276) 
5.72 <0.001 8.262 9 0 0.00 0.508 
 Positive 
Symptoms 
790 3 0.033 (-0.301 to 
0.36) 
0.187 0.851 3.991 2 49.88 0.051 0.136 465 8 -0.189 (-0.288 to -
0.085) 
-3.547 <0.001 7843 7 10.
74 
0.003 0.347 
 Negative 
Symptoms 
- - - - - - - - - - 399 5 -0.3 (-0.396 to -
0.198) 
-5.56 <0.001 4.389 4 8.8
7 
0.002 0.356 
ARMS, at-risk mental state; FEP, first episode psychoisis; H; Heterogeneity p value; K, number of studies; DF, degrees of freedom. Bold pooled estimates indicate significant result.  
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3.4.3. Risk of bias in each meta-analysis  
For each meta-analysis the trim and fill method was used by constructing funnel 
plots to identify how many, if any, studies might be missing from each analysis that would 
make the funnel plot symmetrical. Analyses were conducted using a random effects model 
and the unadjusted and adjusted pooled correlation coefficients along with 95% confidence 
intervals are presented in Table 3.5. Each funnel plot can be visually inspected in 
Appendix D. Briefly, the range of missing studies for ARMS participants was 1 to 3. As 
can be seen in Table 3.5 below, the adjusted pooled estimates were not largely different 
than unadjusted estimates. Similarly, the range of number of missing studies for FEP 
participants was between 1 to 4. The adjusted estimates were each within the same range as 
unadjusted estimates. Taken together, this suggests that publication bias may not have had 
a major effect on the pooled estimates. However, as fewer studies were included for 
ARMS participants, caution is needed in drawing this conclusion.  
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Table 3.5. Summary table of risk of bias funnel plot analysis showing adjusted and unadjusted pooled estimate  
effect sizes for each meta-analysis in ARMS and FEP participants 
 
 
3.4.4. Effect of Group on the Relationship between social cognition, social functioning 
and psychotic symptoms 
There were no significant group differences between ARMS and FEP 
participants on the relationship between social cognition, ER or ToM and social 
functioning and psychotic symptoms (see Table 3.6. for details). Note, ToM and 
negative symptoms were not included as fewer than three studies reported this 
relationship in ARMS participants. This suggests that the strength of relationship 
between each social cognitive measure and outcomes is similar in ARMS and FEP 
Social 
Cognitive 
Domain 
Outcome 
Measure 
ARMS 
Number 
of missing 
studies 
ARMS  
Unadjusted 
Pooled Estimate 
(95% CI) 
ARMS  
Adjusted 
Pooled Estimate 
(95% CI) 
FEP 
Number of 
missing 
studies 
FEP 
Unadjusted 
Pooled Estimate 
(95% CI) 
FEP 
Adjusted 
Pooled Estimate 
(95% CI) 
Overall Social 
Cognition 
Social 
Functioning 
3 0.118 (0.023 to 
0.210) 
0.149 (0.064 to 
0.233) 
3 0.205 (0.143 to 
0.266) 
.187 ( 0.127 to 
0.246) 
 Positive 
Symptoms 
1 -0.144 (-0.315 to 
0.035) 
-0.114 (-0.284 to -
0.062) 
1 -0.178 (-0.245 to 
0.109) 
-0.157 ( -0.224 to 
-0.088) 
 Negative 
Symptoms 
1 -0.131 ( -0.277 to 
0.021) 
-0.124 (-0.245 to -
0.00003) 
4 -0.211 (95% CI: -
0.282 to -0.137) 
-0.257 (-0.334 to -
0.176) 
Emotion 
Recognition 
Social 
Functioning 
1 0.131 ( 0.031 to 
0.228) 
0.146 (0.031 to 
0.052) 
2 0.222 (0.141 to 
0.299) 
0.211 (0.134 to 
0.285) 
 Positive 
Symptoms 
2 -0.144 (-0.315 to 
0.035) 
-0.055 (-0.02 to -
0.096) 
1 -0.166 (-0.234 to 
0.069) 
-0.177 (-0.268 to -
0.082) 
 Negative 
Symptoms 
1 -0.11 (-0.201 to -
0.017) 
-0.102  -0.163 to -
0.041) 
3 -0.211 ( -0.283 to 
-0.137) 
-0.237 (-0.305 to -
0.167) 
ToM Social 
Functioning 
1 0.178 ( 0.043 to 
0.306) 
0.191 (0.059 to 
0.315) 
1 0.208 ( 0.138 to 
0.276) 
0.198 (0.126 to 
0.269) 
 Positive 
Symptoms 
0 0.033 (-0.301 to 
0.36) 
- 2 -0.189 (-0.288 to -
0.085) 
-0.141 (-0.274 to -
0.004) 
 Negative 
Symptoms 
- - - 2 -0.3 (-0.396 to -
0.198) 
-0.334 (-0.445 to -
0.213) 
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participants. However, the pattern of results indicates a small, but consistent difference 
with a stronger relationship apparent in each analysis for FEP participants when compared 
to ARMS participants. 
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Table 3.6. Group differences on overall correlation coefficient in ARMS versus FEP participants 
Social Cognitive 
Domain 
Outcome Measure Κ studies ARMS N FEP N Pooled Estimate (95% CI) Q Df ARMS vs. FEP  
p- value 
     ARMS FEP    
Overall Social 
Cognition 
Social Functioning 21 446 965 0.118 (0.023 to 0.210) 0.205 (0.143 to 0.266) 2.345 1 0.126 
 Positive Symptoms 22 940 833 -0.144 (-0.315 to 0.035) -0.178 (-0.245 to 0.109) 0.121 1 0.728 
 Negative Symptoms 18 885 973 -0.131 ( -0.277 to 0.021) -0.211 (95% CI: -0.282 to 
-0.137) 
0.882 1 0.348 
Emotion Recognition Social Functioning 13 396 577 0.131 ( 0.031 to 0.228) 0.222 (0.141 to 0.299) 1.98 1 0.159 
 Positive Symptoms 12 913 459 -0.144 (-0.315 to 0.035) -0.166 (-0.234 to 0.069) 0.05 1 0.823 
 Negative Symptoms 13 945 677 -0.11 (-0.201 to -0.017) -0.211 ( -0.283 to -0.137) 2.862 1 0.091 
ToM Social Functioning 14 217 767 0.178 ( 0.043 to 0.306) 0.208 ( 0.138 to 0.276) 1.56 1 0.69 
 Positive Symptoms 11 790 465 0.033 (-0.301 to 0.36) -0.189 (-0.288 to -0.085) 1.485 1 0.223 
ARMS, at risk mental state; DF, degrees of freedom; FEP, first episode psychosis; ToM, Theory of Mind. 
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3.4.5. Meta Regression: Factors explaining between study heterogeneity 
Sample size (Q(1)=11.18, p=0.008) was a significant predictor of between study 
variance for the relationship between social cognition and positive psychotic symptoms. 
Adding study quality to the model (Q(2)= 8.48, p=0.014) explained 87% of between study 
variance. Similarly, sample size and study quality combined (Q(2)=11.46, P=0.032) 
explained 100% of the variance in the relationship between emotion recognition and 
positive psychotic symptoms. A combined model of sample size and publication year 
(Q(2)=6.93, P=0.0313) accounted for 71% of the between study variance in studies 
reporting the relationship between ToM performance and positive psychotic symptoms. 
Taken together, the results from this meta-regression suggest that much of the between 
study variance can be accounted for by sample size and study quality. That publication 
year accounts for some variance may suggest a difference between more recent and earlier 
studies regarding variables such as psychometrically sound outcomes measure. However, 
this hypothesis was not tested in the current study due to a limited range of studies and 
outcome measures available.   
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3.5. Discussion  
Main Findings 
This study aimed to identify the degree to which social cognitive 
functioning, and subdomains, were related to social functioning and psychotic 
symptoms in participants defined as ARMS and having experienced a FEP. Overall 
better social cognition was associated with better social functioning in ARMS and 
FEP participants, with a small effect size in both groups. Better overall social 
cognition was significantly related to lower positive and negative psychotic 
symptoms in FEP but not ARMS participants. In both groups the overall effect size 
was small but it is noteworthy that the direction of effect was the same in both 
groups. A similar pattern was identified when each social cognitive subdomain was 
analysed. In ARMS participants, better emotion recognition and ToM performance 
were significantly related to better social functioning, while the relationship 
between ER and ToM was not significant for psychotic symptoms. In contrast, 
enhanced ER and ToM performance were significantly associated with improved 
social functioning and lower psychotic symptoms in FEP participants. The 
strongest relationship was identified for ToM and negative symptoms in FEP 
participants (r=-0.3). Although effect sizes remained in the small range, they were 
as predicted, in that better social cognitive functioning was associated with better 
social functioning and lower positive and negative symptomatology.  
Our findings are in line with a previous meta-analysis conducted on studies 
with patients with chronic course schizophrenia (Fett et al., 2011). In this study, the 
largest effect size was for the relationship between ToM and community 
functioning (r= 0.48). This effect size is larger than that identified in the current 
study for the relationship between ToM and social functioning in FEP (r=0.208)  
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and ARMS participants (r=0.178). Our findings are in line with a previous meta-analysis 
demonstrating that ER and ToM performance are significantly related to psychotic 
symptoms in a mixed sample of FEP and longer duration psychotic disorder (Fett, Maat, & 
Investigators, 2011). In this analysis, the effect sizes were similarly small and showed an 
inverse relationship between social cognitive functioning, and positive and negative 
psychotic symptoms.  
We did not find any significant differences between the pooled estimates for overall 
social cognition, or subdomains, and outcome measures in at risk and FEP participants. 
This may indicate that social cognitive impairments impact on social functioning and level 
of psychotic symptoms similarly before and after the onset of frank psychosis. However, 
this conclusion should be treated with caution as all data included in our meta-analyses 
were cross-sectional and future longitudinal studies are needed to confirm this conclusion. 
In addition, although group differences were not significant, there was a consistent 
difference in magnitude of relationship between ARMS and FEP participants in each meta-
analysis.  
Heterogeneity between studies was generally low when ARMS and FEP groups 
were combined in each meta-analysis. However, within the ARMS group greater between 
study heterogeneity was identified. This may reflect that this population of individuals are 
more heterogeneous as regards a range of psychological factors, including level of 
psychotic symptomatology and social functioning. However, it is likely to reflect that there 
smaller number of ARMS studies that were different to one another in terms of sample 
sizes.  As there were a limited number of studies in the ARMS group for some 
subdomains, we choose to carry out meta-regression analyses on the groups combined, so 
as to increase statistical power. This showed that sample size and study quality moderated 
the relationship between social cognition (explained variance=87%), emotion recognition 
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(explained variance=100% of variance) and positive symptoms. Similarly, the 
combined model of sample size and publication year moderated the relationship 
between ToM performance and positive psychotic symptoms (explained 
variance=71%). Unfortunately, many studies did not report important variables that 
may have been significant moderators such as neuropsychological function (Fett et 
al., 2011), duration of illness (Savla et al., 2012), and medication usage in both 
ARMS and FEP participants. In addition, few studies reported mental health 
diagnoses in ARMS participants which is likely to be an important moderator of the 
relationship between social cognitive functioning, social functioning and psychotic 
symptoms. It has been shown that social cognitive impairments are evident to 
varying degrees in all the major psychiatric diagnosis (Cotter et al., 2018). As such, 
the degree to which social cognitive deficits ARMS participants is a function of the 
underlying aetiology of psychosis, or reflects the severity of psychopathology in 
general, is unclear. Psychosis, or psychotic symptoms, may be viewed as a marker 
of severe psychopathology (Guloksuz & van Os, 2018), and it is important to note 
that not all individuals identified as being ARMS subsequently transition to full 
have a full psychotic episode (estimated at 36% after 3 years; Fusar-Poli, Bonoldi, 
et al., 2012). A such, although the current findings suggest that the effect of social 
cognitive performance on social functioning and psychotic symptoms is similar 
before and after the onset of psychosis, future investigation is needed to confirm if 
this remains the case when co-morbidity and general psychological distress is 
factored into the analysis.  
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Theoretical Links  
The mechanisms by which social cognitive abilities influence social functioning 
likely involves the individual being able to predict others’ behaviour, understand others’ 
emotional state, intentions, desires, wants and needs, thus conferring positive social 
experiences and reinforcing the pursuit of social interactions. If an individual struggles to 
make sense of others, the social world may be confusing and lead to social misperceptions, 
unexpected responses and actions by others, and eventually social withdrawal, as social 
interactions are experienced as unpleasant (Couture et al., 2006). The mechanisms 
involved in how social cognitive functioning and psychotic symptoms are related to one 
another have been described in psychological models of psychosis. These models indicate 
that aspects of social cognition, including ToM, influence the expression of both positive 
and negative symptoms before the onset of frank psychotic symptoms, and that social 
functioning difficulties may be related to these symptoms (Beck et al., 2011; Frith, 1992; 
Garety et al., 2001; Morrison, 2001; Rector et al., 2005).  There is a significant literature 
indicating that certain attributional biases, such as jumping to conclusions, are related to 
paranoia and delusions in psychosis (Ross et al., 2015), and negative appraisals of 
expectancy of pleasure, success, acceptance and perceived resources influence the 
expression of negative symptoms, which lead to social functioning impairments (Beck et 
al., 2011; Rector et al., 2005). The processes involved in how ER influences psychotic 
symptoms has not yet been fully delineated, and it is important to note that poorer ER 
performance may be an outcome of increased psychotic symptoms (Bliksted, Videbech, 
Fagerlund, & Frith, 2017).  Nevertheless, if an individual views social interactions as 
anxiety provoking and confusing or threatening, this may trigger positive symptoms such 
as paranoia and delusions which left unchallenged, may become problematic (Arguedas, 
Green, Langdon, & Coltheart, 2006; Garety et al., 2001).   
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Strengths and Methodological Limitations 
To the best of our knowledge, this is the first comprehensive review of the 
literature and detailed meta-analysis of the relationship between overall social 
cognitive functioning, ER and ToM, social functioning and psychotic 
symptomatology in ARMS and FEP. There was only a small amount of between 
study heterogeneity with combined sample sizes large enough to provide accurate 
correlational point estimates. In addition, our analysis allowed to us to determine if 
ARMS and FEP participants significantly differed regarding the strength of 
relationship between social cognition and social functioning and psychotic 
symptoms. However, there are some important methodological limitation that 
should be considered when interpreting these findings. As noted above, many 
studies did not report data for important moderator variables, and future studies are 
needed in which these factors are accounted for in the analysis. Another major 
limitation in this study is the total number of studies for ARMS participants in each 
meta-analysis conducted. It is clear that while a sufficient number of independent 
studies have investigated the relationship between social cognition, functional 
outcomes and psychotic symptoms, in FEP, but further studies are needed in 
ARMS to determine the consistency of findings. Similarly, due to a limited number 
of studies that met inclusion criteria we weren’t able to include performance on 
tests of social perception and attributional bias in our analysis, and this is an 
important area for future study. Finally, we aimed to be inclusive as regards the 
particular test used to assess social cognitive performance in each domain. 
However, there is a lack of consistency between studies in which test is used to 
assess ER and ToM, and the presumption is that each test will measure an 
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underlying psychological function in a similar manner. However, the degree to which this 
assumption is valid should be tested in future studies.  
 
Clinical Implications 
The findings presented in the current study suggest that targeting social cognition, 
particularly ER and ToM, may have beneficial effects on social functioning and psychotic 
symptomatology. These findings are consistent with prior research in longer duration 
schizophrenia, in which it has been reported that various psychological interventions, such 
as cognitive remediation, can lead to significant improvements in ER performance which is 
associated with a large increase in social functioning (Bordon et al., 2017).  Similarly, a 
meta-analysis reported that social cognitive training produces significant improvements in 
ER and ToM in individuals diagnosed with schizophrenia (Grant et al., 2017). However, 
the authors of this report found limited evidence for concurrent improvements in functional 
outcomes. In ARMS participants, few studies have investigated the effects of social 
cognition targeted interventions (Glenthøj et al., 2017). Taken together, while there is 
evidence that social cognition targeted interventions may improve performance on 
particular tests in individuals with longer duration schizophrenia, it is unclear if a similar 
effect is apparent in FEP or ARMS participants. Moreover, the degree to which improving 
social cognition positively effects functioning and psychotic symptomatology is unclear at 
present. The current findings indicate that the relationship between social cognition, social 
functioning and psychotic symptoms in ARMS and FEP is small, and the clinical relevance 
of this relationship is unclear. Nevertheless, social cognitive targeted interventions may 
form part of multicomponent interventions to improve outcomes in ARMS and FEP.  
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Conclusions  
This meta-analytic study has demonstrated that better social cognitive 
performance is related to increased social functioning and lower psychotic 
symptomatology. Although the overall effect sizes were small, our findings were 
consistent in ARMS and FEP participants when a combined social cognition 
measure was used. The clinical utility of modulating social cognition to improve 
outcomes in ARMS and FEP participants has yet to be determined but studies in 
longer term schizophrenia suggest that improving ER or ToM may prove beneficial 
in enhancing recovery for these individuals. Finally, future studies are needed to 
delineate the influence of co-morbidity in ARMS participants, in addition to 
accounting for other important moderating factors.  
                                                                                                                                                    
 
122 
 
Chapter 4   
General Discussion  
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4.1. Overview and summary  
In this thesis, we have identified that the current evidence base supporting 
psychological therapy for improving social functioning in ARMS participants, or 
having developed a FEP, is limited. For ARMS participants, there is evidence that 
cognitive remediation therapy improves social functioning. Whilst in FEP, there is 
evidence that a number of different therapeutic approaches confer beneficial effects 
for social functioning. Further, in this thesis we have identified that social 
cognition is significantly, but differentially, depending on social cognitive sub 
domain, related to psychotic symptomatology and social functioning in ARMS and 
FEP participants. These findings add to a growing literature identifying the 
importance of social cognition in psychosis, and highlight where future effort 
should be focused to improve social functioning outcomes across the psychosis 
continuum.  
The importance of social cognition in functional outcomes, particularly 
social functioning, in psychosis has gained an increasing amount of attention in 
recent years (Pinkham et al., 2014). These developments owe much to the 
introduction of the Clinical Staging Model (McGorry et al., 2006), the view of 
psychosis or psychotic disorders as continuum of interrelated conditions (Guloksuz 
& van Os, 2018), and a shift in focus to prevention and early intervention. 
However, despite increased efforts to enhance outcomes for ARMS and FEP 
participants, the state of the current evidence base for psychological interventions 
to improve social functioning has not been subject to systematic analysis and 
synthesis. Moreover, whilst individual studies have reported the relationship 
between social cognition, psychotic symptoms and social functioning in ARMS and 
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FEP, this data had not yet been quantitatively synthesised to determine the size and 
direction of effect between these two factors.  
To this end, we conducted a systematic review of the literature to determine which 
psychological therapies had demonstrated efficacy in improving social functioning in 
ARMS and FEP. Furthermore, we conducted a meta-analysis of studies which have 
measured social cognition and social functioning, and provided correlational data, in 
ARMS and FEP. In Chapter 2, we identified that in ARMS participants there is evidence 
from two of three included studies that CRT therapy is effective in improving social 
functioning (Choi et al., 2017; Piskulic et al., 2015) with one study reporting a large effect 
size (g= 1.0; Choi et al., 2017). Group level effects for CBT interventions did not reach 
statistical significance indicating there is currently no evidence that CBT focused 
interventions had any beneficial effect for social functioning in ARMS participants. Effect 
sizes for CBT were small (g= -0.1 to 0.41). In contrast, three of five studies in FEP 
utilising a CBT model reported a beneficial effect in FEP participants studies (Fowler et 
al., 2018; Fowler et al., 2009; Jackson et al., 2008), with small effect sizes (g=0.39). Only 
one of three CRT studies (Lee et al., 2013) reported a beneficial outcome for social 
functioning in FEP participants with a small effect size (g=0.21). Two included 
multicomponent interventions (Penn et al., 2011; Petersen et al., 2005)  and service level 
interventions (Craig et al., 2014; Garety et al., 2006) reported a significant beneficial 
outcome for social functioning in FEP with small to moderate effect sizes (range: 0.29 to 
0.69). With the exception of two studies (Fowler et al., 2018; van der Gaag et al., 2012), 
the methodological quality was poor and risk of bias high across CBT, CRT, 
multicomponent and service level trials. As such, findings from these studies should be 
interpreted with caution.  
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In Chapter 3, our quantitative analysis identified some differential findings 
between ARMS and FEP participants in the relationship between social cognition, 
psychotic symptoms and social functioning. Better overall social cognitive 
performance, emotion recognition and ToM was associated with enhanced social 
functioning in ARMS and FEP participants, with small effect sizes in each group. 
For psychotic symptoms, findings were mixed between groups. In ARMS, better 
overall social cognitive performance was not significantly related to positive or 
negative symptoms. However, better emotion recognition performance was 
significantly related to lower negative symptoms in ARMS participants. In FEP, 
better emotion recognition and ToM performance were significantly associated 
with lower psychotic symptomatology. Effect sizes for the relationship between 
social cognition and psychotic symptoms were small in each meta-analysis. The 
strongest effect size was identified for the relationship between ToM and negative 
psychotic symptoms in FEP (r= -0.3).  Interestingly, we found no significant 
between group differences (ARMS versus FEP) in the overall effect sizes in each 
meta-analysis of the relationship between social cognition, and subdomains, social 
functioning and psychotic symptoms.  
 
4.2. Improving social functioning outcomes in psychosis: More trials or a 
new approach?  
The role for psychological therapy in psychosis is a topic which has resulted 
in significant controversy and debate over recent years (Jauhar et al., 2014; Lynch, 
Laws, & McKenna, 2010). Much of this debate has centred on the efficacy of 
psychological therapy, particularly CBT-p, in reducing psychotic symptomatology 
(Birchwood, Shiers, & Smith, 2014). While a full discussion of this debate is 
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beyond the scope of this thesis, it is suffice to say that there has been a change in our 
understanding of what constitutes ‘Recovery’ (Roberts & Boardman, 2013) and what 
outcomes should be the focus of psychological interventions.  
The empirical evidence reviewed above and in Chapter 2 supports that for FEP, 
there are effective treatments for improving social functioning. In ARMS participants, the 
evidence is limited to one CRT trial (Choi et al, 2017). As such, the current evidence 
indicates that for FEP, more trials utilising social recovery focused CBT within a 
multidisciplinary care context would lend greater support for this approach to be rolled out 
to the wider population (Roberts & Boardman, 2013). For ARMS participants, much work 
is still yet to be done. Considering current CBT approaches have not proved effective in 
improving social functioning, a new approach may be necessary. Replication of the results 
by Choi et al., (2017) is an important next step to determine the potential role for CRT. 
However, it appears that future trials of social recovery focused CBT, or a similar approach 
provided within a multidisciplinary care context, are a necessary next step in determining 
the best psychological intervention for improving social functioning in ARMS participants.  
 
4.3. Social cognitive impairments in psychosis: A viable therapeutic target 
to improve social functioning?  
Of the studies included in Chapter 2 for systematic synthesis, none specifically 
targeted social cognitive performance. One study utilised a CRT intervention which 
targeted different domains of neuropsychological function and social cognition in FEP 
participants (Fernandez-Gonzalo et al., 2015), but did not report a statistically significant 
effect on social functioning. As such, it is currently unclear if targeting social cognition in 
the earlier stages of psychosis has beneficial effects on social functioning. However, 
drawing on the literature in longer duration schizophrenia, there is reason to propose that 
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explicitly targeting social cognition should be a focus of future study. In longer 
duration schizophrenia, social cognitive remediation therapy has been shown to 
improve social cognitive performance, which was associated with improvements in 
social functioning. Thus applying the social cognitive remediation approaches 
already established with longer duration schizophrenia, to ARMS and FEP 
populations, may prove to be effective for improving both social cognitive 
performance and social functioning. Although these studies may be warranted, it is 
important to hold in mind that the overall effect sizes we identified in Chapter 3 in 
the relationship between social cognitive performance, psychotic symptoms and 
social functioning were small. The results presented in Chapter 3 certainly suggest 
that in ARMS and FEP participant’s social cognition is an important variable 
related social functioning, but not the only variable. As such, modulating social 
cognition may have only small effects on social functioning in ARMS and FEP. 
The question for future study is what impact a small change in social cognition and 
social functioning has for ARMS and FEP participants. Another important question 
that follows, is what other variables may be involved in the relationship between 
social cognition and social functioning? Important psychological variables that may 
mediate this relationship include meta-cognition (Bright et al., 2018), self-efficacy 
(Kurtz, Olfson, & Rose, 2013), and emotion regulation (Kimhy et al., 2016). Future 
studies should aim to test the mediating relationship of these variables in the 
relationship between social cognition and social functioning.  
 
4.4. Social cognition and social functioning: Issues with measurement 
A range of different measures of social cognition and social functioning are 
utilised in the literature with varying psychometric quality and validation which 
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may lead to a lack of accurate measurement, and the ability to meaningfully draw 
comparisons between individual studies. Indeed, the range of measures used in Chapter 2 
and 3 to measure social function and social cognition respectively, was broad, and this is 
an important consideration when interpreting these findings.  
The Social Cognition Psychometric Evaluation (SCOPE) study was designed to 
address the measurement issue in studies aiming to characterise and develop interventions, 
for social cognition in schizophrenia (Pinkham et al., 2014). This study had five phases; 1. 
Identify the core domains of social cognition in schizophrenia and the best existing 
measures of each domain through consultation with experts in this area; 2. Short list the 
best tasks within each domain based on expert consensus; 3. Determine the reliability and 
validity of each task in a sample of individuals diagnosed with schizophrenia; 5. Modify 
and re-test measures with poor psychometric quality; 5. Large validation study of final 
selected measures including determining the correlation with functional measures 
(Pinkham et al., 2014). The SCOPE study published the final phase of findings last year 
and produced a finalised list of social cognitive tests that have appropriate psychometric 
properties and are predictive of functional outcomes (Pinkham, Harvey, & Penn, 2018). As 
these recommendations have only recently been published, many of the studies included in 
Chapter 3 did not use measures as per these guidelines. Moving forward, it will be 
important that studies in ARMS and FEP participants follow the guidelines produced by 
the SCOPE study so that consistency can be achieved between studies, and accurate and 
replicable results can be produced.  
As discussed in Chapter 2, a wide of range of measures of social functioning are 
utilised in the literature. These measures vary based on whether they are clinician rated, 
self-report or performance based. Current psychometric data indicates that performance 
based measures such as the Social Skills Performance Assessment (SSPA), may be most 
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reliable and valid in assessing social functioning in psychosis (Patterson et al., 
2001). Indeed, the SCOPE study utilised the SSPA in each phase of this project. In 
addition, the investigators utilised the UCSD Performance-Based Skills 
Assessment, Brief (UPSA-B; Mausbach, Harvey, Goldman, Jeste, & Patterson, 
2007) and the informant reported Specific Level of Functioning Scale (SLOF; 
Schneider & Struening, 1983). Most studies measure social functioning using one 
approach; self-report, clinician rated or performance based. Self-report and 
clinician rated measures have the limitation of relying on memory recall and may 
be subject to a degree of recall bias (Coughlin, 1990). However, such measures 
tend to be quick and cost effective to administer. In contrast, performance based 
measures may provide a more accurate picture of real world functioning and are not 
limited by recall bias. Moreover, some such as the SSPA are short to administer 
(~12 minutes; Pinkham et al., 2018) but rely on an expert rater to code and score. 
Informant reported measures such as the SLOF may be an important adjunct to 
performance based measures. However, there may still be a degree of recall bias 
when using these measures and they rely on an available informant to complete the 
measure so will not be practical in all studies. The evidence reviewed in this thesis 
indicates that a measure, such as the Time Use Survey (TUS), which identifies 
average number of hours per week spent doing a range of structured activities 
might be more sensitive to intervention effects and may be more appropriate to 
what outcomes an individual may want to change when engaged in a therapeutic 
intervention (Hodgekins et al., 2015). Moreover, cut-off scores for clinical and non-
clinical samples have been identified for the TUS which increases its utility as a 
measure of social functioning (Hodgekins et al., 2015).  
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In summary, there is now a published battery of social cognitive tests along with 
psychometric data that should be used in future studies investigating social cognitive 
performance in ARMS and FEP participants. Social functioning measures have not been 
subject to such extensive validation and it would be pertinent that future research should 
aim to define the key domains of social functioning that are important for the psychosis 
continuum, which measures are best suited to characterise these domains, and which are 
reliable enough to show changes due therapeutic intervention.  
  
4.5. Limitations of the reported studies  
Whilst the studies reported in this thesis add novel and important information to the 
evidence base, there are a number of limitations that must be borne in mind when 
interpreting these findings. In Chapter 2, many different treatment modalities were used 
and the target of each intervention varied. As such, generalising from these studies is 
limited. Moreover, the methodological quality of many of the studies was poor and there 
was a high risk of bias. Only three included studies had social functioning as the primary 
outcome measure and many did not report a sample size calculation. As such, it is not clear 
if they were powered to detect an effect on social functioning. As discussed above, there 
was a variety of social functioning measures utilised across studies and standardisation of 
outcomes is a necessary future development.  
In Chapter 3 a wide range of social cognitive tests were used between studies, and 
as noted above, not all have been subject to full psychometric validation. Of the studies 
included in our meta-analysis, many did not report important data such as medication 
usage, neuropsychological function, duration of illness and co-morbid mental health 
diagnoses. As such, these factors could not be entered into the analysis as moderator 
variables. This is a significant limitation which should be addressed in future when a 
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sufficient number of studies have been conducted that report this additional data to 
determine the degree to which these factors explain between study variance. 
Nonetheless, it should be noted that the between study variance was generally small 
in each meta-analysis in Chapter 3 for FEP participants.  The total number of 
studies of ARMS studies in Chapter 3 was small and further analysis should be 
conducted when more studies are available to determine the consistency of the 
findings reported. In addition, we were unable to conduct an analysis of studies into 
social perception and attributional bias in Chapter 3, and this is an important goal 
once more data is available.  
 
4.6. Conclusions and Clinical Implications  
With the noted limitations in mind, our results nevertheless indicate that 
social functioning impairments in ARMS and FEP are amenable to psychological 
intervention. In addition, the results presented in this thesis indicate that better 
social cognition is significantly related to better social functioning and lower 
psychotic symptomatology. Regarding psychological interventions for social 
functioning, there is still much work to be done as studies specifically targeting 
social functioning in ARMS participants are currently non-existent. However, there 
is an ongoing multi-centre trial- the PRODIGY trial- which aims to determine the 
efficacy of Social Recovery CBT in young people with attenuated psychotic 
symptoms and complex mental health problems (Fowler et al., 2017). The results 
from this trial will be critical in determining if targeting social functioning in 
ARMS participants confers beneficial outcomes. If successful, this trial may lead to 
a wider implementation of Social Recovery CBT for young people identified as 
being ARMS for developing psychosis.  
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There is sufficient evidence from the analysis reported in Chapter 3 to establish a 
consistent, but small, relationship between social cognition, social functioning and 
psychotic symptomatology in ARMS and FEP. However, the clinical implications of this 
relationship are unclear at present. As an important next step, intervention trials which 
specifically target social cognition should be conducted to determine the magnitude of 
change in social functioning due to modulating social cognition. It is unlikely that the 
effects will be very large. However, social cognitive training may prove to be useful as an 
adjunct to other therapeutic approaches, such as Social Recovery CBT. The cost 
effectiveness of such approaches will of course play a major role in what becomes 
available for day to day clinical practice.  
Despite many important advances in recent decades in our understanding of 
psychosis and psychotic disorders, there is still much improvement to be made. The points 
discussed herein are important developments which should be undertaken to further 
expand the evidence base, with the ultimate aim of promoting the best possible outcomes 
for individuals along the psychosis continuum.  
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Appendix C  
Forrest plots for each meta-analysis in Chapter 3  
 
Overall Social Cognition and Social Functioning in ARMS and FEP 
A total of seven studies reported the correlation coefficient between at least 
one social cognitive measure and social functioning in ARMS participants (see 
Figure C1) which ranged from -0.062 to 0.177 with a significant (Z=2.443, 
p=0.015) positive pooled correlation coefficient of 0.118 (95% CI: 0.023 to 0.210,) 
indicating a small effect size. Heterogeneity between and within studies was very 
low (Q (6) = 2.458, p=0.873, I
2
=0%, Tau
2
= 0.00).     
A total of 14 studies reported the correlation coefficient between at least one 
social cognitive measure and social functioning in FEP participants (see Figure 
C1) with a range of 0.076 to 0.38 and a significant (Z=6.327, p<0.001) positive 
pooled correlation coefficient of 0.205 (95% CI: 0.143 to 0.266,) indicating a small 
to medium effect size. Heterogeneity of variance between studies was low (Q (13) 
= 7.448, p=0.878, I
2
=0%, Tau
2
= 0.00).     
The overall pooled correlation coefficient for ARMS and FEP studies 
combined was positive and significant at 0.178 (Z=6.607, p<0.001) indicating a 
small effect size with low heterogeneity (Q (20) = 12.251, p=0.907, I
2
=0%, Tau
2
= 
0.00). 
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Overall Social Cognition and Positive Psychotic Symptoms in ARMS and FEP 
A total of six studies reported the correlation coefficient between at least one social 
cognitive function test and positive psychotic symptoms in ARMS participants (see Figure 
C2). The range was from -0.01 to -0.427 with a non-significant (Z=-1.575, p=0.115) 
negative pooled correlation coefficient of -0.144 (95% CI: -0.315 to 0.035) indicating a 
small effect size. There was moderate between study heterogeneity (Q (5) = 12.141, 
p=0.033, I
2
=58.82%, Tau
2
= 0.025).     
A total of 15 studies reported the correlation coefficient between at least one social 
cognitive function test and positive psychotic symptoms in FEP participants (see Figure 
C2). The range was from -0.57 to 0.028 with a significant (Z=-5.036, p<0.001) positive 
pooled correlation coefficient of -0.178 (95% CI: -0.245 to -0.109) indicating a small effect 
Figure C1. Forest plot for meta-analysis of the strength (r) and direction of relationship 
between overall social cognition and social functioning in ARMS and FEP participants.   
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size. Heterogeneity of variance was very low (Q (15) = 13.405, p=0.571, I
2
=0%, 
Tau
2
= 0.00).   
The overall pooled correlation coefficient for ARMS and FEP studies 
combined was negative and significant at -0.173 (Z=-5.036, p<0.001) indicating a 
small effect size with low heterogeneity (Q (21) = 32.951, p=0.047, I
2
=36.268%, 
Tau
2
= 0.009).     
 
 
 
 
 
Overall Social Cognition and Negative Psychotic Symptoms in ARMS and FEP 
A total of four studies reported the correlation coefficient between at least 
one social cognitive functioning test and negative psychotic symptoms in ARMS 
Figure C2. Forest plot for meta-analysis of the strength (r) and direction of relationship 
between Overall social cognition and positive psychotic symptoms in ARMS and FEP 
participants.  
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participants (see Figure C3). The range was from -0.0425 to 0.042 with a non-significant 
(Z=-1.691, p=0.091) negative pooled correlation coefficient of -0.131 (95% CI: -0.277 to 
0.021) indicating a small effect size. There was low to moderate heterogeneity between  (Q 
(3) = 5.01, p=0.171, I
2
=40.11%, Tau
2
= 0.01).     
A total of 14 studies reported the correlation coefficient between emotion 
recognition performance and positive psychotic symptoms in FEP participants (see Figure 
C3). The range was from -0.5 to 0.04 with a significant (Z=-5.514, p<0.001) positive 
pooled correlation coefficient of -0.211 (95% CI: -0.282 to -0.137) indicating a small effect 
size. Heterogeneity of variance was very low (Q (13) = 16.086, p=0.245, I
2
=19.18%, 
Tau
2
= 0.004).     
The overall pooled correlation coefficient for ARMS and FEP studies combined 
was negative and significant at -0.195 (Z=-5.69, p<0.001) indicating a small effect size 
with low heterogeneity (Q (17) = 28.778, p=0.037, I
2
=40.927%, Tau
2
= 0.008). 
 
 
Figure C3. Forest plot for meta-analysis of the strength (r) and direction of relationship 
between Overall social cognition and negative psychotic symptoms in ARMS and FEP participants  
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Emotion Recognition  
Emotion Recognition and Social Functioning in ARMS and First Episode Psychosis 
A total of five studies reported the correlation coefficient between emotion 
recognition performance and social functioning in ARMS participants (see Figure 
C4). The range was from 0 to 0.181 with a significant (Z=2.571, p=0.01) positive 
pooled correlation coefficient of 0.131 (95% CI: 0.031 to 0.228) indicating a small 
effect size. Heterogeneity was very low (Q (4) = 1.651, p=0.8, I
2
=0%, Tau
2
= 0.00).     
A total of eight studies reported the correlation coefficient between emotion 
recognition performance and social functioning in FEP participants (see Figure 
C4). The range was from 0.154 to 0.31 with a significant (Z=5.3, p<0.001) positive 
pooled correlation coefficient of 0.222 (95% CI: 0.141 to 0.299,) indicating a small 
to medium effect size. Heterogeneity of variance was very low (Q (7) = 1.097, 
p=0.993, I
2
=0%, Tau
2
= 0.00).     
The overall pooled correlation coefficient for ARMS and FEP studies 
combined was positive and significant at 0.185 (Z=5.721, p<0.001) indicating a 
small effect size with low heterogeneity (Q (12) = 4.728, p=0.966, I
2
=0%, Tau
2
= 
0.00). 
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Emotion Recognition and Positive Psychotic Symptoms in ARMS and FEP 
A total of four studies reported the correlation coefficient between emotion 
recognition performance and positive psychotic symptoms in ARMS participants (see 
Figure C5). The range was from -0.427 to -0.01 to with a non-significant (Z=-1.575, 
p=0.115) negative pooled correlation coefficient of -0.144 (95% CI: -0.315 to 0.035) 
indicating a small effect size. There was moderate heterogeneity between studies  (Q (5) = 
12.141, p=0.033, I
2
=58.82%, Tau
2
= 0.025).     
A total of eight studies reported the correlation coefficient between emotion 
recognition performance and positive psychotic symptoms in FEP participants (see Figure 
C5). The range was from -0.433 to 0.028 with a significant (Z=-4.633, p<0.001) positive 
pooled correlation coefficient of -0.166 (95% CI: -0.234 to 0.069) indicating a small effect 
size. Heterogeneity of variance was very low (Q (14) = 8.914, p=0.836, I
2
=0%, Tau
2
= 
0.00).   
Figure C4. Forest plot for meta-analysis of the strength (r) and direction of relationship 
between emotion recognition and social functioning in ARMS and FEP participants  
 
                                                                                                                                                    
 
181 
 
The overall pooled correlation coefficient for ARMS and FEP studies 
combined was negative and significant at -0.163 (Z=-4.888, p<0.001) indicating a 
small effect size with low heterogeneity (Q (20) = 27.068, p=0.133, I
2
=26.11%, 
Tau
2
= 0.005).     
 
 
 
 
 
Emotion Recognition and Negative Psychotic Symptoms in ARMS and FEP 
A total of four studies reported the correlation coefficient between emotion 
recognition performance and negative psychotic symptoms in ARMS participants 
(see Figure C6). The range was from -0.07 to 0.393 with a significant (Z=-2.317, 
p=0.021) negative pooled correlation coefficient of -0.11 (95% CI: -0.201 to -
0.017) indicating a small effect size with low heterogeneity   (Q (3) = 3.64, 
p=0.303, I
2
=17.59%, Tau
2
= 0.002).     
Figure C5. Forest plot for meta-analysis of the strength (r) and direction of relationship 
between emotion recognition and positive psychotic symptoms in ARMS and FEP 
participants  
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A total of nine studies reported the correlation coefficient between emotion 
recognition performance and negative psychotic symptoms in FEP participants (see Figure 
C6). The range was from -0.355 to 0.04 with a significant (Z=-5.465, p<0.001) negative 
pooled correlation coefficient of -0.211 (95% CI: -0.283 to -0.137) indicating a small effect 
size. Heterogeneity of variance was low (Q (8) = 6.086, p=0.638, I
2
=0%, Tau
2
= 0.00).     
The overall pooled correlation coefficient for at risk and FEP studies combined was 
negative and significant at –0.17 (Z=-5.69, p<0.001) indicating a small effect size with low 
heterogeneity (Q (12) = 14.716, p=0.257, I
2
=18.454%, Tau
2
= 0.002).  
 
 
 
 
 
 
 
 
Figure C6. Forest plot for meta-analysis of the strength (r) and direction of relationship 
between emotion recognition and negative psychotic symptoms in ARMS and FEP 
participants  
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Theory of Mind 
Theory of Mind and Social Functioning in ARMS and FEP  
A total of four studies reported the correlation coefficient between theory of 
mind performance and social functioning in ARMS participants (see Figure C7). 
The range was from -0.062 to 0.369 with a significant (Z=2.571, p=0.01) positive 
pooled correlation coefficient of 0.178 (95% CI: 0.043 to 0.306) indicating a small 
effect size. Heterogeneity was very low (Q (3) = 2.134, p=0.545, I
2
=0%, Tau
2
= 
0.00).     
A total of 10 studies reported the correlation coefficient between theory of 
mind performance and social functioning in FEP participants (see Figure C7). The 
range was from 0.04 to 0.45 with a significant (Z=5.72, p<0.001) positive pooled 
correlation coefficient of 0.208 (95% CI: 0.138 to 0.276,) indicating a small to 
medium effect size. Heterogeneity of variance was very low (Q (9) = 8.262, 
p=0.508, I
2
=0%, Tau
2
= 0.00).     
The overall pooled correlation coefficient for ARMS and FEP studies 
combined was positive and significant at 0.201 (Z=6.258, p<0.001) indicating a 
small effect size with low heterogeneity (Q (13) = 10.552, p=0.648, I
2
=0%, Tau
2
= 
0.00) 
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Theory of Mind and Positive Psychotic Symptoms in ARMS and FEP 
A total of three studies reported the correlation coefficient between theory of mind 
performance and positive psychotic symptoms in ARMS participants (see Figure C8). The 
range was from -0.427 to 0.415 with a non-significant (Z=0.187, p=0.851) negative pooled 
correlation coefficient of 0.033 (95% CI: -0.301 to 0.36) indicating a small effect size. 
There was low to moderate heterogeneity of variance (Q (2) = 3.991, p=0.136, 
I
2
=49.882%, Tau
2
= 0.051).     
A total of eight studies reported the correlation coefficient between theory of mind 
performance and positive psychotic symptoms in FEP participants (See Figure C8). The 
range was from -0.57 to 0.01 with a significant (Z=-3.547, p<0.001) positive pooled 
correlation coefficient of -0.189 (95% CI: -0.288 to -0.085) indicating a small effect size. 
Heterogeneity of variance very low (Q (7) =7.843, p=0.347, I
2
=10.74%, Tau
2
= 0.003).     
Figure C7. Forest plot for meta-analysis of the strength (r) and direction of relationship 
between Theory of Mind and social functioning in ARMS and FEP participants  
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The overall pooled correlation coefficient for ARMS and FEP studies 
combined was negative and significant at -0.17 (Z=-3.337, p=0.001) indicating a 
small effect size with moderate heterogeneity (Q (10) = 25.703, p=0.004, 
I
2
=61.09%, Tau
2
= 0.022). 
 
     
 
Theory of Mind and Negative Psychotic Symptoms in ARMS and FEP 
A total of five studies reported the correlation coefficient between theory of 
mind performance and negative psychotic symptoms in FEP participants (see 
Figure C9). The range was from -0.365 to -0.035 with a significant (Z=-5.555, 
p<0.001) negative pooled correlation coefficient of -0.3 (95% CI: -0.396 to -0.198) 
indicating a small effect size. Heterogeneity of variance was low (Q (4) = 4.389, 
p=0.356, I
2
=8.87%, Tau
2
= 0.002).     
Figure C8. Forest plot for meta-analysis of the strength (r) and direction of relationship 
between theory of mind and positive psychotic symptoms in ARMS and FEP participants  
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Figure C9. Forest plot for meta-analysis of the strength (r) and direction of relationship 
between theory of mind and negative psychotic symptoms in FEP participants  
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Appendix D 
Risk of bias analysis and funnel plots from Chapter 3.  
 
Risk of Bias for studies investigating overall social cognition and social functioning in 
ARMS and FEP 
The trim and fill method for studies investigating overall social cognition 
and social functioning in ARMS participants indicated three potentially missing 
studies that would need to fall to the right of the mean to make the funnel plot 
symmetrical (see Figure D1). Assuming a random-effects model, the new pooled 
correlation coefficient increased to 0.149 (95 CI: 0.064 to 0.233).  
The trim and fill method for studies investigating overall social cognition 
and social functioning in participants with FEP indicated three potentially missing 
studies that would have to fall to the left of the pooled mean to make the funnel plot 
symmetrical (see Figure D2). Assuming a random effects model, the new pooled 
correlation coefficient decreased to 0.187 (95% CI: 0.127 to 0.246).  
 
 
Figure D1. Risk of bias funnel plot for meta-analysis of the relationship between 
overall social cognition and social functioning in ARMS participants 
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Risk of Bias for studies investigating overall social cognition and positive psychotic 
symptoms in ARMS and FEP 
The trim and fill method for studies investigating overall social cognition and 
positive psychotic symptoms in ARMS participants indicated one potentially missing study 
that would need to fall to the right of the mean to make the funnel plot symmetrical (see 
Figure D3). Assuming a random-effects model, the new pooled correlation coefficient 
decreased to -0.114 (95 CI: -0.284 to -0.062). The trim and fill method for studies 
investigating overall social cognition and positive psychotic symptoms in participants with 
FEP indicated one potentially missing study that would have to fall to the right of the 
pooled mean to make the funnel plot symmetrical (see Figure D4). Assuming a random 
effects model, the new pooled correlation coefficient decreased to -0.157 (95% CI: -0.224 
to -0.088).  
Figure D2. Risk of bias funnel plot for meta-analysis of the relationship between social 
cognition and overall social functioning in FEP participants 
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Figure D3. Risk of bias funnel plot for meta-analysis of the relationship between overall 
social cognition and positive psychotic symptoms in ARMS participants 
Figure D4. Risk of bias funnel plot for meta-analysis of the relationship between overall 
social cognition and positive psychotic symptoms in FEP participants 
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Risk of Bias for studies investigating overall social cognition and negative psychotic 
symptoms in ARMS and FEP 
The trim and fill method for studies investigating overall social cognition and 
negative psychotic symptoms in ARMS participants indicated one potentially missing 
study that would need to fall to the left of the mean to make the funnel plot symmetrical 
(see Figure D5). Assuming a random-effects model, the new pooled correlation coefficient 
decreased to -0.124 (95 CI: -0.245 to -0.00003). The trim and fill method for studies 
investigating overall social cognition and negative psychotic symptoms in participants with 
FEP indicated four potentially missing study that would have to fall to the left of the 
pooled mean to make the funnel plot symmetrical (see Figure D6). Assuming a random 
effects model, the new pooled correlation coefficient increased to -0.257 (95% CI: -0.334 
to -0.176).  
 
 
 
Figure D5. Risk of bias funnel plot for meta-analysis of the relationship between overall 
social cognition and negative psychotic symptoms in ARMS participants 
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Risk of Bias for studies investigating emotion recognition and social functioning in ARMS 
and FEP 
The trim and fill method for studies investigating emotion recognition and 
social functioning in ARMS participants indicated one potentially missing study 
that would need to fall to the right of the mean to make the funnel plot symmetrical 
(see Figure D7). Assuming a random-effects model, the new pooled correlation 
coefficient increased to 0.146 (95 CI: 0.031 to 0.052). The trim and fill method for 
studies investigating emotion recognition and social functioning in participants 
with FEP indicated two potentially missing studies that would have to fall to the 
left of the pooled mean to make the funnel plot symmetrical (see Figure D8). 
Assuming a random effects model, the new pooled correlation coefficient 
decreased to 0.211 (95% CI: 0.134 to 0.285).  
Figure D6. Risk of bias funnel plot for meta-analysis of the relationship between overall 
social cognition and negative psychotic symptoms in FEP participants 
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Figure D7. Risk of bias funnel plot for meta-analysis of the relationship between emotion 
recognition and social functioning in ARMS participants 
Figure D8. Risk of bias funnel plot for meta-analysis of the relationship between emotion 
recognition and social functioning in FEP participants 
                                                                                                                                                    
 
193 
 
Risk of Bias for studies investigating emotion recognition and positive psychotic symptoms 
in ARMS and FEP 
The trim and fill method for studies investigating emotion recognition 
performance and positive psychotic symptoms in ARMS participants indicated two 
potentially missing study that would need to fall to the right of the mean to make 
the funnel plot symmetrical (see Figure D9). Assuming a random-effects model, 
the new pooled correlation coefficient decreased to -0.055 (95 CI: -0.02 to -0.096). 
The trim and fill method for studies investigating emotion recognition performance 
and positive psychotic symptoms in participants with FEP indicated one potentially 
missing study that would have to fall to the right of the pooled mean to make the 
funnel plot symmetrical (see Figure D10). Assuming a random effects model, the 
new pooled correlation coefficient decreased to -0.177 (95% CI: -0.268 to -0.082).  
 
 
 
Figure D9. Risk of bias funnel plot for meta-analysis of the relationship between emotion 
recognition and positive psychotic symptoms in ARMS participants 
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Risk of Bias for studies investigating emotion recognition and negative psychotic symptoms 
in ARMS and FEP 
The trim and fill method for studies investigating emotion recognition performance 
and negative psychotic symptoms in ARMS participants indicated one potentially missing 
study that would need to fall to the left of the mean to make the funnel plot symmetrical 
(see Figure D11). Assuming a random-effects model, the new pooled correlation 
coefficient decreased to -0.102 (95 CI: -0.163 to -0.041). The trim and fill method for 
studies investigating social cognition and negative psychotic symptoms in participants with 
FEP indicated three potentially missing studies that would have to fall to the left of the 
pooled mean to make the funnel plot symmetrical (see Figure D12). Assuming a random 
effects model, the new pooled correlation coefficient increased to -0.237 (95% CI: -0.305 
to -0.167).  
 
Figure D10. Risk of bias funnel plot for meta-analysis of the relationship between emotion 
recognition and positive psychotic symptoms in FEP participants 
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Figure D11. Risk of bias funnel plot for meta-analysis of the relationship between emotion 
recognition and negative psychotic symptoms in ARMS participants 
Figure D12. Risk of bias funnel plot for meta-analysis of the relationship between emotion 
recognition and negative psychotic symptoms in FEP participants 
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Risk of Bias for studies investigating theory of mind and social functioning in at risk and 
FEP 
 
The trim and fill method for studies investigating theory of mind and social 
functioning in ARMS participants indicated one potentially missing study that would need 
to fall to the right of the mean to make the funnel plot symmetrical (see Figure D13). 
Assuming a random-effects model, the new pooled correlation coefficient increased to 
0.191 (95 CI: 0.059 to 0.315). The trim and fill method for studies investigating theory of 
mind and social functioning in participants with FEP indicated one potentially missing 
study that would have to fall to the left of the pooled mean to make the funnel plot 
symmetrical (see Figure D14). Assuming a random effects model, the new pooled 
correlation coefficient decreased to 0.198 (95% CI: 0.126 to 0.269).  
 
 
 
Figure D13. Risk of bias funnel plot for meta-analysis of the relationship between 
theory of mind and social functioning in ARMS participants 
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Risk of Bias for studies investigating theory of mind and positive psychotic symptoms in 
ARMS and FEP 
The trim and fill method for studies investigating theory of mind 
performance and positive psychotic symptoms in ARMS participants indicated zero 
potentially missing studies to make the funnel plot symmetrical (see Figure D15). 
The trim and fill method for studies investigating theory of mind performance and 
positive psychotic symptoms in participants with FEP indicated two potentially 
missing study that would have to fall to the right of the pooled mean to make the 
funnel plot symmetrical (see Figure D16). Assuming a random effects model, the 
new pooled correlation coefficient decreased to -0.141 (95% CI: -0.274 to -0.004).  
 
Figure D14. Risk of bias funnel plot for meta-analysis of the relationship between 
theory of mind and social functioning in FEP participants 
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Figure D15. Risk of bias funnel plot for the relationship between theory of mind and 
positive psychotic symptoms in ARMS participants 
Figure D16. Risk of bias funnel plot for meta-analysis of the relationship between theory 
of mind and positive psychotic symptoms in FEP participants 
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Risk of Bias for studies investigating theory of mind and negative psychotic symptoms in 
ARMS and FEP 
The trim and fill method for studies investigating social cognition and 
negative psychotic symptoms in participants with FEP indicated two potentially 
missing studies that would have to fall to the left of the pooled mean to make the 
funnel plot symmetrical (see Figure D17). Assuming a random effects model, the 
new pooled correlation coefficient increased to -0.334 (95% CI: -0.445 to -0.213).  
 
 
 
 
 
 
 
Figure D17. Risk of bias funnel plot for meta-analysis of the relationship between theory of 
mind and negative psychotic symptoms in FEP participants 
